{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "07",
                "@timestamp": "2023-09-07T08:11:49.000049-04:00",
                "@year": "2023",
                "@month": "09"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2019",
                "@month": "01"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding-addon-generated-timestamp": "2021-05-29T19:47:06.246Z",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Singapore",
                            "@afid": "60017958",
                            "@country": "sgp",
                            "organization": [
                                {"$": "Department of Gastroenterology and Hepatology"},
                                {"$": "Singapore General Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60017958",
                                "@dptid": "112811698"
                            },
                            "@affiliation-instance-id": "2010748563-a0256f217ba8b0630dd30efe2a35a43a",
                            "ce:source-text": "Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore",
                            "@dptid": "112811698"
                        },
                        "author": [{
                            "ce:given-name": "Choon Jin",
                            "preferred-name": {
                                "ce:given-name": "Choon Jin",
                                "ce:initials": "C.J.",
                                "ce:surname": "Ooi",
                                "ce:indexed-name": "Ooi C.J."
                            },
                            "@author-instance-id": "2010748563-3953193312a5d555e23148af092d93e2",
                            "@seq": "1",
                            "ce:initials": "C.J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Ooi",
                            "@auid": "57200088391",
                            "@orcid": "0000-0001-8961-5455",
                            "ce:indexed-name": "Ooi C.J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Singapore",
                            "@afid": "60095034",
                            "@country": "sgp",
                            "organization": {"$": "Duke-NUS Medical School"},
                            "affiliation-id": {"@afid": "60095034"},
                            "@affiliation-instance-id": "2010748563-3cda1979f57edcc5d6dbbe634db6569b",
                            "ce:source-text": "Duke-NUS Medical School, Singapore"
                        },
                        "author": [
                            {
                                "ce:given-name": "Choon Jin",
                                "preferred-name": {
                                    "ce:given-name": "Choon Jin",
                                    "ce:initials": "C.J.",
                                    "ce:surname": "Ooi",
                                    "ce:indexed-name": "Ooi C.J."
                                },
                                "@author-instance-id": "2010748563-3953193312a5d555e23148af092d93e2",
                                "@seq": "1",
                                "ce:initials": "C.J.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Ooi",
                                "@auid": "57200088391",
                                "@orcid": "0000-0001-8961-5455",
                                "ce:indexed-name": "Ooi C.J."
                            },
                            {
                                "ce:given-name": "Khoon Lin",
                                "preferred-name": {
                                    "ce:given-name": "Khoon Lin",
                                    "ce:initials": "K.L.",
                                    "ce:surname": "Ling",
                                    "ce:indexed-name": "Ling K.L."
                                },
                                "@author-instance-id": "2010748563-39afd255af6b54f196acb5a1a488322b",
                                "@seq": "13",
                                "ce:initials": "K.L.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Ling",
                                "@auid": "7102763009",
                                "ce:indexed-name": "Ling K.L."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Malaysia",
                            "@afid": "60013665",
                            "@country": "mys",
                            "city": "Kuala Lumpur",
                            "organization": [
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "University Malaya Medical Centre"}
                            ],
                            "affiliation-id": {
                                "@afid": "60013665",
                                "@dptid": "112792260"
                            },
                            "@affiliation-instance-id": "2010748563-dbd27819305d3b44bc7993505d9739f5",
                            "ce:source-text": "Department of Medicine, Faculty of Medicine, University Malaya Medical Centre, Kuala Lumpur, Malaysia",
                            "@dptid": "112792260"
                        },
                        "author": [{
                            "ce:given-name": "Ida",
                            "preferred-name": {
                                "ce:given-name": "Ida",
                                "ce:initials": "I.",
                                "ce:surname": "Hilmi",
                                "ce:indexed-name": "Hilmi I."
                            },
                            "@author-instance-id": "2010748563-94c9680e94f5d0ebc6b18b1cba916e88",
                            "@seq": "2",
                            "ce:initials": "I.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Hilmi",
                            "@auid": "12780634900",
                            "@orcid": "0000-0001-7091-0032",
                            "ce:indexed-name": "Hilmi I."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "India",
                            "@afid": "60016172",
                            "@country": "ind",
                            "city": "New Delhi",
                            "organization": {"$": "Asian Institute of Gastroenterology"},
                            "affiliation-id": {"@afid": "60016172"},
                            "@affiliation-instance-id": "2010748563-292beef3500850bd7ae470f053c375ce",
                            "ce:source-text": "Asian Institute of Gastroenterology, New Delhi, India"
                        },
                        "author": [{
                            "ce:given-name": "Rupa",
                            "preferred-name": {
                                "ce:given-name": "Rupa",
                                "ce:initials": "R.",
                                "ce:surname": "Banerjee",
                                "ce:indexed-name": "Banerjee R."
                            },
                            "@author-instance-id": "2010748563-9bacbc4c44db497546968d15bee4ed54",
                            "@seq": "3",
                            "ce:initials": "R.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Banerjee",
                            "@auid": "8976969300",
                            "ce:indexed-name": "Banerjee R."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Singapore",
                            "@afid": "60007189",
                            "@country": "sgp",
                            "organization": {"$": "Gleneagles Medical Centre"},
                            "affiliation-id": {"@afid": "60007189"},
                            "@affiliation-instance-id": "2010748563-44efe95a9aa37647d44d9e8fc85681c1",
                            "ce:source-text": "Gleneagles Medical Centre, Singapore"
                        },
                        "author": [{
                            "ce:given-name": "Sai Wei",
                            "preferred-name": {
                                "ce:given-name": "Sai Wei",
                                "ce:initials": "S.W.",
                                "ce:surname": "Chuah",
                                "ce:indexed-name": "Chuah S.W."
                            },
                            "@author-instance-id": "2010748563-d673be3970c334cd1bce52304a6c08b2",
                            "@seq": "4",
                            "ce:initials": "S.W.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Chuah",
                            "@auid": "55659296200",
                            "ce:indexed-name": "Chuah S.W."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Hong Kong",
                            "@afid": "60002798",
                            "@country": "hkg",
                            "organization": [
                                {"$": "Department of Medicine and Therapeutics"},
                                {"$": "The Chinese University of Hong Kong"}
                            ],
                            "affiliation-id": {
                                "@afid": "60002798",
                                "@dptid": "113324909"
                            },
                            "@affiliation-instance-id": "2010748563-831a6c2334bd812e20f708ca3a8be775",
                            "ce:source-text": "Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong",
                            "@dptid": "113324909"
                        },
                        "author": [{
                            "ce:given-name": "Siew Chien",
                            "preferred-name": {
                                "ce:given-name": "Siew Chien",
                                "ce:initials": "S.C.",
                                "ce:surname": "Ng",
                                "ce:indexed-name": "Ng S.C."
                            },
                            "@author-instance-id": "2010748563-910bc0b35c6924644374a59ebbf21cd7",
                            "@seq": "5",
                            "ce:initials": "S.C.",
                            "@date-locked": "2023-08-26T11:44:57.228",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Ng",
                            "@auid": "16319816500",
                            "ce:indexed-name": "Ng S.C."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Taiwan",
                            "@afid": "60073385",
                            "@country": "twn",
                            "city": "Taipei",
                            "organization": [
                                {"$": "Department of Internal Medicine"},
                                {"$": "National Taiwan University Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60073385",
                                "@dptid": "112649795"
                            },
                            "@affiliation-instance-id": "2010748563-9e69c362e99732c9202982ee3daa96da",
                            "ce:source-text": "Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan",
                            "@dptid": "112649795"
                        },
                        "author": [
                            {
                                "ce:given-name": "Shu Chen",
                                "preferred-name": {
                                    "ce:given-name": "Shu Chen",
                                    "ce:initials": "S.C.",
                                    "ce:surname": "Wei",
                                    "ce:indexed-name": "Wei S.C."
                                },
                                "@author-instance-id": "2010748563-4943a05ab2f207814e26baed0535b10a",
                                "@seq": "6",
                                "ce:initials": "S.C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Wei",
                                "@auid": "7401765271",
                                "ce:indexed-name": "Wei S.C."
                            },
                            {
                                "ce:given-name": "Vineet",
                                "preferred-name": {
                                    "ce:given-name": "Vineet",
                                    "ce:initials": "V.",
                                    "ce:surname": "Ahuja",
                                    "ce:indexed-name": "Ahuja V."
                                },
                                "@author-instance-id": "2010748563-cf21b5bce0b673a76cc694b6a82c347b",
                                "@seq": "15",
                                "ce:initials": "V.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Ahuja",
                                "@auid": "24176922100",
                                "ce:indexed-name": "Ahuja V."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "India",
                            "@afid": "60009790",
                            "@country": "ind",
                            "city": "New Delhi",
                            "organization": [
                                {"$": "Department of Gastroenterology and Human Nutrition"},
                                {"$": "All India Institute of Medical Sciences"}
                            ],
                            "affiliation-id": {
                                "@afid": "60009790",
                                "@dptid": "103532294"
                            },
                            "@affiliation-instance-id": "2010748563-b553f7167b7c80f186b50128f3959c91",
                            "ce:source-text": "Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India",
                            "@dptid": "103532294"
                        },
                        "author": [{
                            "ce:given-name": "Govind K",
                            "preferred-name": {
                                "ce:given-name": "Govind K.",
                                "ce:initials": "G.K.",
                                "ce:surname": "Makharia",
                                "ce:indexed-name": "Makharia G.K."
                            },
                            "@author-instance-id": "2010748563-465241b4deb5c93a4a29b2bc5241b715",
                            "@seq": "7",
                            "ce:initials": "G.K.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Makharia",
                            "@auid": "6701885809",
                            "ce:indexed-name": "Makharia G.K."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "122799584",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Gastroenterology and Hepatology"},
                                {"$": "Bumrungrad International University"}
                            ],
                            "affiliation-id": {
                                "@afid": "122799584",
                                "@dptid": "125712544"
                            },
                            "@affiliation-instance-id": "2010748563-65f5491b6057bc3d59f701cdc7a51ee2",
                            "ce:source-text": "Gastroenterology and Hepatology, Bumrungrad International University, Bangkok, Thailand",
                            "@dptid": "125712544"
                        },
                        "author": [{
                            "ce:given-name": "Pises",
                            "preferred-name": {
                                "ce:given-name": "Pises",
                                "ce:initials": "P.",
                                "ce:surname": "Pisespongsa",
                                "ce:indexed-name": "Pisespongsa P."
                            },
                            "@author-instance-id": "2010748563-0116a1037bc0b8fa823053cf80746774",
                            "@seq": "8",
                            "ce:initials": "P.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Pisespongsa",
                            "@auid": "15846592300",
                            "ce:indexed-name": "Pisespongsa P."
                        }]
                    },
                    {
                        "affiliation": {
                            "@afid": "60021182",
                            "city": "Guangzhou",
                            "organization": [
                                {"$": "Division of Gastroenterology"},
                                {"$": "The First University Hospital"},
                                {"$": "Sun Yat-sen University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60021182",
                                "@dptid": "100257051"
                            },
                            "@affiliation-instance-id": "2010748563-149dc384157260de45aed69cf0411e58",
                            "ce:source-text": "Division of Gastroenterology, The First University Hospital, Sun Yat-sen University, Guangzhou",
                            "@dptid": "100257051"
                        },
                        "author": [{
                            "ce:given-name": "Min Hu",
                            "preferred-name": {
                                "ce:given-name": "Min Hu",
                                "ce:initials": "M.H.",
                                "ce:surname": "Chen",
                                "ce:indexed-name": "Chen M.H."
                            },
                            "@author-instance-id": "2010748563-27434eef6a6c2b9a9768c71864a1c434",
                            "@seq": "9",
                            "ce:initials": "M.H.",
                            "@date-locked": "2022-04-23T19:13:02.368",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Chen",
                            "@auid": "8642044500",
                            "ce:indexed-name": "Chen M.H."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60082819",
                            "@country": "chn",
                            "city": "Shanghai",
                            "organization": [
                                {"$": "Department of Gastroenterology and Hepatology"},
                                {"$": "Renji Hospital"},
                                {"$": "School of Medicine"},
                                {"$": "Shanghai Jiao Tong University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60082819",
                                    "@dptid": "115300604"
                                },
                                {"@afid": "60087536"},
                                {"@afid": "60025084"}
                            ],
                            "@affiliation-instance-id": "2010748563-930efd6513fe979ab7e812a320d6f147",
                            "ce:source-text": "Department of Gastroenterology and Hepatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China",
                            "@dptid": "115300604"
                        },
                        "author": [{
                            "ce:given-name": "Zhi Hua",
                            "preferred-name": {
                                "ce:given-name": "Zhi Hua",
                                "ce:initials": "Z.H.",
                                "ce:surname": "Ran",
                                "ce:indexed-name": "Ran Z.H."
                            },
                            "@author-instance-id": "2010748563-12bb61a5e79506e1e11b527cc66f4329",
                            "@seq": "10",
                            "ce:initials": "Z.H.",
                            "@date-locked": "2021-06-05T22:27:25.139",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Ran",
                            "@auid": "7003301114",
                            "ce:indexed-name": "Ran Z.H."
                        }]
                    },
                    {
                        "affiliation": {
                            "@afid": "60006240",
                            "city": "Seoul",
                            "organization": [
                                {"$": "Department of Gastroenterology and IBD Center"},
                                {"$": "University of Ulsan College of Medicine"}
                            ],
                            "affiliation-id": {
                                "@afid": "60006240",
                                "@dptid": "122801224"
                            },
                            "@affiliation-instance-id": "2010748563-14c971107f986ca8cd3a1a4d01245fe6",
                            "ce:source-text": "Department of Gastroenterology and IBD Center, University of Ulsan College of Medicine, Seoul",
                            "@dptid": "122801224"
                        },
                        "author": [{
                            "ce:given-name": "Byong Duk",
                            "preferred-name": {
                                "ce:given-name": "Byong Duk",
                                "ce:initials": "B.D.",
                                "ce:surname": "Ye",
                                "ce:indexed-name": "Ye B.D."
                            },
                            "@author-instance-id": "2010748563-c10071d55127eb59f702c761f0908b52",
                            "@seq": "11",
                            "ce:initials": "B.D.",
                            "@date-locked": "2021-07-05T06:19:36.312",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Ye",
                            "@auid": "14069472300",
                            "ce:indexed-name": "Ye B.D."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "@afid": "60016329",
                            "@country": "kor",
                            "city": "Seoul",
                            "organization": [
                                {"$": "Department of Internal Medicine"},
                                {"$": "Kangbuk Samsung Hospital"},
                                {"$": "Sungkyunkwan University School of Medicine"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60016329",
                                    "@dptid": "107891966"
                                },
                                {"@afid": "60010484"}
                            ],
                            "@affiliation-instance-id": "2010748563-599577ffa2588e630039cc6c806b5777",
                            "ce:source-text": "Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea",
                            "@dptid": "107891966"
                        },
                        "author": [{
                            "ce:given-name": "Dong Il",
                            "preferred-name": {
                                "ce:given-name": "Dong Il",
                                "ce:initials": "D.I.",
                                "ce:surname": "Park",
                                "ce:indexed-name": "Park D.I."
                            },
                            "@author-instance-id": "2010748563-703bfd2d8a78a9289fe2837ab9f055af",
                            "@seq": "12",
                            "ce:initials": "D.I.",
                            "@date-locked": "2021-08-09T13:56:58.745",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Park",
                            "@auid": "56524839700",
                            "ce:indexed-name": "Park D.I."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Singapore",
                            "@afid": "60031325",
                            "@country": "sgp",
                            "organization": [
                                {"$": "Division of Gastroenterology and Hepatology"},
                                {"$": "National University Hospital of Singapore"},
                                {"$": "University Medicine Cluster"}
                            ],
                            "affiliation-id": {
                                "@afid": "60031325",
                                "@dptid": "113192340"
                            },
                            "@affiliation-instance-id": "2010748563-6f7a6d58d02b02fae97d40ec0116bc6b",
                            "ce:source-text": "Division of Gastroenterology and Hepatology, National University Hospital of Singapore, University Medicine Cluster, Singapore",
                            "@dptid": "113192340"
                        },
                        "author": [{
                            "ce:given-name": "David",
                            "preferred-name": {
                                "ce:given-name": "David",
                                "ce:initials": "D.",
                                "ce:surname": "Ong",
                                "ce:indexed-name": "Ong D."
                            },
                            "@author-instance-id": "2010748563-d9d37ce889d1984cab23c93a7f06d38e",
                            "@seq": "14",
                            "ce:initials": "D.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Ong",
                            "@auid": "56013316700",
                            "ce:indexed-name": "Ong D."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Malaysia",
                            "@afid": "60029157",
                            "@country": "mys",
                            "city": "Kuala Lumpur",
                            "organization": {"$": "University of Malaya Specialist Centre"},
                            "affiliation-id": {"@afid": "60029157"},
                            "@affiliation-instance-id": "2010748563-65989d5634036c92ec39ac26b5a4523e",
                            "ce:source-text": "University of Malaya Specialist Centre, Kuala Lumpur, Malaysia"
                        },
                        "author": [{
                            "ce:given-name": "Khean Lee",
                            "preferred-name": {
                                "ce:given-name": "Khean Lee",
                                "ce:initials": "K.L.",
                                "ce:surname": "Goh",
                                "ce:indexed-name": "Goh K.L."
                            },
                            "@author-instance-id": "2010748563-d1aa83aa83daddeb16390b9009bf4418",
                            "@seq": "16",
                            "ce:initials": "K.L.",
                            "@date-locked": "2022-09-23T11:04:57.450",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Goh",
                            "@auid": "7201860992",
                            "ce:indexed-name": "Goh K.L."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Philippines",
                            "@afid": "60071488",
                            "@country": "phl",
                            "city": "Manila",
                            "organization": [
                                {"$": "Department of Medicine"},
                                {"$": "University of Santo Tomas"}
                            ],
                            "affiliation-id": {
                                "@afid": "60071488",
                                "@dptid": "104791421"
                            },
                            "@affiliation-instance-id": "2010748563-b7fdeece7c295cc0983a0898301eee95",
                            "ce:source-text": "Department of Medicine, University of Santo Tomas, Manila, Philippines",
                            "@dptid": "104791421"
                        },
                        "author": [
                            {
                                "ce:given-name": "Jose",
                                "preferred-name": {
                                    "ce:given-name": "Jose",
                                    "ce:initials": "J.",
                                    "ce:surname": "Sollano",
                                    "ce:indexed-name": "Sollano J."
                                },
                                "@author-instance-id": "2010748563-8a3a345d5caa68bd1d0d7f2b0b7689d1",
                                "@seq": "17",
                                "ce:initials": "J.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Sollano",
                                "@auid": "6602099153",
                                "ce:indexed-name": "Sollano J."
                            },
                            {
                                "ce:given-name": "Evan",
                                "preferred-name": {
                                    "ce:given-name": "Evan",
                                    "ce:initials": "E.",
                                    "ce:surname": "Ong",
                                    "ce:indexed-name": "Ong E."
                                },
                                "@author-instance-id": "2010748563-3dd04d0a471b026f5a98933fa10402f6",
                                "@seq": "22",
                                "ce:initials": "E.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Ong",
                                "@auid": "57220521066",
                                "ce:indexed-name": "Ong E."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Singapore",
                            "@afid": "60002481",
                            "@country": "sgp",
                            "organization": [
                                {"$": "Department of Gastroenterology and Hepatology"},
                                {"$": "Tan Tock Seng Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60002481",
                                "@dptid": "110055741"
                            },
                            "@affiliation-instance-id": "2010748563-7101d5da59f1c48cacbee0422c1bee12",
                            "ce:source-text": "Department of Gastroenterology and Hepatology, Tan Tock Seng Hospital, Singapore",
                            "@dptid": "110055741"
                        },
                        "author": [{
                            "ce:given-name": "Wee Chian",
                            "preferred-name": {
                                "ce:given-name": "Wee Chian",
                                "ce:initials": "W.C.",
                                "ce:surname": "Lim",
                                "ce:indexed-name": "Lim W.C."
                            },
                            "@author-instance-id": "2010748563-2b663a5e4b9510d818f99383dbb71e09",
                            "@seq": "18",
                            "ce:initials": "W.C.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Lim",
                            "@auid": "8752049200",
                            "ce:indexed-name": "Lim W.C."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Hong Kong",
                            "@afid": "60006541",
                            "@country": "hkg",
                            "organization": [
                                {"$": "Division of Gastroenterology and Hepatology"},
                                {"$": "Department of Medicine"},
                                {"$": "University of Hong Kong"}
                            ],
                            "affiliation-id": {
                                "@afid": "60006541",
                                "@dptid": "112758478"
                            },
                            "@affiliation-instance-id": "2010748563-3ca6b0fe7870df4ff7288ba9fa08f426",
                            "ce:source-text": "Division of Gastroenterology and Hepatology, Department of Medicine, University of Hong Kong, Hong Kong",
                            "@dptid": "112758478"
                        },
                        "author": [{
                            "ce:given-name": "Wai Keung",
                            "preferred-name": {
                                "ce:given-name": "Wai Keung",
                                "ce:initials": "W.K.",
                                "ce:surname": "Leung",
                                "ce:indexed-name": "Leung W.K."
                            },
                            "@author-instance-id": "2010748563-0e4ddca3cbe853ceedad187d27019795",
                            "@seq": "19",
                            "ce:initials": "W.K.",
                            "@date-locked": "2022-01-14T11:02:12.772",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Leung",
                            "@auid": "57188802557",
                            "ce:indexed-name": "Leung W.K."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Malaysia",
                            "@afid": "60001821",
                            "@country": "mys",
                            "city": "Kuala Lumpur",
                            "organization": [
                                {"$": "Faculty of Medicine"},
                                {"$": "UKM Medical and Specialist Centres"},
                                {"$": "The National University of Malaysia"}
                            ],
                            "affiliation-id": {
                                "@afid": "60001821",
                                "@dptid": "103143390"
                            },
                            "@affiliation-instance-id": "2010748563-9f24011b4d69bed4720f7b687db1fa99",
                            "ce:source-text": "Faculty of Medicine, UKM Medical and Specialist Centres, The National University of Malaysia, Kuala Lumpur, Malaysia",
                            "@dptid": "103143390"
                        },
                        "author": [{
                            "ce:given-name": "Raja Affendi Raja",
                            "preferred-name": {
                                "ce:given-name": "Raja Affendi Raja",
                                "ce:initials": "R.A.R.",
                                "ce:surname": "Ali",
                                "ce:indexed-name": "Ali R.A.R."
                            },
                            "@author-instance-id": "2010748563-e0709b544ee24907b34918016184c463",
                            "@seq": "20",
                            "ce:initials": "R.A.R.",
                            "@date-locked": "2023-09-07T06:46:39.689",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Ali",
                            "@auid": "40762153700",
                            "ce:indexed-name": "Ali R.A.R."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Taiwan",
                            "@afid": "60012256",
                            "@country": "twn",
                            "city": "Kaohsiung",
                            "organization": [
                                {"$": "Department of Medicine"},
                                {"$": "Kaohsiung Medical University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60012256",
                                "@dptid": "113078662"
                            },
                            "@affiliation-instance-id": "2010748563-d447e0dcc17a22f75edde76629bfafa7",
                            "ce:source-text": "Department of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan",
                            "@dptid": "113078662"
                        },
                        "author": [{
                            "ce:given-name": "Deng Chyang",
                            "preferred-name": {
                                "ce:given-name": "Deng Chyang",
                                "ce:initials": "D.C.",
                                "ce:surname": "Wu",
                                "ce:indexed-name": "Wu D.C."
                            },
                            "@author-instance-id": "2010748563-584fb158ce2545c0394e8b6ee0cdffe8",
                            "@seq": "21",
                            "ce:initials": "D.C.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Wu",
                            "@auid": "57154894800",
                            "ce:indexed-name": "Wu D.C."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Malaysia",
                            "@afid": "60002512",
                            "@date-locked": "2021-07-14T18:16:59.938",
                            "@country": "mys",
                            "city": "Kubang Kerian",
                            "organization": [
                                {"$": "Department of Internal Medicine"},
                                {"$": "School of Medical Sciences"},
                                {"$": "Health Campus"},
                                {"$": "Sains University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60002512",
                                "@dptid": "103179997"
                            },
                            "@affiliation-instance-id": "2010748563-8f5f882f55a3c5d88e8502f47cd446fb",
                            "ce:source-text": "Department of Internal Medicine, School of Medical Sciences, Health Campus, Sains University, Kubang Kerian, Malaysia",
                            "@dptid": "103179997"
                        },
                        "author": [{
                            "ce:given-name": "Nazri",
                            "preferred-name": {
                                "ce:given-name": "Nazri",
                                "ce:initials": "N.",
                                "ce:surname": "Mustaffa",
                                "ce:indexed-name": "Mustaffa N."
                            },
                            "@author-instance-id": "2010748563-10059be9fca0d53eb3ecf16810733e7b",
                            "@seq": "23",
                            "ce:initials": "N.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Mustaffa",
                            "@auid": "37108082500",
                            "ce:indexed-name": "Mustaffa N."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60199575",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Siriraj Hospital"},
                                {"$": "Mahidol University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60199575",
                                    "@dptid": "125758157"
                                },
                                {"@afid": "60012718"}
                            ],
                            "@affiliation-instance-id": "2010748563-60258df7f39885c44eaabec469ac97a9",
                            "ce:source-text": "Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand",
                            "@dptid": "125758157"
                        },
                        "author": [{
                            "ce:given-name": "Julajak",
                            "preferred-name": {
                                "ce:given-name": "Julajak",
                                "ce:initials": "J.",
                                "ce:surname": "Limsrivilai",
                                "ce:indexed-name": "Limsrivilai J."
                            },
                            "@author-instance-id": "2010748563-f9791610025ed066a4cc7257f9000c58",
                            "@seq": "24",
                            "ce:initials": "J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Limsrivilai",
                            "@auid": "12772292800",
                            "ce:indexed-name": "Limsrivilai J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Japan",
                            "@afid": "60019092",
                            "@country": "jpn",
                            "city": "Mitaka",
                            "organization": [
                                {"$": "The Third Department of Internal Medicine"},
                                {"$": "Kyorin University School of Medicine"}
                            ],
                            "affiliation-id": {
                                "@afid": "60019092",
                                "@dptid": "113178841"
                            },
                            "@affiliation-instance-id": "2010748563-75631894d67a5627472e3c334b0227cd",
                            "ce:source-text": "The Third Department of Internal Medicine, Kyorin University School of Medicine, Mitaka, Japan",
                            "@dptid": "113178841"
                        },
                        "author": [{
                            "ce:given-name": "Tadakazu",
                            "preferred-name": {
                                "ce:given-name": "Tadakazu",
                                "ce:initials": "T.",
                                "ce:surname": "Hisamatsu",
                                "ce:indexed-name": "Hisamatsu T."
                            },
                            "@author-instance-id": "2010748563-726655b0889b8762755f9c6fd9b48675",
                            "@seq": "25",
                            "ce:initials": "T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Hisamatsu",
                            "@auid": "7005662302",
                            "ce:indexed-name": "Hisamatsu T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "@afid": "60006240",
                            "@country": "kor",
                            "city": "Seoul",
                            "organization": [
                                {"$": "Department of Gastroenterology"},
                                {"$": "University of Ulsan College of Medicine"}
                            ],
                            "affiliation-id": {
                                "@afid": "60006240",
                                "@dptid": "113669103"
                            },
                            "@affiliation-instance-id": "2010748563-06c17be7cb93e2ce9093baae0b6a4e57",
                            "ce:source-text": "Department of Gastroenterology, University of Ulsan College of Medicine, Seoul, Korea",
                            "@dptid": "113669103"
                        },
                        "author": [{
                            "ce:given-name": "Suk Kyun",
                            "preferred-name": {
                                "ce:given-name": "Suk Kyun",
                                "ce:initials": "S.K.",
                                "ce:surname": "Yang",
                                "ce:indexed-name": "Yang S.K."
                            },
                            "@author-instance-id": "2010748563-78d5d08bdca32838b096b6688535fdd2",
                            "@seq": "26",
                            "ce:initials": "S.K.",
                            "@date-locked": "2021-07-02T12:48:16.117",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Yang",
                            "@auid": "7406948347",
                            "ce:indexed-name": "Yang S.K."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60073509",
                            "@country": "chn",
                            "city": "Chengdu",
                            "organization": [
                                {"$": "Department of Gastroenterology"},
                                {"$": "West China Hospital"},
                                {"$": "Sichuan University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60073509",
                                    "@dptid": "107930715"
                                },
                                {"@afid": "60016521"}
                            ],
                            "@affiliation-instance-id": "2010748563-2ec68a4f8a3e3a473a6734a50f657765",
                            "ce:source-text": "Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China",
                            "@dptid": "107930715"
                        },
                        "author": [{
                            "ce:given-name": "Qin",
                            "preferred-name": {
                                "ce:given-name": "Qin",
                                "ce:initials": "Q.",
                                "ce:surname": "Ouyang",
                                "ce:indexed-name": "Ouyang Q."
                            },
                            "@author-instance-id": "2010748563-3d6fe9c2de81444bc126c8e6f0818e29",
                            "@seq": "27",
                            "ce:initials": "Q.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Ouyang",
                            "@auid": "55626361500",
                            "ce:indexed-name": "Ouyang Q."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "New Zealand",
                            "@afid": "60002143",
                            "@country": "nzl",
                            "city": "Christchurch",
                            "organization": [
                                {"$": "Department of Medicine"},
                                {"$": "University of Otago"}
                            ],
                            "affiliation-id": {
                                "@afid": "60002143",
                                "@dptid": "100256440"
                            },
                            "@affiliation-instance-id": "2010748563-16235383a08c69eecad2b88d83ad4065",
                            "ce:source-text": "Department of Medicine, University of Otago, Christchurch, New Zealand",
                            "@dptid": "100256440"
                        },
                        "author": [{
                            "ce:given-name": "Richard",
                            "preferred-name": {
                                "ce:given-name": "Richard",
                                "ce:initials": "R.",
                                "ce:surname": "Geary",
                                "ce:indexed-name": "Geary R."
                            },
                            "@author-instance-id": "2010748563-55714a3c9ce0626b5254910bc96eed73",
                            "@seq": "28",
                            "ce:initials": "R.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Geary",
                            "@auid": "57209651723",
                            "ce:indexed-name": "Geary R."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Sri Lanka",
                            "@afid": "60071104",
                            "@country": "lka",
                            "city": "Dalugama",
                            "organization": [
                                {"$": "Faculty of Medicine"},
                                {"$": "University of Kelaniya"}
                            ],
                            "affiliation-id": {"@afid": "60071104"},
                            "@affiliation-instance-id": "2010748563-0a01af151e0ca94298fb8cb4c191949a",
                            "ce:source-text": "Faculty of Medicine, University of Kelaniya, Dalugama, Sri Lanka"
                        },
                        "author": [{
                            "ce:given-name": "Janaka H",
                            "preferred-name": {
                                "ce:given-name": "Janaka H.",
                                "ce:initials": "J.H.",
                                "ce:surname": "De Silva",
                                "ce:indexed-name": "De Silva J.H."
                            },
                            "@author-instance-id": "2010748563-62c916ed8a0d139c32e0b6a0bfdac9f4",
                            "@seq": "29",
                            "ce:initials": "J.H.",
                            "@date-locked": "2022-10-17T00:19:47.894",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "De Silva",
                            "@auid": "7005406595",
                            "ce:indexed-name": "De Silva J.H."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "113019942"
                            },
                            "@affiliation-instance-id": "2010748563-db71f6a57dc6a80df72f47ee8c7f77b2",
                            "ce:source-text": "Department of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "113019942"
                        },
                        "author": [{
                            "ce:given-name": "Rungsun",
                            "preferred-name": {
                                "ce:given-name": "Rungsun",
                                "ce:initials": "R.",
                                "ce:surname": "Rerknimitr",
                                "ce:indexed-name": "Rerknimitr R."
                            },
                            "@author-instance-id": "2010748563-0bada49077aefb71020a43bdbce96847",
                            "@seq": "30",
                            "ce:initials": "R.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Rerknimitr",
                            "@auid": "6603607086",
                            "ce:indexed-name": "Rerknimitr R."
                        }]
                    },
                    {
                        "affiliation": {
                            "@afid": "60069377",
                            "city": "Jakarta",
                            "organization": [
                                {"$": "Department of Internal Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "University of Indonesia"}
                            ],
                            "affiliation-id": {
                                "@afid": "60069377",
                                "@dptid": "100274995"
                            },
                            "@affiliation-instance-id": "2010748563-c5cbef2a581bc066a09904ba8ee2655b",
                            "ce:source-text": "Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Jakarta",
                            "@dptid": "100274995"
                        },
                        "author": [{
                            "ce:given-name": "Marcellus",
                            "preferred-name": {
                                "ce:given-name": "Marcellus",
                                "ce:initials": "M.",
                                "ce:surname": "Simadibrata",
                                "ce:indexed-name": "Simadibrata M."
                            },
                            "@author-instance-id": "2010748563-79b6ef7bc09da6395f177982b5990f0e",
                            "@seq": "31",
                            "ce:initials": "M.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Simadibrata",
                            "@auid": "23499598400",
                            "ce:indexed-name": "Simadibrata M."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Indonesia",
                            "@afid": "60069378",
                            "@country": "idn",
                            "city": "Jakarta",
                            "organization": [
                                {"$": "Division of Gastroenterology"},
                                {"$": "Department of Internal Medicine"},
                                {"$": "Cipto Mangunkusumo National Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60069378",
                                "@dptid": "100277496"
                            },
                            "@affiliation-instance-id": "2010748563-1bb4d4b995f2f0c58918cd67238b8ba6",
                            "ce:source-text": "Division of Gastroenterology, Department of Internal Medicine, Cipto Mangunkusumo National Hospital, Jakarta, Indonesia",
                            "@dptid": "100277496"
                        },
                        "author": [{
                            "ce:given-name": "Murdani",
                            "preferred-name": {
                                "ce:given-name": "Murdani",
                                "ce:initials": "M.",
                                "ce:surname": "Abdullah",
                                "ce:indexed-name": "Abdullah M."
                            },
                            "@author-instance-id": "2010748563-13ef5571929b268b4e8a55c32d7fcda7",
                            "@seq": "32",
                            "ce:initials": "M.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Abdullah",
                            "@auid": "7103393434",
                            "ce:indexed-name": "Abdullah M."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Australia",
                            "@afid": "60029482",
                            "@country": "aus",
                            "city": "Sydney",
                            "organization": [
                                {"$": "Gastroenterology and Liver Services"},
                                {"$": "Concord Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60029482",
                                "@dptid": "104491930"
                            },
                            "@affiliation-instance-id": "2010748563-9c04ae9218c833d07fe0139fc7dc6a13",
                            "ce:source-text": "Gastroenterology and Liver Services, Concord Hospital, Sydney, Australia",
                            "@dptid": "104491930"
                        },
                        "author": [{
                            "ce:given-name": "Rupert WL",
                            "preferred-name": {
                                "ce:given-name": "Rupert WL",
                                "ce:initials": "R.W.",
                                "ce:surname": "Leong",
                                "ce:indexed-name": "Leong R.W."
                            },
                            "@author-instance-id": "2010748563-4feb8d9bd3b9217908d440a742d91da5",
                            "@seq": "33",
                            "ce:initials": "R.W.",
                            "@date-locked": "2021-02-18T12:05:50.575",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Leong",
                            "@auid": "57218574553",
                            "ce:indexed-name": "Leong R.W."
                        }]
                    }
                ],
                "citation-title": "Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia",
                "abstracts": " 2019. Korean Association for the Study of Intestinal Diseases. All Rights Reserved.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The Asia-Pacific Working Group on inflammatory bowel disease (IBD) was established in Cebu, Philippines, under the auspices of the Asian Pacific Association of Gastroenterology with the goal of improving IBD care in Asia. This consensus is carried out in collaboration with Asian Organization for Crohn's and Colitis. With biologic agents and biosimilars becoming more established, it is necessary to conduct a review on existing literature and establish a consensus on when and how to introduce biologic agents and biosimilars in the conjunction with conventional treatments for ulcerative colitis (UC) and Crohn's disease (CD) in Asia. These statements also address how pharmacogenetics influence the treatments of UC and CD and provide guidance on response monitoring and strategies to restore loss of response. Finally, the review includes statements on how to manage treatment alongside possible hepatitis B and tuberculosis infections, both common in Asia. These statements have been prepared and voted upon by members of IBD workgroup employing the modified Delphi process. These statements do not intend to be all-encompassing and future revisions are likely as new data continue to emerge. (Intest Res 2019;17:285-310)",
                "correspondence": {
                    "affiliation": {
                        "country": "Singapore",
                        "address-part": "6 Napier Road, #10-02, Gleneagles Medical Centre",
                        "postal-code": "258499",
                        "@country": "sgp",
                        "city": "Singapore",
                        "organization": [
                            {"$": "Department of Gastroenterology and Hepatology"},
                            {"$": "Singapore General Hospital"}
                        ]
                    },
                    "person": {
                        "ce:given-name": "Choon Jin",
                        "ce:initials": "C.J.",
                        "ce:surname": "Ooi",
                        "ce:indexed-name": "Ooi C.J."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "Adalimumab",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Colitis",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Crohn disease",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Inflammatory bowel disease",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Infliximab",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "ulcerative",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "sourcetitle-abbrev": "Intest. Res.",
                    "website": {"ce:e-address": {
                        "$": "https://www.irjournal.org/",
                        "@type": "email"
                    }},
                    "@country": "kor",
                    "translated-sourcetitle": {"@xml:lang": "eng"},
                    "issn": [
                        {
                            "$": "22881956",
                            "@type": "electronic"
                        },
                        {
                            "$": "15989100",
                            "@type": "print"
                        }
                    ],
                    "volisspag": {
                        "voliss": {
                            "@volume": "17",
                            "@issue": "3"
                        },
                        "pagerange": {
                            "@first": "285",
                            "@last": "310"
                        }
                    },
                    "@type": "j",
                    "publicationyear": {"@first": "2019"},
                    "publisher": {"publishername": "Korean Association for the Study of Intestinal Diseases"},
                    "sourcetitle": "Intestinal Research",
                    "@srcid": "21100788713",
                    "publicationdate": {
                        "year": "2019",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "2019"
                        }
                    }
                },
                "enhancement": {"classificationgroup": {"classifications": [
                    {
                        "@type": "ASJC",
                        "classification": "2715"
                    },
                    {
                        "@type": "SUBJABBR",
                        "classification": "MEDI"
                    }
                ]}}
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2021 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "dbcollection": [
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "SNEMB"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "31",
                    "@timestamp": "BST 10:00:47",
                    "@year": "2021",
                    "@month": "01"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2010748563",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "930991270",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20210420583",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20210303626",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "2021017232",
                            "@idtype": "SNEMB"
                        },
                        {
                            "$": "20210176407690",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85074733082",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85074733082",
                            "@idtype": "SGR"
                        }
                    ],
                    "ce:doi": "10.5217/ir.2019.00026"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "182",
                "reference": [
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "1. Ooi CJ, Makharia GK, Hilmi I, et al. Asia Pacific Consensus Statements on Crohn's disease. Part 1: definition, diagnosis, and epidemiology: (Asia Pacific Crohn's Disease ConsensusPart 1). J Gastroenterol Hepatol 2016;31:45-55.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Asia Pacific Consensus Statements on Crohn's disease. Part 1: definition, diagnosis, and epidemiology: (Asia Pacific Crohn's Disease ConsensusPart 1)"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84956940774",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "31"},
                                "pagerange": {
                                    "@first": "45",
                                    "@last": "55"
                                }
                            },
                            "ref-text": "1",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "CJ",
                                        "@_fa": "true",
                                        "ce:surname": "Ooi",
                                        "ce:indexed-name": "Ooi CJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "GK",
                                        "@_fa": "true",
                                        "ce:surname": "Makharia",
                                        "ce:indexed-name": "Makharia GK"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "I",
                                        "@_fa": "true",
                                        "ce:surname": "Hilmi",
                                        "ce:indexed-name": "Hilmi I"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Gastroenterol Hepatol"
                        },
                        "ce:source-text": "1. Ooi CJ, Makharia GK, Hilmi I, et al. Asia Pacific Consensus Statements on Crohn's disease. Part 1: definition, diagnosis, and epidemiology: (Asia Pacific Crohn's Disease ConsensusPart 1). J Gastroenterol Hepatol 2016;31:45-55."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "2. Ooi CJ, Makharia GK, Hilmi I, et al. Asia-Pacific consensus statements on Crohn's disease. Part 2: management. J Gastroenterol Hepatol 2016;31:56-68.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Asia-Pacific consensus statements on Crohn's disease. Part 2: management"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84956877131",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "31"},
                                "pagerange": {
                                    "@first": "56",
                                    "@last": "68"
                                }
                            },
                            "ref-text": "2",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "CJ",
                                        "@_fa": "true",
                                        "ce:surname": "Ooi",
                                        "ce:indexed-name": "Ooi CJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "GK",
                                        "@_fa": "true",
                                        "ce:surname": "Makharia",
                                        "ce:indexed-name": "Makharia GK"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "I",
                                        "@_fa": "true",
                                        "ce:surname": "Hilmi",
                                        "ce:indexed-name": "Hilmi I"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Gastroenterol Hepatol"
                        },
                        "ce:source-text": "2. Ooi CJ, Makharia GK, Hilmi I, et al. Asia-Pacific consensus statements on Crohn's disease. Part 2: management. J Gastroenterol Hepatol 2016;31:56-68."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "3. Linstone HA, Turoff M. The Delphi method: techniques and applications. Boston: Addison-Wesley, 1975.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1975"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0003676431",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "3. Boston: Addison-Wesley",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "HA",
                                    "@_fa": "true",
                                    "ce:surname": "Linstone",
                                    "ce:indexed-name": "Linstone HA"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Turoff",
                                    "ce:indexed-name": "Turoff M."
                                }
                            ]},
                            "ref-sourcetitle": "The Delphi method: techniques and applications"
                        },
                        "ce:source-text": "3. Linstone HA, Turoff M. The Delphi method: techniques and applications. Boston: Addison-Wesley, 1975."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "4. The periodic health examination. Canadian Task Force on the Periodic Health Examination. Can Med Assoc J 1979;121: 1193-1254.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1979"},
                            "ref-title": {"ref-titletext": "The periodic health examination. Canadian Task Force on the Periodic Health Examination"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0018569077",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "121"},
                                "pagerange": {
                                    "@first": "1193",
                                    "@last": "1254"
                                }
                            },
                            "ref-text": "4",
                            "ref-sourcetitle": "Can Med Assoc J"
                        },
                        "ce:source-text": "4. The periodic health examination. Canadian Task Force on the Periodic Health Examination. Can Med Assoc J 1979;121: 1193-1254."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "5. Renna S, Cottone M, Orlando A. Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease. World J Gastroenterol 2014;20:9675-9690.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84905862124",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "20"},
                                "pagerange": {
                                    "@first": "9675",
                                    "@last": "9690"
                                }
                            },
                            "ref-text": "5",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Renna",
                                    "ce:indexed-name": "Renna S"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Cottone",
                                    "ce:indexed-name": "Cottone M"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Orlando",
                                    "ce:indexed-name": "Orlando A."
                                }
                            ]},
                            "ref-sourcetitle": "World J Gastroenterol"
                        },
                        "ce:source-text": "5. Renna S, Cottone M, Orlando A. Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease. World J Gastroenterol 2014;20:9675-9690."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "6. Sandborn WJ. Current directions in IBD therapy: what goals are feasible with biological modifiers? Gastroenterology 2008; 135:1442-1447.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Current directions in IBD therapy: what goals are feasible with biological modifiers?"},
                            "refd-itemidlist": {"itemid": {
                                "$": "55249091834",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "135"},
                                "pagerange": {
                                    "@first": "1442",
                                    "@last": "1447"
                                }
                            },
                            "ref-text": "6",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "WJ.",
                                "@_fa": "true",
                                "ce:surname": "Sandborn",
                                "ce:indexed-name": "Sandborn WJ."
                            }]},
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "6. Sandborn WJ. Current directions in IBD therapy: what goals are feasible with biological modifiers? Gastroenterology 2008; 135:1442-1447."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "7. Lichtenstein GR, Yan S, Bala M, Blank M, Sands BE. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology 2005;128:862-869.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "17144388945",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "128"},
                                "pagerange": {
                                    "@first": "862",
                                    "@last": "869"
                                }
                            },
                            "ref-text": "7",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "GR",
                                    "@_fa": "true",
                                    "ce:surname": "Lichtenstein",
                                    "ce:indexed-name": "Lichtenstein GR"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Yan",
                                    "ce:indexed-name": "Yan S"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Bala",
                                    "ce:indexed-name": "Bala M"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Blank",
                                    "ce:indexed-name": "Blank M"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "BE.",
                                    "@_fa": "true",
                                    "ce:surname": "Sands",
                                    "ce:indexed-name": "Sands BE."
                                }
                            ]},
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "7. Lichtenstein GR, Yan S, Bala M, Blank M, Sands BE. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology 2005;128:862-869."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "8. Colombel JF, Rutgeerts PJ, Sandborn WJ, et al. Adalimumab induces deep remission in patients with Crohn's disease. Clin Gastroenterol Hepatol 2014;12:414-422.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Adalimumab induces deep remission in patients with Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84893915665",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {
                                    "@first": "414",
                                    "@last": "422"
                                }
                            },
                            "ref-text": "8",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JF",
                                        "@_fa": "true",
                                        "ce:surname": "Colombel",
                                        "ce:indexed-name": "Colombel JF"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "PJ",
                                        "@_fa": "true",
                                        "ce:surname": "Rutgeerts",
                                        "ce:indexed-name": "Rutgeerts PJ"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "WJ",
                                        "@_fa": "true",
                                        "ce:surname": "Sandborn",
                                        "ce:indexed-name": "Sandborn WJ"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Gastroenterol Hepatol"
                        },
                        "ce:source-text": "8. Colombel JF, Rutgeerts PJ, Sandborn WJ, et al. Adalimumab induces deep remission in patients with Crohn's disease. Clin Gastroenterol Hepatol 2014;12:414-422."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "9. D'haens G, Van Deventer S, Van Hogezand R, et al. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: a European multicenter trial. Gastroenterology 1999;116:1029-1034.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1999"},
                            "ref-title": {"ref-titletext": "Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: a European multicenter trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0032913394",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "116"},
                                "pagerange": {
                                    "@first": "1029",
                                    "@last": "1034"
                                }
                            },
                            "ref-text": "9",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "D'haens",
                                        "ce:indexed-name": "D'haens G"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Van Deventer",
                                        "ce:indexed-name": "Van Deventer S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Van Hogezand",
                                        "ce:indexed-name": "Van Hogezand R"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "9. D'haens G, Van Deventer S, Van Hogezand R, et al. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: a European multicenter trial. Gastroenterology 1999;116:1029-1034."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "10. Rutgeerts P, Van Assche G, Sandborn WJ, et al. Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial. Gastroenterology 2012; 142:1102-1111.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84862777782",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "142"},
                                "pagerange": {
                                    "@first": "1102",
                                    "@last": "1111"
                                }
                            },
                            "ref-text": "10",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Rutgeerts",
                                        "ce:indexed-name": "Rutgeerts P"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Van Assche",
                                        "ce:indexed-name": "Van Assche G"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "WJ",
                                        "@_fa": "true",
                                        "ce:surname": "Sandborn",
                                        "ce:indexed-name": "Sandborn WJ"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "10. Rutgeerts P, Van Assche G, Sandborn WJ, et al. Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial. Gastroenterology 2012; 142:1102-1111."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "11. Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 2002;359:1541-1549.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0037018761",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "359"},
                                "pagerange": {
                                    "@first": "1541",
                                    "@last": "1549"
                                }
                            },
                            "ref-text": "11",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "SB",
                                        "@_fa": "true",
                                        "ce:surname": "Hanauer",
                                        "ce:indexed-name": "Hanauer SB"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "BG",
                                        "@_fa": "true",
                                        "ce:surname": "Feagan",
                                        "ce:indexed-name": "Feagan BG"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "GR",
                                        "@_fa": "true",
                                        "ce:surname": "Lichtenstein",
                                        "ce:indexed-name": "Lichtenstein GR"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "11. Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 2002;359:1541-1549."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "12. Colombel JF, Sandborn WJ, Rutgeerts P, et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Gastroenterology 2007;132:52-65.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33846242958",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "132"},
                                "pagerange": {
                                    "@first": "52",
                                    "@last": "65"
                                }
                            },
                            "ref-text": "12",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JF",
                                        "@_fa": "true",
                                        "ce:surname": "Colombel",
                                        "ce:indexed-name": "Colombel JF"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "WJ",
                                        "@_fa": "true",
                                        "ce:surname": "Sandborn",
                                        "ce:indexed-name": "Sandborn WJ"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Rutgeerts",
                                        "ce:indexed-name": "Rutgeerts P"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "12. Colombel JF, Sandborn WJ, Rutgeerts P, et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Gastroenterology 2007;132:52-65."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "13. Schreiber S. Certolizumab pegol for the treatment of Crohn's disease. Therap Adv Gastroenterol 2011;4:375-389.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Certolizumab pegol for the treatment of Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "80054743856",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "4"},
                                "pagerange": {
                                    "@first": "375",
                                    "@last": "389"
                                }
                            },
                            "ref-text": "13",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "ce:surname": "Schreiber",
                                "ce:indexed-name": "Schreiber S."
                            }]},
                            "ref-sourcetitle": "Therap Adv Gastroenterol"
                        },
                        "ce:source-text": "13. Schreiber S. Certolizumab pegol for the treatment of Crohn's disease. Therap Adv Gastroenterol 2011;4:375-389."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "14. Schreiber S, Khaliq-Kareemi M, Lawrance IC, et al. Maintenance therapy with certolizumab pegol for Crohn's disease. N Engl J Med 2007;357:239-250.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Maintenance therapy with certolizumab pegol for Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "34447515607",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "357"},
                                "pagerange": {
                                    "@first": "239",
                                    "@last": "250"
                                }
                            },
                            "ref-text": "14",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Schreiber",
                                        "ce:indexed-name": "Schreiber S"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Khaliq-Kareemi",
                                        "ce:indexed-name": "Khaliq-Kareemi M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "IC",
                                        "@_fa": "true",
                                        "ce:surname": "Lawrance",
                                        "ce:indexed-name": "Lawrance IC"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "14. Schreiber S, Khaliq-Kareemi M, Lawrance IC, et al. Maintenance therapy with certolizumab pegol for Crohn's disease. N Engl J Med 2007;357:239-250."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "15. Orlando A, Armuzzi A, Papi C, et al. The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of inflammatory bowel disease (IG-IBD) clinical practice guidelines: the use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease. Dig Liver Dis 2011;43:1-20.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of inflammatory bowel disease (IG-IBD) clinical practice guidelines: the use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "78649912194",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "43"},
                                "pagerange": {
                                    "@first": "1",
                                    "@last": "20"
                                }
                            },
                            "ref-text": "15",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Orlando",
                                        "ce:indexed-name": "Orlando A"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Armuzzi",
                                        "ce:indexed-name": "Armuzzi A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Papi",
                                        "ce:indexed-name": "Papi C"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Dig Liver Dis"
                        },
                        "ce:source-text": "15. Orlando A, Armuzzi A, Papi C, et al. The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of inflammatory bowel disease (IG-IBD) clinical practice guidelines: the use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease. Dig Liver Dis 2011;43:1-20."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "16. Sandborn WJ, Feagan BG, Rutgeerts P, et al. Vedolizumab as induction and maintenance therapy for Crohn's disease. N Engl J Med 2013;369:711-721.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Vedolizumab as induction and maintenance therapy for Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84882749768",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "369"},
                                "pagerange": {
                                    "@first": "711",
                                    "@last": "721"
                                }
                            },
                            "ref-text": "16",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "WJ",
                                        "@_fa": "true",
                                        "ce:surname": "Sandborn",
                                        "ce:indexed-name": "Sandborn WJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "BG",
                                        "@_fa": "true",
                                        "ce:surname": "Feagan",
                                        "ce:indexed-name": "Feagan BG"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Rutgeerts",
                                        "ce:indexed-name": "Rutgeerts P"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "16. Sandborn WJ, Feagan BG, Rutgeerts P, et al. Vedolizumab as induction and maintenance therapy for Crohn's disease. N Engl J Med 2013;369:711-721."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "17. Sands BE, Feagan BG, Rutgeerts P, et al. Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed. Gastroenterology 2014;147:618-627.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84906569062",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "147"},
                                "pagerange": {
                                    "@first": "618",
                                    "@last": "627"
                                }
                            },
                            "ref-text": "17",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "BE",
                                        "@_fa": "true",
                                        "ce:surname": "Sands",
                                        "ce:indexed-name": "Sands BE"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "BG",
                                        "@_fa": "true",
                                        "ce:surname": "Feagan",
                                        "ce:indexed-name": "Feagan BG"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Rutgeerts",
                                        "ce:indexed-name": "Rutgeerts P"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "17. Sands BE, Feagan BG, Rutgeerts P, et al. Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed. Gastroenterology 2014;147:618-627."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "18. Gomollon F, Dignass A, Annese V et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016. Part 1: diagnosis and medical management. J Crohns Colitis 2017;11:3-25.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016. Part 1: diagnosis and medical management"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85016186433",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {
                                    "@first": "3",
                                    "@last": "25"
                                }
                            },
                            "ref-text": "18",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Gomollon",
                                        "ce:indexed-name": "Gomollon F"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Dignass",
                                        "ce:indexed-name": "Dignass A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Annese",
                                        "ce:indexed-name": "Annese V"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Crohns Colitis"
                        },
                        "ce:source-text": "18. Gomollon F, Dignass A, Annese V et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016. Part 1: diagnosis and medical management. J Crohns Colitis 2017;11:3-25."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "19. Sandborn WJ, Gasink C, Gao LL, et al. Ustekinumab induction and maintenance therapy in refractory Crohn's disease. N Engl J Med 2012;367:1519-1528.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Ustekinumab induction and maintenance therapy in refractory Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84871701834",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "367"},
                                "pagerange": {
                                    "@first": "1519",
                                    "@last": "1528"
                                }
                            },
                            "ref-text": "19",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "WJ",
                                        "@_fa": "true",
                                        "ce:surname": "Sandborn",
                                        "ce:indexed-name": "Sandborn WJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Gasink",
                                        "ce:indexed-name": "Gasink C"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "LL",
                                        "@_fa": "true",
                                        "ce:surname": "Gao",
                                        "ce:indexed-name": "Gao LL"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "19. Sandborn WJ, Gasink C, Gao LL, et al. Ustekinumab induction and maintenance therapy in refractory Crohn's disease. N Engl J Med 2012;367:1519-1528."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "20. Chen QQ, Yan L, Wan J. Select a suitable treatment strategy for Crohn's disease: step-up or top-down. EXCLI J 2014;13: 111-122.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Select a suitable treatment strategy for Crohn's disease: step-up or top-down"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84896815292",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "111",
                                    "@last": "122"
                                }
                            },
                            "ref-text": "20",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "QQ",
                                    "@_fa": "true",
                                    "ce:surname": "Chen",
                                    "ce:indexed-name": "Chen QQ"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L",
                                    "@_fa": "true",
                                    "ce:surname": "Yan",
                                    "ce:indexed-name": "Yan L"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Wan",
                                    "ce:indexed-name": "Wan J."
                                }
                            ]},
                            "ref-sourcetitle": "EXCLI J"
                        },
                        "ce:source-text": "20. Chen QQ, Yan L, Wan J. Select a suitable treatment strategy for Crohn's disease: step-up or top-down. EXCLI J 2014;13: 111-122."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "21. D'Haens GR. Top-down therapy for IBD: rationale and requisite evidence. Nat Rev Gastroenterol Hepatol 2010;7:86-92.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Top-down therapy for IBD: rationale and requisite evidence"},
                            "refd-itemidlist": {"itemid": {
                                "$": "76949095663",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {
                                    "@first": "86",
                                    "@last": "92"
                                }
                            },
                            "ref-text": "21",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "GR.",
                                "@_fa": "true",
                                "ce:surname": "D'Haens",
                                "ce:indexed-name": "D'Haens GR."
                            }]},
                            "ref-sourcetitle": "Nat Rev Gastroenterol Hepatol"
                        },
                        "ce:source-text": "21. D'Haens GR. Top-down therapy for IBD: rationale and requisite evidence. Nat Rev Gastroenterol Hepatol 2010;7:86-92."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "22. Navarra SV, Tang B, Lu L, et al. Risk of tuberculosis with antitumor necrosis factor-alpha therapy: substantially higher number of patients at risk in Asia. Int J Rheum Dis 2014;17:291-298.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Risk of tuberculosis with antitumor necrosis factor-alpha therapy: substantially higher number of patients at risk in Asia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84897024635",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "17"},
                                "pagerange": {
                                    "@first": "291",
                                    "@last": "298"
                                }
                            },
                            "ref-text": "22",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "SV",
                                        "@_fa": "true",
                                        "ce:surname": "Navarra",
                                        "ce:indexed-name": "Navarra SV"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Tang",
                                        "ce:indexed-name": "Tang B"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Lu",
                                        "ce:indexed-name": "Lu L"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int J Rheum Dis"
                        },
                        "ce:source-text": "22. Navarra SV, Tang B, Lu L, et al. Risk of tuberculosis with antitumor necrosis factor-alpha therapy: substantially higher number of patients at risk in Asia. Int J Rheum Dis 2014;17:291-298."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "23. Wei SC. Differences in the public medical insurance systems for inflammatory bowel disease treatment in Asian countries. Intest Res 2016;14:218-223.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Differences in the public medical insurance systems for inflammatory bowel disease treatment in Asian countries"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85005943345",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {
                                    "@first": "218",
                                    "@last": "223"
                                }
                            },
                            "ref-text": "23",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "SC.",
                                "@_fa": "true",
                                "ce:surname": "Wei",
                                "ce:indexed-name": "Wei SC."
                            }]},
                            "ref-sourcetitle": "Intest Res"
                        },
                        "ce:source-text": "23. Wei SC. Differences in the public medical insurance systems for inflammatory bowel disease treatment in Asian countries. Intest Res 2016;14:218-223."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "24. Lin MV, Blonski W, Lichtenstein GR. What is the optimal therapy for Crohn's disease: step-up or top-down? Expert Rev Gastroenterol Hepatol 2010;4:167-180.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "What is the optimal therapy for Crohn's disease: step-up or top-down?"},
                            "refd-itemidlist": {"itemid": {
                                "$": "77950467505",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "4"},
                                "pagerange": {
                                    "@first": "167",
                                    "@last": "180"
                                }
                            },
                            "ref-text": "24",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "MV",
                                    "@_fa": "true",
                                    "ce:surname": "Lin",
                                    "ce:indexed-name": "Lin MV"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "W",
                                    "@_fa": "true",
                                    "ce:surname": "Blonski",
                                    "ce:indexed-name": "Blonski W"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "GR.",
                                    "@_fa": "true",
                                    "ce:surname": "Lichtenstein",
                                    "ce:indexed-name": "Lichtenstein GR."
                                }
                            ]},
                            "ref-sourcetitle": "Expert Rev Gastroenterol Hepatol"
                        },
                        "ce:source-text": "24. Lin MV, Blonski W, Lichtenstein GR. What is the optimal therapy for Crohn's disease: step-up or top-down? Expert Rev Gastroenterol Hepatol 2010;4:167-180."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "25. Shergill AK, Terdiman JP. Controversies in the treatment of Crohn's disease: the case for an accelerated step-up treatment approach. World J Gastroenterol 2008;14:2670-2677.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Controversies in the treatment of Crohn's disease: the case for an accelerated step-up treatment approach"},
                            "refd-itemidlist": {"itemid": {
                                "$": "49649101871",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {
                                    "@first": "2670",
                                    "@last": "2677"
                                }
                            },
                            "ref-text": "25",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "AK",
                                    "@_fa": "true",
                                    "ce:surname": "Shergill",
                                    "ce:indexed-name": "Shergill AK"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "JP.",
                                    "@_fa": "true",
                                    "ce:surname": "Terdiman",
                                    "ce:indexed-name": "Terdiman JP."
                                }
                            ]},
                            "ref-sourcetitle": "World J Gastroenterol"
                        },
                        "ce:source-text": "25. Shergill AK, Terdiman JP. Controversies in the treatment of Crohn's disease: the case for an accelerated step-up treatment approach. World J Gastroenterol 2008;14:2670-2677."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "26. Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J. Predictors of Crohn's disease. Gastroenterology 2006;130: 650-656.",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Predictors of Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33644859927",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "130"},
                                "pagerange": {
                                    "@first": "650",
                                    "@last": "656"
                                }
                            },
                            "ref-text": "26",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L",
                                    "@_fa": "true",
                                    "ce:surname": "Beaugerie",
                                    "ce:indexed-name": "Beaugerie L"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P",
                                    "@_fa": "true",
                                    "ce:surname": "Seksik",
                                    "ce:indexed-name": "Seksik P"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "I",
                                    "@_fa": "true",
                                    "ce:surname": "Nion-Larmurier",
                                    "ce:indexed-name": "Nion-Larmurier I"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "JP",
                                    "@_fa": "true",
                                    "ce:surname": "Gendre",
                                    "ce:indexed-name": "Gendre JP"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Cosnes",
                                    "ce:indexed-name": "Cosnes J."
                                }
                            ]},
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "26. Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J. Predictors of Crohn's disease. Gastroenterology 2006;130: 650-656."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "27. Sands BE, Arsenault JE, Rosen MJ, et al. Risk of early surgery for Crohn's disease: implications for early treatment strategies. Am J Gastroenterol 2003;98:2712-2718.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Risk of early surgery for Crohn's disease: implications for early treatment strategies"},
                            "refd-itemidlist": {"itemid": {
                                "$": "9144228789",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "98"},
                                "pagerange": {
                                    "@first": "2712",
                                    "@last": "2718"
                                }
                            },
                            "ref-text": "27",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "BE",
                                        "@_fa": "true",
                                        "ce:surname": "Sands",
                                        "ce:indexed-name": "Sands BE"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "JE",
                                        "@_fa": "true",
                                        "ce:surname": "Arsenault",
                                        "ce:indexed-name": "Arsenault JE"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "MJ",
                                        "@_fa": "true",
                                        "ce:surname": "Rosen",
                                        "ce:indexed-name": "Rosen MJ"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Am J Gastroenterol"
                        },
                        "ce:source-text": "27. Sands BE, Arsenault JE, Rosen MJ, et al. Risk of early surgery for Crohn's disease: implications for early treatment strategies. Am J Gastroenterol 2003;98:2712-2718."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "28. Miheller P, Kiss LS, Juhasz M, Mandel M, Lakatos PL. Recommendations for identifying Crohn's disease patients with poor prognosis. Expert Rev Clin Immunol 2013;9:65-75.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Recommendations for identifying Crohn's disease patients with poor prognosis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84871560558",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {
                                    "@first": "65",
                                    "@last": "75"
                                }
                            },
                            "ref-text": "28",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P",
                                    "@_fa": "true",
                                    "ce:surname": "Miheller",
                                    "ce:indexed-name": "Miheller P"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "LS",
                                    "@_fa": "true",
                                    "ce:surname": "Kiss",
                                    "ce:indexed-name": "Kiss LS"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Juhasz",
                                    "ce:indexed-name": "Juhasz M"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Mandel",
                                    "ce:indexed-name": "Mandel M"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "PL.",
                                    "@_fa": "true",
                                    "ce:surname": "Lakatos",
                                    "ce:indexed-name": "Lakatos PL."
                                }
                            ]},
                            "ref-sourcetitle": "Expert Rev Clin Immunol"
                        },
                        "ce:source-text": "28. Miheller P, Kiss LS, Juhasz M, Mandel M, Lakatos PL. Recommendations for identifying Crohn's disease patients with poor prognosis. Expert Rev Clin Immunol 2013;9:65-75."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "29. Aniwan S, Park SH, Loftus EV Jr. Epidemiology, natural history, and risk stratification of Crohn's disease. Gastroenterol Clin North Am 2017;46:463-480.",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Epidemiology, natural history, and risk stratification of Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85024849318",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "46"},
                                "pagerange": {
                                    "@first": "463",
                                    "@last": "480"
                                }
                            },
                            "ref-text": "29",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Aniwan",
                                    "ce:indexed-name": "Aniwan S"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "SH",
                                    "@_fa": "true",
                                    "ce:surname": "Park",
                                    "ce:indexed-name": "Park SH"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "EV",
                                    "@_fa": "true",
                                    "ce:surname": "Loftus",
                                    "ce:indexed-name": "Loftus EV"
                                }
                            ]},
                            "ref-sourcetitle": "Gastroenterol Clin North Am"
                        },
                        "ce:source-text": "29. Aniwan S, Park SH, Loftus EV Jr. Epidemiology, natural history, and risk stratification of Crohn's disease. Gastroenterol Clin North Am 2017;46:463-480."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "30. Mahid SS, Minor KS, Stevens PL, Galandiuk S. The role of smoking in Crohn's disease as defined by clinical variables. Dig Dis Sci 2007;52:2897-2903.",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "The role of smoking in Crohn's disease as defined by clinical variables"},
                            "refd-itemidlist": {"itemid": {
                                "$": "34848854250",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "52"},
                                "pagerange": {
                                    "@first": "2897",
                                    "@last": "2903"
                                }
                            },
                            "ref-text": "30",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "SS",
                                    "@_fa": "true",
                                    "ce:surname": "Mahid",
                                    "ce:indexed-name": "Mahid SS"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "KS",
                                    "@_fa": "true",
                                    "ce:surname": "Minor",
                                    "ce:indexed-name": "Minor KS"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "PL",
                                    "@_fa": "true",
                                    "ce:surname": "Stevens",
                                    "ce:indexed-name": "Stevens PL"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Galandiuk",
                                    "ce:indexed-name": "Galandiuk S."
                                }
                            ]},
                            "ref-sourcetitle": "Dig Dis Sci"
                        },
                        "ce:source-text": "30. Mahid SS, Minor KS, Stevens PL, Galandiuk S. The role of smoking in Crohn's disease as defined by clinical variables. Dig Dis Sci 2007;52:2897-2903."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "31. Sandborn WJ. Crohn's disease evaluation and treatment: clinical decision tool. Gastroenterology 2014;147:702-705.",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Crohn's disease evaluation and treatment: clinical decision tool"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84906936307",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "147"},
                                "pagerange": {
                                    "@first": "702",
                                    "@last": "705"
                                }
                            },
                            "ref-text": "31",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "WJ.",
                                "@_fa": "true",
                                "ce:surname": "Sandborn",
                                "ce:indexed-name": "Sandborn WJ."
                            }]},
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "31. Sandborn WJ. Crohn's disease evaluation and treatment: clinical decision tool. Gastroenterology 2014;147:702-705."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "32. Oh EH, Oh K, Han M, et al. Early anti-TNF/immunomodula-tor therapy is associated with better long-term clinical outcomes in Asian patients with Crohn's disease with poor prognostic factors. PLoS One 2017;12:e0177479.",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Early anti-TNF/immunomodula-tor therapy is associated with better long-term clinical outcomes in Asian patients with Crohn's disease with poor prognostic factors"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85019540284",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {"@first": "e0177479"}
                            },
                            "ref-text": "32",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "EH",
                                        "@_fa": "true",
                                        "ce:surname": "Oh",
                                        "ce:indexed-name": "Oh EH"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Oh",
                                        "ce:indexed-name": "Oh K"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Han",
                                        "ce:indexed-name": "Han M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS One"
                        },
                        "ce:source-text": "32. Oh EH, Oh K, Han M, et al. Early anti-TNF/immunomodula-tor therapy is associated with better long-term clinical outcomes in Asian patients with Crohn's disease with poor prognostic factors. PLoS One 2017;12:e0177479."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "33. D'Haens G, Baert F, van Assche G, et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomized trial. Lancet 2008;371:660-667.",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomized trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "39449085441",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "371"},
                                "pagerange": {
                                    "@first": "660",
                                    "@last": "667"
                                }
                            },
                            "ref-text": "33",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "D'Haens",
                                        "ce:indexed-name": "D'Haens G"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Baert",
                                        "ce:indexed-name": "Baert F"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "van Assche",
                                        "ce:indexed-name": "van Assche G"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "33. D'Haens G, Baert F, van Assche G, et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomized trial. Lancet 2008;371:660-667."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "34. Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 2010;362:1383-1395.",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Infliximab, azathioprine, or combination therapy for Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "77950988234",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "362"},
                                "pagerange": {
                                    "@first": "1383",
                                    "@last": "1395"
                                }
                            },
                            "ref-text": "34",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JF",
                                        "@_fa": "true",
                                        "ce:surname": "Colombel",
                                        "ce:indexed-name": "Colombel JF"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "WJ",
                                        "@_fa": "true",
                                        "ce:surname": "Sandborn",
                                        "ce:indexed-name": "Sandborn WJ"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W",
                                        "@_fa": "true",
                                        "ce:surname": "Reinisch",
                                        "ce:indexed-name": "Reinisch W"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "34. Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 2010;362:1383-1395."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "35. Panaccione R, Ghosh S, Middleton S, et al. Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis. Gastroenterology 2014;146:392-400.",
                        "@id": "35",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84892737455",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "146"},
                                "pagerange": {
                                    "@first": "392",
                                    "@last": "400"
                                }
                            },
                            "ref-text": "35",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Panaccione",
                                        "ce:indexed-name": "Panaccione R"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Ghosh",
                                        "ce:indexed-name": "Ghosh S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Middleton",
                                        "ce:indexed-name": "Middleton S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "35. Panaccione R, Ghosh S, Middleton S, et al. Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis. Gastroenterology 2014;146:392-400."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "36. Jones JL, Kaplan GG, Peyrin-Biroulet L, et al. Effects of concomitant immunomodulator therapy on efficacy and safety of anti-tumor necrosis factor therapy for Crohn's disease: a meta-analysis of placebo-controlled trials. Clin Gastroenterol Hepatol 2015;13:2233-2240.",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Effects of concomitant immunomodulator therapy on efficacy and safety of anti-tumor necrosis factor therapy for Crohn's disease: a meta-analysis of placebo-controlled trials"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84947422075",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "2233",
                                    "@last": "2240"
                                }
                            },
                            "ref-text": "36",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JL",
                                        "@_fa": "true",
                                        "ce:surname": "Jones",
                                        "ce:indexed-name": "Jones JL"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "GG",
                                        "@_fa": "true",
                                        "ce:surname": "Kaplan",
                                        "ce:indexed-name": "Kaplan GG"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Peyrin-Biroulet",
                                        "ce:indexed-name": "Peyrin-Biroulet L"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Gastroenterol Hepatol"
                        },
                        "ce:source-text": "36. Jones JL, Kaplan GG, Peyrin-Biroulet L, et al. Effects of concomitant immunomodulator therapy on efficacy and safety of anti-tumor necrosis factor therapy for Crohn's disease: a meta-analysis of placebo-controlled trials. Clin Gastroenterol Hepatol 2015;13:2233-2240."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "37. Colombel JF, Jharap B, Sandborn WJ, et al. Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy. Aliment Pharmacol Ther 2017;45:50-62.",
                        "@id": "37",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84997712942",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "45"},
                                "pagerange": {
                                    "@first": "50",
                                    "@last": "62"
                                }
                            },
                            "ref-text": "37",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JF",
                                        "@_fa": "true",
                                        "ce:surname": "Colombel",
                                        "ce:indexed-name": "Colombel JF"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Jharap",
                                        "ce:indexed-name": "Jharap B"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "WJ",
                                        "@_fa": "true",
                                        "ce:surname": "Sandborn",
                                        "ce:indexed-name": "Sandborn WJ"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Aliment Pharmacol Ther"
                        },
                        "ce:source-text": "37. Colombel JF, Jharap B, Sandborn WJ, et al. Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy. Aliment Pharmacol Ther 2017;45:50-62."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "38. Ben-Horin S, Waterman M, Kopylov U, et al. Addition of an immunomodulator to infliximab therapy eliminates antidrug antibodies in serum and restores clinical response of patients with inflammatory bowel disease. Clin Gastroenterol Hepa- tol 2013;11:444-447.",
                        "@id": "38",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Addition of an immunomodulator to infliximab therapy eliminates antidrug antibodies in serum and restores clinical response of patients with inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84875371134",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {
                                    "@first": "444",
                                    "@last": "447"
                                }
                            },
                            "ref-text": "38",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Ben-Horin",
                                        "ce:indexed-name": "Ben-Horin S"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Waterman",
                                        "ce:indexed-name": "Waterman M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "U",
                                        "@_fa": "true",
                                        "ce:surname": "Kopylov",
                                        "ce:indexed-name": "Kopylov U"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Gastroenterol Hepa- tol"
                        },
                        "ce:source-text": "38. Ben-Horin S, Waterman M, Kopylov U, et al. Addition of an immunomodulator to infliximab therapy eliminates antidrug antibodies in serum and restores clinical response of patients with inflammatory bowel disease. Clin Gastroenterol Hepa- tol 2013;11:444-447."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "39. Strik AS, van den Brink GR, Ponsioen C, Mathot R, Lwenberg M, D'Haens GR. Suppression of anti-drug antibodies to infliximab or adalimumab with the addition of an immunomodulator in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2017;45:1128-1134.",
                        "@id": "39",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Suppression of anti-drug antibodies to infliximab or adalimumab with the addition of an immunomodulator in patients with inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85013639032",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "45"},
                                "pagerange": {
                                    "@first": "1128",
                                    "@last": "1134"
                                }
                            },
                            "ref-text": "39",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "AS",
                                    "@_fa": "true",
                                    "ce:surname": "Strik",
                                    "ce:indexed-name": "Strik AS"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "GR",
                                    "@_fa": "true",
                                    "ce:surname": "van den Brink",
                                    "ce:indexed-name": "van den Brink GR"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C",
                                    "@_fa": "true",
                                    "ce:surname": "Ponsioen",
                                    "ce:indexed-name": "Ponsioen C"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Mathot",
                                    "ce:indexed-name": "Mathot R"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Lwenberg",
                                    "ce:indexed-name": "Lowenberg M"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "GR.",
                                    "@_fa": "true",
                                    "ce:surname": "D'Haens",
                                    "ce:indexed-name": "D'Haens GR."
                                }
                            ]},
                            "ref-sourcetitle": "Aliment Pharmacol Ther"
                        },
                        "ce:source-text": "39. Strik AS, van den Brink GR, Ponsioen C, Mathot R, Lwenberg M, D'Haens GR. Suppression of anti-drug antibodies to infliximab or adalimumab with the addition of an immunomodulator in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2017;45:1128-1134."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "40. Feagan BG, McDonald JW, Panaccione R, et al. Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn's disease. Gastroenterology 2014;146:681-688.",
                        "@id": "40",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84894302120",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "146"},
                                "pagerange": {
                                    "@first": "681",
                                    "@last": "688"
                                }
                            },
                            "ref-text": "40",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "BG",
                                        "@_fa": "true",
                                        "ce:surname": "Feagan",
                                        "ce:indexed-name": "Feagan BG"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "JW",
                                        "@_fa": "true",
                                        "ce:surname": "McDonald",
                                        "ce:indexed-name": "McDonald JW"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Panaccione",
                                        "ce:indexed-name": "Panaccione R"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "40. Feagan BG, McDonald JW, Panaccione R, et al. Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn's disease. Gastroenterology 2014;146:681-688."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "41. Van Assche G, Magdelaine-Beuzelin C, D'Haens G, et al. Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial. Gastroenterology 2008;134:1861-1868.",
                        "@id": "41",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "44649090092",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "134"},
                                "pagerange": {
                                    "@first": "1861",
                                    "@last": "1868"
                                }
                            },
                            "ref-text": "41",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Van Assche",
                                        "ce:indexed-name": "Van Assche G"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Magdelaine-Beuzelin",
                                        "ce:indexed-name": "Magdelaine-Beuzelin C"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "D'Haens",
                                        "ce:indexed-name": "D'Haens G"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "41. Van Assche G, Magdelaine-Beuzelin C, D'Haens G, et al. Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial. Gastroenterology 2008;134:1861-1868."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "42. Roblin X, Boschetti G, Williet N, et al. Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open-label, prospective and randomised clinical trial. Aliment Pharmacol Ther 2017;46:142-149.",
                        "@id": "42",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open-label, prospective and randomised clinical trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85018689315",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "46"},
                                "pagerange": {
                                    "@first": "142",
                                    "@last": "149"
                                }
                            },
                            "ref-text": "42",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "X",
                                        "@_fa": "true",
                                        "ce:surname": "Roblin",
                                        "ce:indexed-name": "Roblin X"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Boschetti",
                                        "ce:indexed-name": "Boschetti G"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Williet",
                                        "ce:indexed-name": "Williet N"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Aliment Pharmacol Ther"
                        },
                        "ce:source-text": "42. Roblin X, Boschetti G, Williet N, et al. Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open-label, prospective and randomised clinical trial. Aliment Pharmacol Ther 2017;46:142-149."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "43. Bots S, Gecse K, Barclay M, D'Haens G. Combination immunosuppression in IBD. Inflamm Bowel Dis 2018;24:539-545.",
                        "@id": "43",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Combination immunosuppression in IBD"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85050825456",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "24"},
                                "pagerange": {
                                    "@first": "539",
                                    "@last": "545"
                                }
                            },
                            "ref-text": "43",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Bots",
                                    "ce:indexed-name": "Bots S"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "K",
                                    "@_fa": "true",
                                    "ce:surname": "Gecse",
                                    "ce:indexed-name": "Gecse K"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Barclay",
                                    "ce:indexed-name": "Barclay M"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "D'Haens",
                                    "ce:indexed-name": "D'Haens G."
                                }
                            ]},
                            "ref-sourcetitle": "Inflamm Bowel Dis"
                        },
                        "ce:source-text": "43. Bots S, Gecse K, Barclay M, D'Haens G. Combination immunosuppression in IBD. Inflamm Bowel Dis 2018;24:539-545."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "44. Hanauer SB, Wagner CL, Bala M, et al. Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease. Clin Gastroenterol Hepatol 2004;2:542-553.",
                        "@id": "44",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "3042579454",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "2"},
                                "pagerange": {
                                    "@first": "542",
                                    "@last": "553"
                                }
                            },
                            "ref-text": "44",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "SB",
                                        "@_fa": "true",
                                        "ce:surname": "Hanauer",
                                        "ce:indexed-name": "Hanauer SB"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "CL",
                                        "@_fa": "true",
                                        "ce:surname": "Wagner",
                                        "ce:indexed-name": "Wagner CL"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Bala",
                                        "ce:indexed-name": "Bala M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Gastroenterol Hepatol"
                        },
                        "ce:source-text": "44. Hanauer SB, Wagner CL, Bala M, et al. Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease. Clin Gastroenterol Hepatol 2004;2:542-553."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "45. Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 2004;350:876-885.",
                        "@id": "45",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Infliximab maintenance therapy for fistulizing Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "10744221312",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "350"},
                                "pagerange": {
                                    "@first": "876",
                                    "@last": "885"
                                }
                            },
                            "ref-text": "45",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "BE",
                                        "@_fa": "true",
                                        "ce:surname": "Sands",
                                        "ce:indexed-name": "Sands BE"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "FH",
                                        "@_fa": "true",
                                        "ce:surname": "Anderson",
                                        "ce:indexed-name": "Anderson FH"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "CN",
                                        "@_fa": "true",
                                        "ce:surname": "Bernstein",
                                        "ce:indexed-name": "Bernstein CN"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "45. Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 2004;350:876-885."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "46. Torres J, Boyapati RK, Kennedy NA, Louis E, Colombel JF, Satsangi J. Systematic review of effects of withdrawal of immunomodulators or biologic agents from patients with inflammatory bowel disease. Gastroenterology 2015;149:1716-1730.",
                        "@id": "46",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Systematic review of effects of withdrawal of immunomodulators or biologic agents from patients with inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84952936248",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "149"},
                                "pagerange": {
                                    "@first": "1716",
                                    "@last": "1730"
                                }
                            },
                            "ref-text": "46",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Torres",
                                    "ce:indexed-name": "Torres J"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "RK",
                                    "@_fa": "true",
                                    "ce:surname": "Boyapati",
                                    "ce:indexed-name": "Boyapati RK"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "NA",
                                    "@_fa": "true",
                                    "ce:surname": "Kennedy",
                                    "ce:indexed-name": "Kennedy NA"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "E",
                                    "@_fa": "true",
                                    "ce:surname": "Louis",
                                    "ce:indexed-name": "Louis E"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "JF",
                                    "@_fa": "true",
                                    "ce:surname": "Colombel",
                                    "ce:indexed-name": "Colombel JF"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Satsangi",
                                    "ce:indexed-name": "Satsangi J."
                                }
                            ]},
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "46. Torres J, Boyapati RK, Kennedy NA, Louis E, Colombel JF, Satsangi J. Systematic review of effects of withdrawal of immunomodulators or biologic agents from patients with inflammatory bowel disease. Gastroenterology 2015;149:1716-1730."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "47. Louis E, Mary JY, Vernier-Massouille G, et al. Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped. Gastroenterology 2012;142:63-70.",
                        "@id": "47",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped"},
                            "refd-itemidlist": {"itemid": {
                                "$": "83955162272",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "142"},
                                "pagerange": {
                                    "@first": "63",
                                    "@last": "70"
                                }
                            },
                            "ref-text": "47",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Louis",
                                        "ce:indexed-name": "Louis E"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "JY",
                                        "@_fa": "true",
                                        "ce:surname": "Mary",
                                        "ce:indexed-name": "Mary JY"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Vernier-Massouille",
                                        "ce:indexed-name": "Vernier-Massouille G"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "47. Louis E, Mary JY, Vernier-Massouille G, et al. Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped. Gastroenterology 2012;142:63-70."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "48. Frias Gomes C, Colombel JF, Torres J. De-escalation of therapy in inflammatory bowel disease. Curr Gastroenterol Rep 2018;20:35.",
                        "@id": "48",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "De-escalation of therapy in inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85049446566",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "20"},
                                "pagerange": {"@first": "35"}
                            },
                            "ref-text": "48",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C",
                                    "@_fa": "true",
                                    "ce:surname": "Frias Gomes",
                                    "ce:indexed-name": "Frias Gomes C"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "JF",
                                    "@_fa": "true",
                                    "ce:surname": "Colombel",
                                    "ce:indexed-name": "Colombel JF"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Torres",
                                    "ce:indexed-name": "Torres J."
                                }
                            ]},
                            "ref-sourcetitle": "Curr Gastroenterol Rep"
                        },
                        "ce:source-text": "48. Frias Gomes C, Colombel JF, Torres J. De-escalation of therapy in inflammatory bowel disease. Curr Gastroenterol Rep 2018;20:35."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "49. Sorrentino D, Paviotti A, Terrosu G, Avellini C, Geraci M, Zar-ifi D. Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn's disease. Clin Gastroenterol Hepatol 2010;8:591-599.",
                        "@id": "49",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84876457416",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {
                                    "@first": "591",
                                    "@last": "599"
                                }
                            },
                            "ref-text": "49",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "D",
                                    "@_fa": "true",
                                    "ce:surname": "Sorrentino",
                                    "ce:indexed-name": "Sorrentino D"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Paviotti",
                                    "ce:indexed-name": "Paviotti A"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "G",
                                    "@_fa": "true",
                                    "ce:surname": "Terrosu",
                                    "ce:indexed-name": "Terrosu G"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "C",
                                    "@_fa": "true",
                                    "ce:surname": "Avellini",
                                    "ce:indexed-name": "Avellini C"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Geraci",
                                    "ce:indexed-name": "Geraci M"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Zar-ifi",
                                    "ce:indexed-name": "Zar-ifi D."
                                }
                            ]},
                            "ref-sourcetitle": "Clin Gastroenterol Hepatol"
                        },
                        "ce:source-text": "49. Sorrentino D, Paviotti A, Terrosu G, Avellini C, Geraci M, Zar-ifi D. Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn's disease. Clin Gastroenterol Hepatol 2010;8:591-599."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "50. Van Steenbergen S, Bian S, Vermeire S, Van Assche G, Gils A, Ferrante M. Dose de-escalation to adalimumab 40 mg every 3 weeks in patients with Crohn's disease: a nested case-con trol study. Aliment Pharmacol Ther 2017;45:923-932.",
                        "@id": "50",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Dose de-escalation to adalimumab 40 mg every 3 weeks in patients with Crohn's disease: a nested case-con trol study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85012922058",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "45"},
                                "pagerange": {
                                    "@first": "923",
                                    "@last": "932"
                                }
                            },
                            "ref-text": "50",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Van Steenbergen",
                                    "ce:indexed-name": "Van Steenbergen S"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Bian",
                                    "ce:indexed-name": "Bian S"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Vermeire",
                                    "ce:indexed-name": "Vermeire S"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "G",
                                    "@_fa": "true",
                                    "ce:surname": "Van Assche",
                                    "ce:indexed-name": "Van Assche G"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Gils",
                                    "ce:indexed-name": "Gils A"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Ferrante",
                                    "ce:indexed-name": "Ferrante M."
                                }
                            ]},
                            "ref-sourcetitle": "Aliment Pharmacol Ther"
                        },
                        "ce:source-text": "50. Van Steenbergen S, Bian S, Vermeire S, Van Assche G, Gils A, Ferrante M. Dose de-escalation to adalimumab 40 mg every 3 weeks in patients with Crohn's disease: a nested case-con trol study. Aliment Pharmacol Ther 2017;45:923-932."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "51. Kawalec P, Mikrut A, Wisniewska N, Pile A. Tumor necrosis factor-alpha antibodies (infliximab, adalimumab and certoli-zumab) in Crohn's disease: systematic review and meta-analysis. Arch Med Sci 2013;9:765-779.",
                        "@id": "51",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Tumor necrosis factor-alpha antibodies (infliximab, adalimumab and certoli-zumab) in Crohn's disease: systematic review and meta-analysis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84888115148",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {
                                    "@first": "765",
                                    "@last": "779"
                                }
                            },
                            "ref-text": "51",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P",
                                    "@_fa": "true",
                                    "ce:surname": "Kawalec",
                                    "ce:indexed-name": "Kawalec P"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Mikrut",
                                    "ce:indexed-name": "Mikrut A"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "N",
                                    "@_fa": "true",
                                    "ce:surname": "Wisniewska",
                                    "ce:indexed-name": "Wisniewska N"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Pile",
                                    "ce:indexed-name": "Pile A."
                                }
                            ]},
                            "ref-sourcetitle": "Arch Med Sci"
                        },
                        "ce:source-text": "51. Kawalec P, Mikrut A, Wisniewska N, Pile A. Tumor necrosis factor-alpha antibodies (infliximab, adalimumab and certoli-zumab) in Crohn's disease: systematic review and meta-analysis. Arch Med Sci 2013;9:765-779."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "52. Feagan BG, Schwartz D, Danese S, et al. Efficacy of vedolizu-mab in fistulising Crohn's disease: exploratory analyses of data from GEMINI 2. J Crohns Colitis 2018;12:621-626.",
                        "@id": "52",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Efficacy of vedolizu-mab in fistulising Crohn's disease: exploratory analyses of data from GEMINI 2"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85046546950",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {
                                    "@first": "621",
                                    "@last": "626"
                                }
                            },
                            "ref-text": "52",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "BG",
                                        "@_fa": "true",
                                        "ce:surname": "Feagan",
                                        "ce:indexed-name": "Feagan BG"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Schwartz",
                                        "ce:indexed-name": "Schwartz D"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Danese",
                                        "ce:indexed-name": "Danese S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Crohns Colitis"
                        },
                        "ce:source-text": "52. Feagan BG, Schwartz D, Danese S, et al. Efficacy of vedolizu-mab in fistulising Crohn's disease: exploratory analyses of data from GEMINI 2. J Crohns Colitis 2018;12:621-626."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "53. Ji CC, Takano S. Clinical efficacy of adalimumab versus infliximab and the factors associated with recurrence or aggravation during treatment of anal fistulas in Crohn's disease. Intest Res 2017;15:182-186.",
                        "@id": "53",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Clinical efficacy of adalimumab versus infliximab and the factors associated with recurrence or aggravation during treatment of anal fistulas in Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85018955457",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "15"},
                                "pagerange": {
                                    "@first": "182",
                                    "@last": "186"
                                }
                            },
                            "ref-text": "53",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "CC",
                                    "@_fa": "true",
                                    "ce:surname": "Ji",
                                    "ce:indexed-name": "Ji CC"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Takano",
                                    "ce:indexed-name": "Takano S."
                                }
                            ]},
                            "ref-sourcetitle": "Intest Res"
                        },
                        "ce:source-text": "53. Ji CC, Takano S. Clinical efficacy of adalimumab versus infliximab and the factors associated with recurrence or aggravation during treatment of anal fistulas in Crohn's disease. Intest Res 2017;15:182-186."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "54. Pans J, Garca-Olmo D, Van Assche G, et al. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial. Lancet 2016;388:1281-1290.",
                        "@id": "54",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84979752747",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "388"},
                                "pagerange": {
                                    "@first": "1281",
                                    "@last": "1290"
                                }
                            },
                            "ref-text": "54",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Pans",
                                        "ce:indexed-name": "Panes J"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Garca-Olmo",
                                        "ce:indexed-name": "Garcia-Olmo D"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Van Assche",
                                        "ce:indexed-name": "Van Assche G"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "54. Pans J, Garca-Olmo D, Van Assche G, et al. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial. Lancet 2016;388:1281-1290."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "55. Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005;353:2462-2476.",
                        "@id": "55",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Infliximab for induction and maintenance therapy for ulcerative colitis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "28844473957",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "353"},
                                "pagerange": {
                                    "@first": "2462",
                                    "@last": "2476"
                                }
                            },
                            "ref-text": "55",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Rutgeerts",
                                        "ce:indexed-name": "Rutgeerts P"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "WJ",
                                        "@_fa": "true",
                                        "ce:surname": "Sandborn",
                                        "ce:indexed-name": "Sandborn WJ"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "BG",
                                        "@_fa": "true",
                                        "ce:surname": "Feagan",
                                        "ce:indexed-name": "Feagan BG"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "55. Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005;353:2462-2476."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "56. Sandborn WJ, van Assche G, Reinisch W, et al. Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis. Gastroenterology 2012; 142:257-265.",
                        "@id": "56",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84856163835",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "142"},
                                "pagerange": {
                                    "@first": "257",
                                    "@last": "265"
                                }
                            },
                            "ref-text": "56",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "WJ",
                                        "@_fa": "true",
                                        "ce:surname": "Sandborn",
                                        "ce:indexed-name": "Sandborn WJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "van Assche",
                                        "ce:indexed-name": "van Assche G"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W",
                                        "@_fa": "true",
                                        "ce:surname": "Reinisch",
                                        "ce:indexed-name": "Reinisch W"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "56. Sandborn WJ, van Assche G, Reinisch W, et al. Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis. Gastroenterology 2012; 142:257-265."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "57. Sandborn WJ, Feagan BG, Marano C, et al. Subcutaneous go-limumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis. Gastroenterology 2014;146:85-95.",
                        "@id": "57",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Subcutaneous go-limumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84890620601",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "146"},
                                "pagerange": {
                                    "@first": "85",
                                    "@last": "95"
                                }
                            },
                            "ref-text": "57",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "WJ",
                                        "@_fa": "true",
                                        "ce:surname": "Sandborn",
                                        "ce:indexed-name": "Sandborn WJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "BG",
                                        "@_fa": "true",
                                        "ce:surname": "Feagan",
                                        "ce:indexed-name": "Feagan BG"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Marano",
                                        "ce:indexed-name": "Marano C"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "57. Sandborn WJ, Feagan BG, Marano C, et al. Subcutaneous go-limumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis. Gastroenterology 2014;146:85-95."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "58. Sandborn WJ, Feagan BG, Marano C, et al. Subcutaneous go-limumab maintains clinical response in patients with mod-erate-to-severe ulcerative colitis. Gastroenterology 2014;146: 96-109.",
                        "@id": "58",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Subcutaneous go-limumab maintains clinical response in patients with mod-erate-to-severe ulcerative colitis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84890629055",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "146"},
                                "pagerange": {
                                    "@first": "96",
                                    "@last": "109"
                                }
                            },
                            "ref-text": "58",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "WJ",
                                        "@_fa": "true",
                                        "ce:surname": "Sandborn",
                                        "ce:indexed-name": "Sandborn WJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "BG",
                                        "@_fa": "true",
                                        "ce:surname": "Feagan",
                                        "ce:indexed-name": "Feagan BG"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Marano",
                                        "ce:indexed-name": "Marano C"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "58. Sandborn WJ, Feagan BG, Marano C, et al. Subcutaneous go-limumab maintains clinical response in patients with mod-erate-to-severe ulcerative colitis. Gastroenterology 2014;146: 96-109."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "59. Feagan BG, Rutgeerts P, Sands BE, et al. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med 2013;369:699-710.",
                        "@id": "59",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Vedolizumab as induction and maintenance therapy for ulcerative colitis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84882769357",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "369"},
                                "pagerange": {
                                    "@first": "699",
                                    "@last": "710"
                                }
                            },
                            "ref-text": "59",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "BG",
                                        "@_fa": "true",
                                        "ce:surname": "Feagan",
                                        "ce:indexed-name": "Feagan BG"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Rutgeerts",
                                        "ce:indexed-name": "Rutgeerts P"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "BE",
                                        "@_fa": "true",
                                        "ce:surname": "Sands",
                                        "ce:indexed-name": "Sands BE"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "59. Feagan BG, Rutgeerts P, Sands BE, et al. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med 2013;369:699-710."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "60. Jrnerot G, Hertervig E, Friis-Liby I, et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 2005; 128:1805-1811.",
                        "@id": "60",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "20444479336",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "128"},
                                "pagerange": {
                                    "@first": "1805",
                                    "@last": "1811"
                                }
                            },
                            "ref-text": "60",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Jrnerot",
                                        "ce:indexed-name": "Jarnerot G"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Hertervig",
                                        "ce:indexed-name": "Hertervig E"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "I",
                                        "@_fa": "true",
                                        "ce:surname": "Friis-Liby",
                                        "ce:indexed-name": "Friis-Liby I"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "60. Jrnerot G, Hertervig E, Friis-Liby I, et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 2005; 128:1805-1811."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "61. Garca-Lpez S, Gomolln-Garca F, Prez-Gisbert J. Cyclosporine in the treatment of severe attack of ulcerative colitis: a systematic review. Gastroenterol Hepatol 2005;28:607-614.",
                        "@id": "61",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Cyclosporine in the treatment of severe attack of ulcerative colitis: a systematic review"},
                            "refd-itemidlist": {"itemid": {
                                "$": "30944433773",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "28"},
                                "pagerange": {
                                    "@first": "607",
                                    "@last": "614"
                                }
                            },
                            "ref-text": "61",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Garca-Lpez",
                                    "ce:indexed-name": "Garcia-Lopez S"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "F",
                                    "@_fa": "true",
                                    "ce:surname": "Gomolln-Garca",
                                    "ce:indexed-name": "Gomollon-Garcia F"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Prez-Gisbert",
                                    "ce:indexed-name": "Perez-Gisbert J."
                                }
                            ]},
                            "ref-sourcetitle": "Gastroenterol Hepatol"
                        },
                        "ce:source-text": "61. Garca-Lpez S, Gomolln-Garca F, Prez-Gisbert J. Cyclosporine in the treatment of severe attack of ulcerative colitis: a systematic review. Gastroenterol Hepatol 2005;28:607-614."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "62. Laharie D, Bourreille A, Branche J, et al. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Lancet 2012;380:1909-1915.",
                        "@id": "62",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84870293844",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "380"},
                                "pagerange": {
                                    "@first": "1909",
                                    "@last": "1915"
                                }
                            },
                            "ref-text": "62",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Laharie",
                                        "ce:indexed-name": "Laharie D"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Bourreille",
                                        "ce:indexed-name": "Bourreille A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Branche",
                                        "ce:indexed-name": "Branche J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "62. Laharie D, Bourreille A, Branche J, et al. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Lancet 2012;380:1909-1915."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "63. Williams JG, Alam MF, Alrubaiy L, et al. Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial. Lancet Gastroenterol Hepatol 2016;1:15-24.",
                        "@id": "63",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84995899350",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "1"},
                                "pagerange": {
                                    "@first": "15",
                                    "@last": "24"
                                }
                            },
                            "ref-text": "63",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JG",
                                        "@_fa": "true",
                                        "ce:surname": "Williams",
                                        "ce:indexed-name": "Williams JG"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "MF",
                                        "@_fa": "true",
                                        "ce:surname": "Alam",
                                        "ce:indexed-name": "Alam MF"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Alrubaiy",
                                        "ce:indexed-name": "Alrubaiy L"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Gastroenterol Hepatol"
                        },
                        "ce:source-text": "63. Williams JG, Alam MF, Alrubaiy L, et al. Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial. Lancet Gastroenterol Hepatol 2016;1:15-24."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "64. Chen JH, Andrews JM, Kariyawasam V, et al. Review article: acute severe ulcerative colitis - evidence-based consensus statements. Aliment Pharmacol Ther 2016;44:127-144.",
                        "@id": "64",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Review article: acute severe ulcerative colitis - evidence-based consensus statements"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84971434933",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "44"},
                                "pagerange": {
                                    "@first": "127",
                                    "@last": "144"
                                }
                            },
                            "ref-text": "64",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JH",
                                        "@_fa": "true",
                                        "ce:surname": "Chen",
                                        "ce:indexed-name": "Chen JH"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "JM",
                                        "@_fa": "true",
                                        "ce:surname": "Andrews",
                                        "ce:indexed-name": "Andrews JM"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Kariyawasam",
                                        "ce:indexed-name": "Kariyawasam V"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Aliment Pharmacol Ther"
                        },
                        "ce:source-text": "64. Chen JH, Andrews JM, Kariyawasam V, et al. Review article: acute severe ulcerative colitis - evidence-based consensus statements. Aliment Pharmacol Ther 2016;44:127-144."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "65. Peyrin-Biroulet L, Van Assche G, Gomez-Ulloa D, et al. Systematic review of tumor necrosis factor antagonists in extraintestinal manifestations in inflammatory bowel disease. Clin Gastroenterol Hepatol 2017;15:25-36.",
                        "@id": "65",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Systematic review of tumor necrosis factor antagonists in extraintestinal manifestations in inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84994893494",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "15"},
                                "pagerange": {
                                    "@first": "25",
                                    "@last": "36"
                                }
                            },
                            "ref-text": "65",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Peyrin-Biroulet",
                                        "ce:indexed-name": "Peyrin-Biroulet L"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Van Assche",
                                        "ce:indexed-name": "Van Assche G"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Gomez-Ulloa",
                                        "ce:indexed-name": "Gomez-Ulloa D"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Gastroenterol Hepatol"
                        },
                        "ce:source-text": "65. Peyrin-Biroulet L, Van Assche G, Gomez-Ulloa D, et al. Systematic review of tumor necrosis factor antagonists in extraintestinal manifestations in inflammatory bowel disease. Clin Gastroenterol Hepatol 2017;15:25-36."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "66. Tadbiri S, Peyrin-Biroulet L, Serrero M, et al. Impact of vedoli-zumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort. Aliment Pharmacol Ther 2018;47:485-493.",
                        "@id": "66",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Impact of vedoli-zumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85038072867",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "47"},
                                "pagerange": {
                                    "@first": "485",
                                    "@last": "493"
                                }
                            },
                            "ref-text": "66",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Tadbiri",
                                        "ce:indexed-name": "Tadbiri S"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Peyrin-Biroulet",
                                        "ce:indexed-name": "Peyrin-Biroulet L"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Serrero",
                                        "ce:indexed-name": "Serrero M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Aliment Pharmacol Ther"
                        },
                        "ce:source-text": "66. Tadbiri S, Peyrin-Biroulet L, Serrero M, et al. Impact of vedoli-zumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort. Aliment Pharmacol Ther 2018;47:485-493."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "67. Colombel JF, Sands BE, Rutgeerts P, et al. The safety of vedoli-zumab for ulcerative colitis and Crohn's disease. Gut 2017; 66:839-851.",
                        "@id": "67",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "The safety of vedoli-zumab for ulcerative colitis and Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84960145681",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "66"},
                                "pagerange": {
                                    "@first": "839",
                                    "@last": "851"
                                }
                            },
                            "ref-text": "67",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JF",
                                        "@_fa": "true",
                                        "ce:surname": "Colombel",
                                        "ce:indexed-name": "Colombel JF"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "BE",
                                        "@_fa": "true",
                                        "ce:surname": "Sands",
                                        "ce:indexed-name": "Sands BE"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Rutgeerts",
                                        "ce:indexed-name": "Rutgeerts P"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gut"
                        },
                        "ce:source-text": "67. Colombel JF, Sands BE, Rutgeerts P, et al. The safety of vedoli-zumab for ulcerative colitis and Crohn's disease. Gut 2017; 66:839-851."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "68. Amiot A, Serrero M, Peyrin-Biroulet L, et al. One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicenter cohort study. Aliment Pharmacol Ther 2017;46:310-321.",
                        "@id": "68",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicenter cohort study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85020291356",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "46"},
                                "pagerange": {
                                    "@first": "310",
                                    "@last": "321"
                                }
                            },
                            "ref-text": "68",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Amiot",
                                        "ce:indexed-name": "Amiot A"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Serrero",
                                        "ce:indexed-name": "Serrero M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Peyrin-Biroulet",
                                        "ce:indexed-name": "Peyrin-Biroulet L"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Aliment Pharmacol Ther"
                        },
                        "ce:source-text": "68. Amiot A, Serrero M, Peyrin-Biroulet L, et al. One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicenter cohort study. Aliment Pharmacol Ther 2017;46:310-321."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "69. Sands BE, Sandborn WJ, Van Assche G, et al. Vedolizumab as induction and maintenance therapy for Crohn's disease in patients nave to or who have failed tumor necrosis factor antagonist therapy. Inflamm Bowel Dis 2017;23:97-106.",
                        "@id": "69",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Vedolizumab as induction and maintenance therapy for Crohn's disease in patients nave to or who have failed tumor necrosis factor antagonist therapy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85002497981",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "23"},
                                "pagerange": {
                                    "@first": "97",
                                    "@last": "106"
                                }
                            },
                            "ref-text": "69",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "BE",
                                        "@_fa": "true",
                                        "ce:surname": "Sands",
                                        "ce:indexed-name": "Sands BE"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "WJ",
                                        "@_fa": "true",
                                        "ce:surname": "Sandborn",
                                        "ce:indexed-name": "Sandborn WJ"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Van Assche",
                                        "ce:indexed-name": "Van Assche G"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Inflamm Bowel Dis"
                        },
                        "ce:source-text": "69. Sands BE, Sandborn WJ, Van Assche G, et al. Vedolizumab as induction and maintenance therapy for Crohn's disease in patients nave to or who have failed tumor necrosis factor antagonist therapy. Inflamm Bowel Dis 2017;23:97-106."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "70. Gottlieb AB, Kalb RE, Langley RG, et al. Safety observations in 12095 patients with psoriasis enrolled in an international registry (PSOLAR): experience with infliximab and other systemic and biologic therapies. J Drugs Dermatol 2014;13:1441-1448.",
                        "@id": "70",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Safety observations in 12095 patients with psoriasis enrolled in an international registry (PSOLAR): experience with infliximab and other systemic and biologic therapies"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84920873215",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "1441",
                                    "@last": "1448"
                                }
                            },
                            "ref-text": "70",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "AB",
                                        "@_fa": "true",
                                        "ce:surname": "Gottlieb",
                                        "ce:indexed-name": "Gottlieb AB"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "RE",
                                        "@_fa": "true",
                                        "ce:surname": "Kalb",
                                        "ce:indexed-name": "Kalb RE"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "RG",
                                        "@_fa": "true",
                                        "ce:surname": "Langley",
                                        "ce:indexed-name": "Langley RG"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Drugs Dermatol"
                        },
                        "ce:source-text": "70. Gottlieb AB, Kalb RE, Langley RG, et al. Safety observations in 12095 patients with psoriasis enrolled in an international registry (PSOLAR): experience with infliximab and other systemic and biologic therapies. J Drugs Dermatol 2014;13:1441-1448."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "71. Tsai TF, Ho V, Song M, et al. The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection. Br J Dermatol 2012;167:1145-1152.",
                        "@id": "71",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84868108815",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "167"},
                                "pagerange": {
                                    "@first": "1145",
                                    "@last": "1152"
                                }
                            },
                            "ref-text": "71",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "TF",
                                        "@_fa": "true",
                                        "ce:surname": "Tsai",
                                        "ce:indexed-name": "Tsai TF"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Ho",
                                        "ce:indexed-name": "Ho V"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Song",
                                        "ce:indexed-name": "Song M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Br J Dermatol"
                        },
                        "ce:source-text": "71. Tsai TF, Ho V, Song M, et al. The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection. Br J Dermatol 2012;167:1145-1152."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "72. Papp K, Gottlieb AB, Naldi L, et al. Safety surveillance for ust-ekinumab and other psoriasis treatments from the Psoriasis Longitudinal Assessment and Registry (PSOLAR). J Drugs Dermatol 2015;14:706-714.",
                        "@id": "72",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Safety surveillance for ust-ekinumab and other psoriasis treatments from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84941599682",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {
                                    "@first": "706",
                                    "@last": "714"
                                }
                            },
                            "ref-text": "72",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Papp",
                                        "ce:indexed-name": "Papp K"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "AB",
                                        "@_fa": "true",
                                        "ce:surname": "Gottlieb",
                                        "ce:indexed-name": "Gottlieb AB"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Naldi",
                                        "ce:indexed-name": "Naldi L"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Drugs Dermatol"
                        },
                        "ce:source-text": "72. Papp K, Gottlieb AB, Naldi L, et al. Safety surveillance for ust-ekinumab and other psoriasis treatments from the Psoriasis Longitudinal Assessment and Registry (PSOLAR). J Drugs Dermatol 2015;14:706-714."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "73. McInnes IB, Kavanaugh A, Gottlieb AB, et al. Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial. Lancet 2013;382:780-789.",
                        "@id": "73",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84883134297",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "382"},
                                "pagerange": {
                                    "@first": "780",
                                    "@last": "789"
                                }
                            },
                            "ref-text": "73",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "IB",
                                        "@_fa": "true",
                                        "ce:surname": "McInnes",
                                        "ce:indexed-name": "McInnes IB"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Kavanaugh",
                                        "ce:indexed-name": "Kavanaugh A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "AB",
                                        "@_fa": "true",
                                        "ce:surname": "Gottlieb",
                                        "ce:indexed-name": "Gottlieb AB"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "73. McInnes IB, Kavanaugh A, Gottlieb AB, et al. Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial. Lancet 2013;382:780-789."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "74. Ritchlin C, Rahman P, Kavanaugh A, et al. Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUM-MIT 2 trial. Ann Rheum Dis 2014;73:990-999.",
                        "@id": "74",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUM-MIT 2 trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84899991797",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "73"},
                                "pagerange": {
                                    "@first": "990",
                                    "@last": "999"
                                }
                            },
                            "ref-text": "74",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Ritchlin",
                                        "ce:indexed-name": "Ritchlin C"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Rahman",
                                        "ce:indexed-name": "Rahman P"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Kavanaugh",
                                        "ce:indexed-name": "Kavanaugh A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Rheum Dis"
                        },
                        "ce:source-text": "74. Ritchlin C, Rahman P, Kavanaugh A, et al. Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUM-MIT 2 trial. Ann Rheum Dis 2014;73:990-999."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "75. Lynch M, Roche L, Horgan M, Ahmad K, Hackett C, Ramsay B. Peritoneal tuberculosis in the setting of ustekinumab treatment for psoriasis. JAAD Case Rep 2017;3:230-232.",
                        "@id": "75",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Peritoneal tuberculosis in the setting of ustekinumab treatment for psoriasis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85017464785",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "3"},
                                "pagerange": {
                                    "@first": "230",
                                    "@last": "232"
                                }
                            },
                            "ref-text": "75",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Lynch",
                                    "ce:indexed-name": "Lynch M"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L",
                                    "@_fa": "true",
                                    "ce:surname": "Roche",
                                    "ce:indexed-name": "Roche L"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Horgan",
                                    "ce:indexed-name": "Horgan M"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "K",
                                    "@_fa": "true",
                                    "ce:surname": "Ahmad",
                                    "ce:indexed-name": "Ahmad K"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "C",
                                    "@_fa": "true",
                                    "ce:surname": "Hackett",
                                    "ce:indexed-name": "Hackett C"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Ramsay",
                                    "ce:indexed-name": "Ramsay B."
                                }
                            ]},
                            "ref-sourcetitle": "JAAD Case Rep"
                        },
                        "ce:source-text": "75. Lynch M, Roche L, Horgan M, Ahmad K, Hackett C, Ramsay B. Peritoneal tuberculosis in the setting of ustekinumab treatment for psoriasis. JAAD Case Rep 2017;3:230-232."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "76. Sanchez-Moya AI, Dauden E. Peripheral lymph node recurrence of tuberculosis after ustekinumab treatment. Arch Dermatol 2012;148:1332-1333.",
                        "@id": "76",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Peripheral lymph node recurrence of tuberculosis after ustekinumab treatment"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84869841655",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "148"},
                                "pagerange": {
                                    "@first": "1332",
                                    "@last": "1333"
                                }
                            },
                            "ref-text": "76",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "AI",
                                    "@_fa": "true",
                                    "ce:surname": "Sanchez-Moya",
                                    "ce:indexed-name": "Sanchez-Moya AI"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Dauden",
                                    "ce:indexed-name": "Dauden E."
                                }
                            ]},
                            "ref-sourcetitle": "Arch Dermatol"
                        },
                        "ce:source-text": "76. Sanchez-Moya AI, Dauden E. Peripheral lymph node recurrence of tuberculosis after ustekinumab treatment. Arch Dermatol 2012;148:1332-1333."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "77. Scott FI, Lichtenstein GR. Biosimilars in the treatment of inflammatory bowel disease: supporting evidence in 2017. Curr Treat Options Gastroenterol 2018;16:147-164.",
                        "@id": "77",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Biosimilars in the treatment of inflammatory bowel disease: supporting evidence in 2017"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85052051342",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {
                                    "@first": "147",
                                    "@last": "164"
                                }
                            },
                            "ref-text": "77",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "FI",
                                    "@_fa": "true",
                                    "ce:surname": "Scott",
                                    "ce:indexed-name": "Scott FI"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "GR.",
                                    "@_fa": "true",
                                    "ce:surname": "Lichtenstein",
                                    "ce:indexed-name": "Lichtenstein GR."
                                }
                            ]},
                            "ref-sourcetitle": "Curr Treat Options Gastroenterol"
                        },
                        "ce:source-text": "77. Scott FI, Lichtenstein GR. Biosimilars in the treatment of inflammatory bowel disease: supporting evidence in 2017. Curr Treat Options Gastroenterol 2018;16:147-164."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "78. Avila-Ribeiro P, Fiorino G, Danese S. The experience with biosimilars of infliximab in inflammatory bowel disease. Curr Pharm Des 2017;23:6759-6769.",
                        "@id": "78",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "The experience with biosimilars of infliximab in inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85046872242",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "23"},
                                "pagerange": {
                                    "@first": "6759",
                                    "@last": "6769"
                                }
                            },
                            "ref-text": "78",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P",
                                    "@_fa": "true",
                                    "ce:surname": "Avila-Ribeiro",
                                    "ce:indexed-name": "Avila-Ribeiro P"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "G",
                                    "@_fa": "true",
                                    "ce:surname": "Fiorino",
                                    "ce:indexed-name": "Fiorino G"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Danese",
                                    "ce:indexed-name": "Danese S."
                                }
                            ]},
                            "ref-sourcetitle": "Curr Pharm Des"
                        },
                        "ce:source-text": "78. Avila-Ribeiro P, Fiorino G, Danese S. The experience with biosimilars of infliximab in inflammatory bowel disease. Curr Pharm Des 2017;23:6759-6769."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "79. Cohen HP, Blauvelt A, Rifkin RM, Danese S, Gokhale SB, Wool-lett G. Switching reference medicines to biosimilars: a systematic literature review of clinical outcomes. Drugs 2018;78: 463-478.",
                        "@id": "79",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Switching reference medicines to biosimilars: a systematic literature review of clinical outcomes"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85044199780",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "78"},
                                "pagerange": {
                                    "@first": "463",
                                    "@last": "478"
                                }
                            },
                            "ref-text": "79",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "HP",
                                    "@_fa": "true",
                                    "ce:surname": "Cohen",
                                    "ce:indexed-name": "Cohen HP"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Blauvelt",
                                    "ce:indexed-name": "Blauvelt A"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "RM",
                                    "@_fa": "true",
                                    "ce:surname": "Rifkin",
                                    "ce:indexed-name": "Rifkin RM"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Danese",
                                    "ce:indexed-name": "Danese S"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "SB",
                                    "@_fa": "true",
                                    "ce:surname": "Gokhale",
                                    "ce:indexed-name": "Gokhale SB"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Wool-lett",
                                    "ce:indexed-name": "Wool-lett G."
                                }
                            ]},
                            "ref-sourcetitle": "Drugs"
                        },
                        "ce:source-text": "79. Cohen HP, Blauvelt A, Rifkin RM, Danese S, Gokhale SB, Wool-lett G. Switching reference medicines to biosimilars: a systematic literature review of clinical outcomes. Drugs 2018;78: 463-478."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "80. Fiorino G, Manetti N, Armuzzi A, et al. The PROSIT-BIO cohort: a prospective observational study of patients with inflammatory bowel disease treated with infliximab biosimilar. Inflamm Bowel Dis 2017;23:233-243.",
                        "@id": "80",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "The PROSIT-BIO cohort: a prospective observational study of patients with inflammatory bowel disease treated with infliximab biosimilar"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85010905756",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "23"},
                                "pagerange": {
                                    "@first": "233",
                                    "@last": "243"
                                }
                            },
                            "ref-text": "80",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Fiorino",
                                        "ce:indexed-name": "Fiorino G"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Manetti",
                                        "ce:indexed-name": "Manetti N"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Armuzzi",
                                        "ce:indexed-name": "Armuzzi A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Inflamm Bowel Dis"
                        },
                        "ce:source-text": "80. Fiorino G, Manetti N, Armuzzi A, et al. The PROSIT-BIO cohort: a prospective observational study of patients with inflammatory bowel disease treated with infliximab biosimilar. Inflamm Bowel Dis 2017;23:233-243."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "81. Schmitz EMH, Boekema PJ, Straathof JWA, et al. Switching from infliximab innovator to biosimilar in patients with inflammatory bowel disease: a 12-month multicentre observational prospective cohort study. Aliment Pharmacol Ther 2018; 47:356-363.",
                        "@id": "81",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Switching from infliximab innovator to biosimilar in patients with inflammatory bowel disease: a 12-month multicentre observational prospective cohort study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85037363144",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "47"},
                                "pagerange": {
                                    "@first": "356",
                                    "@last": "363"
                                }
                            },
                            "ref-text": "81",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "EMH",
                                        "@_fa": "true",
                                        "ce:surname": "Schmitz",
                                        "ce:indexed-name": "Schmitz EMH"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "PJ",
                                        "@_fa": "true",
                                        "ce:surname": "Boekema",
                                        "ce:indexed-name": "Boekema PJ"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "JWA",
                                        "@_fa": "true",
                                        "ce:surname": "Straathof",
                                        "ce:indexed-name": "Straathof JWA"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Aliment Pharmacol Ther"
                        },
                        "ce:source-text": "81. Schmitz EMH, Boekema PJ, Straathof JWA, et al. Switching from infliximab innovator to biosimilar in patients with inflammatory bowel disease: a 12-month multicentre observational prospective cohort study. Aliment Pharmacol Ther 2018; 47:356-363."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "82. Park SH, Kim YH, Lee JH, et al. Post-marketing study of biosimilar infliximab (CT-P13) to evaluate its safety and efficacy in Korea. Expert Rev Gastroenterol Hepatol 2015;9 Suppl 1: 35-44.",
                        "@id": "82",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Post-marketing study of biosimilar infliximab (CT-P13) to evaluate its safety and efficacy in Korea"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84942325078",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {
                                    "@first": "35",
                                    "@last": "44"
                                }
                            },
                            "ref-text": "82. Suppl 1",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "SH",
                                        "@_fa": "true",
                                        "ce:surname": "Park",
                                        "ce:indexed-name": "Park SH"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "YH",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim YH"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "JH",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee JH"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Expert Rev Gastroenterol Hepatol"
                        },
                        "ce:source-text": "82. Park SH, Kim YH, Lee JH, et al. Post-marketing study of biosimilar infliximab (CT-P13) to evaluate its safety and efficacy in Korea. Expert Rev Gastroenterol Hepatol 2015;9 Suppl 1: 35-44."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "83. Kurti Z, Gonczi L, Lakatos PL. Progress with infliximab biosimilars for inflammatory bowel disease. Expert Opin Biol Ther 2018;18:633-640.",
                        "@id": "83",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Progress with infliximab biosimilars for inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85048303532",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "18"},
                                "pagerange": {
                                    "@first": "633",
                                    "@last": "640"
                                }
                            },
                            "ref-text": "83",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "Z",
                                    "@_fa": "true",
                                    "ce:surname": "Kurti",
                                    "ce:indexed-name": "Kurti Z"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L",
                                    "@_fa": "true",
                                    "ce:surname": "Gonczi",
                                    "ce:indexed-name": "Gonczi L"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "PL.",
                                    "@_fa": "true",
                                    "ce:surname": "Lakatos",
                                    "ce:indexed-name": "Lakatos PL."
                                }
                            ]},
                            "ref-sourcetitle": "Expert Opin Biol Ther"
                        },
                        "ce:source-text": "83. Kurti Z, Gonczi L, Lakatos PL. Progress with infliximab biosimilars for inflammatory bowel disease. Expert Opin Biol Ther 2018;18:633-640."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "84. Peyrin-Biroulet L, Sandborn W, Sands BE, et al. Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target. Am J Gastroenterol 2015;110:1324-1338.",
                        "@id": "84",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84941260661",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "110"},
                                "pagerange": {
                                    "@first": "1324",
                                    "@last": "1338"
                                }
                            },
                            "ref-text": "84",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Peyrin-Biroulet",
                                        "ce:indexed-name": "Peyrin-Biroulet L"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "W",
                                        "@_fa": "true",
                                        "ce:surname": "Sandborn",
                                        "ce:indexed-name": "Sandborn W"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "BE",
                                        "@_fa": "true",
                                        "ce:surname": "Sands",
                                        "ce:indexed-name": "Sands BE"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Am J Gastroenterol"
                        },
                        "ce:source-text": "84. Peyrin-Biroulet L, Sandborn W, Sands BE, et al. Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target. Am J Gastroenterol 2015;110:1324-1338."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "85. Levesque BG, Sandborn WJ, Ruel J, Feagan BG, Sands BE, Colombel JF. Converging goals of treatment of inflammatory bowel disease from clinical trials and practice. Gastroenterology 2015;148:37-51.",
                        "@id": "85",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Converging goals of treatment of inflammatory bowel disease from clinical trials and practice"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84922890759",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "148"},
                                "pagerange": {
                                    "@first": "37",
                                    "@last": "51"
                                }
                            },
                            "ref-text": "85",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "BG",
                                    "@_fa": "true",
                                    "ce:surname": "Levesque",
                                    "ce:indexed-name": "Levesque BG"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "WJ",
                                    "@_fa": "true",
                                    "ce:surname": "Sandborn",
                                    "ce:indexed-name": "Sandborn WJ"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Ruel",
                                    "ce:indexed-name": "Ruel J"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "BG",
                                    "@_fa": "true",
                                    "ce:surname": "Feagan",
                                    "ce:indexed-name": "Feagan BG"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "BE",
                                    "@_fa": "true",
                                    "ce:surname": "Sands",
                                    "ce:indexed-name": "Sands BE"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "JF.",
                                    "@_fa": "true",
                                    "ce:surname": "Colombel",
                                    "ce:indexed-name": "Colombel JF."
                                }
                            ]},
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "85. Levesque BG, Sandborn WJ, Ruel J, Feagan BG, Sands BE, Colombel JF. Converging goals of treatment of inflammatory bowel disease from clinical trials and practice. Gastroenterology 2015;148:37-51."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "86. Walsh AJ, Bryant RV, Travis SP. Current best practice for dis ease activity assessment in IBD. Nat Rev Gastroenterol Hepatol 2016;13:567-579.",
                        "@id": "86",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Current best practice for dis ease activity assessment in IBD"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84984846322",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "567",
                                    "@last": "579"
                                }
                            },
                            "ref-text": "86",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "AJ",
                                    "@_fa": "true",
                                    "ce:surname": "Walsh",
                                    "ce:indexed-name": "Walsh AJ"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "RV",
                                    "@_fa": "true",
                                    "ce:surname": "Bryant",
                                    "ce:indexed-name": "Bryant RV"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "SP.",
                                    "@_fa": "true",
                                    "ce:surname": "Travis",
                                    "ce:indexed-name": "Travis SP."
                                }
                            ]},
                            "ref-sourcetitle": "Nat Rev Gastroenterol Hepatol"
                        },
                        "ce:source-text": "86. Walsh AJ, Bryant RV, Travis SP. Current best practice for dis ease activity assessment in IBD. Nat Rev Gastroenterol Hepatol 2016;13:567-579."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "87. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index: national cooperative Crohn's disease study. Gastroenterology 1976;70:439-444.",
                        "@id": "87",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1976"},
                            "ref-title": {"ref-titletext": "Development of a Crohn's disease activity index: national cooperative Crohn's disease study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0017227303",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "70"},
                                "pagerange": {
                                    "@first": "439",
                                    "@last": "444"
                                }
                            },
                            "ref-text": "87",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "WR",
                                    "@_fa": "true",
                                    "ce:surname": "Best",
                                    "ce:indexed-name": "Best WR"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "JM",
                                    "@_fa": "true",
                                    "ce:surname": "Becktel",
                                    "ce:indexed-name": "Becktel JM"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "JW",
                                    "@_fa": "true",
                                    "ce:surname": "Singleton",
                                    "ce:indexed-name": "Singleton JW"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "F",
                                    "@_fa": "true",
                                    "ce:surname": "Kern",
                                    "ce:indexed-name": "Kern F"
                                }
                            ]},
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "87. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index: national cooperative Crohn's disease study. Gastroenterology 1976;70:439-444."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "88. Thia KT, Sandborn WJ, Lewis JD, et al. Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's disease. Am J Gastroenterol 2008;103:3123-3131.",
                        "@id": "88",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "58149396867",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "103"},
                                "pagerange": {
                                    "@first": "3123",
                                    "@last": "3131"
                                }
                            },
                            "ref-text": "88",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "KT",
                                        "@_fa": "true",
                                        "ce:surname": "Thia",
                                        "ce:indexed-name": "Thia KT"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "WJ",
                                        "@_fa": "true",
                                        "ce:surname": "Sandborn",
                                        "ce:indexed-name": "Sandborn WJ"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "JD",
                                        "@_fa": "true",
                                        "ce:surname": "Lewis",
                                        "ce:indexed-name": "Lewis JD"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Am J Gastroenterol"
                        },
                        "ce:source-text": "88. Thia KT, Sandborn WJ, Lewis JD, et al. Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's disease. Am J Gastroenterol 2008;103:3123-3131."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "89. Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet 1980;1:514.",
                        "@id": "89",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1980"},
                            "ref-title": {"ref-titletext": "A simple index of Crohn's-disease activity"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0019319257",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "1"},
                                "pagerange": {"@first": "514"}
                            },
                            "ref-text": "89",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "RF",
                                    "@_fa": "true",
                                    "ce:surname": "Harvey",
                                    "ce:indexed-name": "Harvey RF"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "JM.",
                                    "@_fa": "true",
                                    "ce:surname": "Bradshaw",
                                    "ce:indexed-name": "Bradshaw JM."
                                }
                            ]},
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "89. Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet 1980;1:514."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "90. Sandborn WJ, Sands BE, Wolf DC, et al. Repifermin (kerati-nocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, doseescalation trial. Aliment Pharmacol Ther 2003;17:1355-1364.",
                        "@id": "90",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Repifermin (kerati-nocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, doseescalation trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0038095637",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "17"},
                                "pagerange": {
                                    "@first": "1355",
                                    "@last": "1364"
                                }
                            },
                            "ref-text": "90",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "WJ",
                                        "@_fa": "true",
                                        "ce:surname": "Sandborn",
                                        "ce:indexed-name": "Sandborn WJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "BE",
                                        "@_fa": "true",
                                        "ce:surname": "Sands",
                                        "ce:indexed-name": "Sands BE"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "DC",
                                        "@_fa": "true",
                                        "ce:surname": "Wolf",
                                        "ce:indexed-name": "Wolf DC"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Aliment Pharmacol Ther"
                        },
                        "ce:source-text": "90. Sandborn WJ, Sands BE, Wolf DC, et al. Repifermin (kerati-nocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, doseescalation trial. Aliment Pharmacol Ther 2003;17:1355-1364."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "91. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-ami-nosalicylic acid therapy for mildly to moderately active ulcerative colitis: a randomized study. N Engl J Med 1987;317:1625-1629.",
                        "@id": "91",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1987"},
                            "ref-title": {"ref-titletext": "Coated oral 5-ami-nosalicylic acid therapy for mildly to moderately active ulcerative colitis: a randomized study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0023521441",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "317"},
                                "pagerange": {
                                    "@first": "1625",
                                    "@last": "1629"
                                }
                            },
                            "ref-text": "91",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "KW",
                                    "@_fa": "true",
                                    "ce:surname": "Schroeder",
                                    "ce:indexed-name": "Schroeder KW"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "WJ",
                                    "@_fa": "true",
                                    "ce:surname": "Tremaine",
                                    "ce:indexed-name": "Tremaine WJ"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "DM.",
                                    "@_fa": "true",
                                    "ce:surname": "Ilstrup",
                                    "ce:indexed-name": "Ilstrup DM."
                                }
                            ]},
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "91. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-ami-nosalicylic acid therapy for mildly to moderately active ulcerative colitis: a randomized study. N Engl J Med 1987;317:1625-1629."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "92. Fr0slie KF, Jahnsen J, Moum BA, Vatn MH; IBSEN Group. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 2007; 133:412-422.",
                        "@id": "92",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort"},
                            "refd-itemidlist": {"itemid": {
                                "$": "34547503869",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "133"},
                                "pagerange": {
                                    "@first": "412",
                                    "@last": "422"
                                }
                            },
                            "ref-text": "92. IBSEN Group",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "KF",
                                    "@_fa": "true",
                                    "ce:surname": "Fr0slie",
                                    "ce:indexed-name": "Fr0slie KF"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Jahnsen",
                                    "ce:indexed-name": "Jahnsen J"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "BA",
                                    "@_fa": "true",
                                    "ce:surname": "Moum",
                                    "ce:indexed-name": "Moum BA"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "MH",
                                    "@_fa": "true",
                                    "ce:surname": "Vatn",
                                    "ce:indexed-name": "Vatn MH"
                                }
                            ]},
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "92. Fr0slie KF, Jahnsen J, Moum BA, Vatn MH; IBSEN Group. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 2007; 133:412-422."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "93. Rutgeerts P, Diamond RH, Bala M, et al. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease. Gastrointest Endosc 2006;63:433-442.",
                        "@id": "93",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "32944461717",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "63"},
                                "pagerange": {
                                    "@first": "433",
                                    "@last": "442"
                                }
                            },
                            "ref-text": "93",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Rutgeerts",
                                        "ce:indexed-name": "Rutgeerts P"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "RH",
                                        "@_fa": "true",
                                        "ce:surname": "Diamond",
                                        "ce:indexed-name": "Diamond RH"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Bala",
                                        "ce:indexed-name": "Bala M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastrointest Endosc"
                        },
                        "ce:source-text": "93. Rutgeerts P, Diamond RH, Bala M, et al. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease. Gastrointest Endosc 2006;63:433-442."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "94. Schnitzler F, Fidder H, Ferrante M, et al. Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease. Inflamm Bowel Dis 2009;15:1295-1301.",
                        "@id": "94",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "70350172248",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "15"},
                                "pagerange": {
                                    "@first": "1295",
                                    "@last": "1301"
                                }
                            },
                            "ref-text": "94",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Schnitzler",
                                        "ce:indexed-name": "Schnitzler F"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Fidder",
                                        "ce:indexed-name": "Fidder H"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Ferrante",
                                        "ce:indexed-name": "Ferrante M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Inflamm Bowel Dis"
                        },
                        "ce:source-text": "94. Schnitzler F, Fidder H, Ferrante M, et al. Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease. Inflamm Bowel Dis 2009;15:1295-1301."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "95. Colombel JF, Rutgeerts P, Reinisch W, et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology 2011; 141:1194-1201.",
                        "@id": "95",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "80053130407",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "141"},
                                "pagerange": {
                                    "@first": "1194",
                                    "@last": "1201"
                                }
                            },
                            "ref-text": "95",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JF",
                                        "@_fa": "true",
                                        "ce:surname": "Colombel",
                                        "ce:indexed-name": "Colombel JF"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Rutgeerts",
                                        "ce:indexed-name": "Rutgeerts P"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W",
                                        "@_fa": "true",
                                        "ce:surname": "Reinisch",
                                        "ce:indexed-name": "Reinisch W"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "95. Colombel JF, Rutgeerts P, Reinisch W, et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology 2011; 141:1194-1201."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "96. Jones J, Loftus EV Jr, Panaccione R, et al. Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease. Clin Gastroenterol Hepatol 2008;6:1218-1224.",
                        "@id": "96",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "55149092209",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "6"},
                                "pagerange": {
                                    "@first": "1218",
                                    "@last": "1224"
                                }
                            },
                            "ref-text": "96",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Jones",
                                        "ce:indexed-name": "Jones J"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "EV",
                                        "@_fa": "true",
                                        "ce:surname": "Loftus",
                                        "ce:indexed-name": "Loftus EV"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Panaccione",
                                        "ce:indexed-name": "Panaccione R"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Gastroenterol Hepatol"
                        },
                        "ce:source-text": "96. Jones J, Loftus EV Jr, Panaccione R, et al. Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease. Clin Gastroenterol Hepatol 2008;6:1218-1224."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "97. Peyrin-Biroulet L, Reinisch W, Colombel JF, et al. Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial. Gut 2014;63:88-95.",
                        "@id": "97",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84888400869",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "63"},
                                "pagerange": {
                                    "@first": "88",
                                    "@last": "95"
                                }
                            },
                            "ref-text": "97",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Peyrin-Biroulet",
                                        "ce:indexed-name": "Peyrin-Biroulet L"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "W",
                                        "@_fa": "true",
                                        "ce:surname": "Reinisch",
                                        "ce:indexed-name": "Reinisch W"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "JF",
                                        "@_fa": "true",
                                        "ce:surname": "Colombel",
                                        "ce:indexed-name": "Colombel JF"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gut"
                        },
                        "ce:source-text": "97. Peyrin-Biroulet L, Reinisch W, Colombel JF, et al. Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial. Gut 2014;63:88-95."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "98. Boschetti G, Garnero P, Moussata D, et al. Accuracies of serum and fecal S100 proteins (calprotectin and calgranulin C) to predict the response to TNF antagonists in patients with Crohn's disease. Inflamm Bowel Dis 2015;21:331-336.",
                        "@id": "98",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Accuracies of serum and fecal S100 proteins (calprotectin and calgranulin C) to predict the response to TNF antagonists in patients with Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84927711222",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "21"},
                                "pagerange": {
                                    "@first": "331",
                                    "@last": "336"
                                }
                            },
                            "ref-text": "98",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Boschetti",
                                        "ce:indexed-name": "Boschetti G"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Garnero",
                                        "ce:indexed-name": "Garnero P"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Moussata",
                                        "ce:indexed-name": "Moussata D"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Inflamm Bowel Dis"
                        },
                        "ce:source-text": "98. Boschetti G, Garnero P, Moussata D, et al. Accuracies of serum and fecal S100 proteins (calprotectin and calgranulin C) to predict the response to TNF antagonists in patients with Crohn's disease. Inflamm Bowel Dis 2015;21:331-336."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "99. Cornillie F, Hanauer SB, Diamond RH, et al. Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial. Gut 2014;63:1721-1727.",
                        "@id": "99",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84892979466",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "63"},
                                "pagerange": {
                                    "@first": "1721",
                                    "@last": "1727"
                                }
                            },
                            "ref-text": "99",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Cornillie",
                                        "ce:indexed-name": "Cornillie F"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "SB",
                                        "@_fa": "true",
                                        "ce:surname": "Hanauer",
                                        "ce:indexed-name": "Hanauer SB"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "RH",
                                        "@_fa": "true",
                                        "ce:surname": "Diamond",
                                        "ce:indexed-name": "Diamond RH"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gut"
                        },
                        "ce:source-text": "99. Cornillie F, Hanauer SB, Diamond RH, et al. Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial. Gut 2014;63:1721-1727."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "100. Molander P, af Bjorkesten CG, Mustonen H, et al. Fecal cal-protectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFalpha blocking agents. Inflamm Bowel Dis 2012;18:2011-2017.",
                        "@id": "100",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Fecal cal-protectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFalpha blocking agents"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84866548953",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "18"},
                                "pagerange": {
                                    "@first": "2011",
                                    "@last": "2017"
                                }
                            },
                            "ref-text": "100",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Molander",
                                        "ce:indexed-name": "Molander P"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "CG",
                                        "@_fa": "true",
                                        "ce:surname": "af Bjorkesten",
                                        "ce:indexed-name": "af Bjorkesten CG"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Mustonen",
                                        "ce:indexed-name": "Mustonen H"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Inflamm Bowel Dis"
                        },
                        "ce:source-text": "100. Molander P, af Bjorkesten CG, Mustonen H, et al. Fecal cal-protectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFalpha blocking agents. Inflamm Bowel Dis 2012;18:2011-2017."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "101. Kiss LS, Szamosi T, Molnar T, et al. Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's disease. Aliment Pharmacol Ther 2011;34:911-922.",
                        "@id": "101",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "80053182153",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "34"},
                                "pagerange": {
                                    "@first": "911",
                                    "@last": "922"
                                }
                            },
                            "ref-text": "101",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "LS",
                                        "@_fa": "true",
                                        "ce:surname": "Kiss",
                                        "ce:indexed-name": "Kiss LS"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Szamosi",
                                        "ce:indexed-name": "Szamosi T"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Molnar",
                                        "ce:indexed-name": "Molnar T"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Aliment Pharmacol Ther"
                        },
                        "ce:source-text": "101. Kiss LS, Szamosi T, Molnar T, et al. Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's disease. Aliment Pharmacol Ther 2011;34:911-922."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "102. Guidi L, Marzo M, Andrisani G, et al. Faecal calprotectin assay after induction with anti-tumour necrosis factor alpha agents in inflammatory bowel disease: prediction of clinical response and mucosal healing at one year. Dig Liver Dis 2014; 46:974-979.",
                        "@id": "102",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Faecal calprotectin assay after induction with anti-tumour necrosis factor alpha agents in inflammatory bowel disease: prediction of clinical response and mucosal healing at one year"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84908236692",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "46"},
                                "pagerange": {
                                    "@first": "974",
                                    "@last": "979"
                                }
                            },
                            "ref-text": "102",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Guidi",
                                        "ce:indexed-name": "Guidi L"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Marzo",
                                        "ce:indexed-name": "Marzo M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Andrisani",
                                        "ce:indexed-name": "Andrisani G"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Dig Liver Dis"
                        },
                        "ce:source-text": "102. Guidi L, Marzo M, Andrisani G, et al. Faecal calprotectin assay after induction with anti-tumour necrosis factor alpha agents in inflammatory bowel disease: prediction of clinical response and mucosal healing at one year. Dig Liver Dis 2014; 46:974-979."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "103. Iwasa R, Yamada A, Sono K, Furukawa R, Takeuchi K, Suzuki Y. C-reactive protein level at 2 weeks following initiation of infliximab induction therapy predicts outcomes in patients with ulcerative colitis: a 3 year follow-up study. BMC Gastroenterol 2015;15:103.",
                        "@id": "103",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "C-reactive protein level at 2 weeks following initiation of infliximab induction therapy predicts outcomes in patients with ulcerative colitis: a 3 year follow-up study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84939174948",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "15"},
                                "pagerange": {"@first": "103"}
                            },
                            "ref-text": "103",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Iwasa",
                                    "ce:indexed-name": "Iwasa R"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Yamada",
                                    "ce:indexed-name": "Yamada A"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "K",
                                    "@_fa": "true",
                                    "ce:surname": "Sono",
                                    "ce:indexed-name": "Sono K"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Furukawa",
                                    "ce:indexed-name": "Furukawa R"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "K",
                                    "@_fa": "true",
                                    "ce:surname": "Takeuchi",
                                    "ce:indexed-name": "Takeuchi K"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Suzuki",
                                    "ce:indexed-name": "Suzuki Y."
                                }
                            ]},
                            "ref-sourcetitle": "BMC Gastroenterol"
                        },
                        "ce:source-text": "103. Iwasa R, Yamada A, Sono K, Furukawa R, Takeuchi K, Suzuki Y. C-reactive protein level at 2 weeks following initiation of infliximab induction therapy predicts outcomes in patients with ulcerative colitis: a 3 year follow-up study. BMC Gastroenterol 2015;15:103."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "104. Panes J, Bouhnik Y, Reinisch W, et al. Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis 2013;7:556-585.",
                        "@id": "104",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84878643775",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {
                                    "@first": "556",
                                    "@last": "585"
                                }
                            },
                            "ref-text": "104",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Panes",
                                        "ce:indexed-name": "Panes J"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Bouhnik",
                                        "ce:indexed-name": "Bouhnik Y"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W",
                                        "@_fa": "true",
                                        "ce:surname": "Reinisch",
                                        "ce:indexed-name": "Reinisch W"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Crohns Colitis"
                        },
                        "ce:source-text": "104. Panes J, Bouhnik Y, Reinisch W, et al. Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis 2013;7:556-585."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "105. Efthymiou A, Viazis N, Mantzaris G, et al. Does clinical response correlate with mucosal healing in patients with Crohn's disease of the small bowel? A prospective, case-series study using wireless capsule endoscopy. Inflamm Bowel Dis 2008; 14:1542-1547.",
                        "@id": "105",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Does clinical response correlate with mucosal healing in patients with Crohn's disease of the small bowel? A prospective, case-series study using wireless capsule endoscopy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "59249097796",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {
                                    "@first": "1542",
                                    "@last": "1547"
                                }
                            },
                            "ref-text": "105",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Efthymiou",
                                        "ce:indexed-name": "Efthymiou A"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Viazis",
                                        "ce:indexed-name": "Viazis N"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Mantzaris",
                                        "ce:indexed-name": "Mantzaris G"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Inflamm Bowel Dis"
                        },
                        "ce:source-text": "105. Efthymiou A, Viazis N, Mantzaris G, et al. Does clinical response correlate with mucosal healing in patients with Crohn's disease of the small bowel? A prospective, case-series study using wireless capsule endoscopy. Inflamm Bowel Dis 2008; 14:1542-1547."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "106. Hall B, Holleran G, Chin JL, et al. A prospective 52 week mucosal healing assessment of small bowel Crohn's disease as detected by capsule endoscopy. J Crohns Colitis 2014;8:1601-1609.",
                        "@id": "106",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "A prospective 52 week mucosal healing assessment of small bowel Crohn's disease as detected by capsule endoscopy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84918549889",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {
                                    "@first": "1601",
                                    "@last": "1609"
                                }
                            },
                            "ref-text": "106",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Hall",
                                        "ce:indexed-name": "Hall B"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Holleran",
                                        "ce:indexed-name": "Holleran G"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "JL",
                                        "@_fa": "true",
                                        "ce:surname": "Chin",
                                        "ce:indexed-name": "Chin JL"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Crohns Colitis"
                        },
                        "ce:source-text": "106. Hall B, Holleran G, Chin JL, et al. A prospective 52 week mucosal healing assessment of small bowel Crohn's disease as detected by capsule endoscopy. J Crohns Colitis 2014;8:1601-1609."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "107. Hall BJ, Holleran GE, Smith SM, Mahmud N, McNamara DA. A prospective 12-week mucosal healing assessment of small bowel Crohn's disease as detected by capsule endoscopy. Eur J Gastroenterol Hepatol 2014;26:1253-1259.",
                        "@id": "107",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "A prospective 12-week mucosal healing assessment of small bowel Crohn's disease as detected by capsule endoscopy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84922743864",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "26"},
                                "pagerange": {
                                    "@first": "1253",
                                    "@last": "1259"
                                }
                            },
                            "ref-text": "107",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "BJ",
                                    "@_fa": "true",
                                    "ce:surname": "Hall",
                                    "ce:indexed-name": "Hall BJ"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "GE",
                                    "@_fa": "true",
                                    "ce:surname": "Holleran",
                                    "ce:indexed-name": "Holleran GE"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "SM",
                                    "@_fa": "true",
                                    "ce:surname": "Smith",
                                    "ce:indexed-name": "Smith SM"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "N",
                                    "@_fa": "true",
                                    "ce:surname": "Mahmud",
                                    "ce:indexed-name": "Mahmud N"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "DA.",
                                    "@_fa": "true",
                                    "ce:surname": "McNamara",
                                    "ce:indexed-name": "McNamara DA."
                                }
                            ]},
                            "ref-sourcetitle": "Eur J Gastroenterol Hepatol"
                        },
                        "ce:source-text": "107. Hall BJ, Holleran GE, Smith SM, Mahmud N, McNamara DA. A prospective 12-week mucosal healing assessment of small bowel Crohn's disease as detected by capsule endoscopy. Eur J Gastroenterol Hepatol 2014;26:1253-1259."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "108. Kopylov U, Yablecovitch D, Lahat A, et al. Detection of small bowel mucosal healing and deep remission in patients with known small bowel Crohn's disease using biomarkers, capsule endoscopy, and imaging. Am J Gastroenterol 2015;110: 1316-1323.",
                        "@id": "108",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Detection of small bowel mucosal healing and deep remission in patients with known small bowel Crohn's disease using biomarkers, capsule endoscopy, and imaging"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84941261797",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "110"},
                                "pagerange": {
                                    "@first": "1316",
                                    "@last": "1323"
                                }
                            },
                            "ref-text": "108",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "U",
                                        "@_fa": "true",
                                        "ce:surname": "Kopylov",
                                        "ce:indexed-name": "Kopylov U"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Yablecovitch",
                                        "ce:indexed-name": "Yablecovitch D"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Lahat",
                                        "ce:indexed-name": "Lahat A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Am J Gastroenterol"
                        },
                        "ce:source-text": "108. Kopylov U, Yablecovitch D, Lahat A, et al. Detection of small bowel mucosal healing and deep remission in patients with known small bowel Crohn's disease using biomarkers, capsule endoscopy, and imaging. Am J Gastroenterol 2015;110: 1316-1323."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "109. Yang L, Ge ZZ, Gao YJ, et al. Assessment of capsule endoscopy scoring index, clinical disease activity, and C-reactive protein in small bowel Crohn's disease. J Gastroenterol Hepatol 2013;28:829-833.",
                        "@id": "109",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Assessment of capsule endoscopy scoring index, clinical disease activity, and C-reactive protein in small bowel Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84876962591",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "28"},
                                "pagerange": {
                                    "@first": "829",
                                    "@last": "833"
                                }
                            },
                            "ref-text": "109",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Yang",
                                        "ce:indexed-name": "Yang L"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "ZZ",
                                        "@_fa": "true",
                                        "ce:surname": "Ge",
                                        "ce:indexed-name": "Ge ZZ"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "YJ",
                                        "@_fa": "true",
                                        "ce:surname": "Gao",
                                        "ce:indexed-name": "Gao YJ"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Gastroenterol Hepatol"
                        },
                        "ce:source-text": "109. Yang L, Ge ZZ, Gao YJ, et al. Assessment of capsule endoscopy scoring index, clinical disease activity, and C-reactive protein in small bowel Crohn's disease. J Gastroenterol Hepatol 2013;28:829-833."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "110. Carvalho PB, Rosa B, Cotter J. Mucosal healing in Crohn's disease - are we reaching as far as possible with capsule endoscopy? J Crohns Colitis 2014;8:1566-1567.",
                        "@id": "110",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Mucosal healing in Crohn's disease - are we reaching as far as possible with capsule endoscopy?"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84927787162",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {
                                    "@first": "1566",
                                    "@last": "1567"
                                }
                            },
                            "ref-text": "110",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "PB",
                                    "@_fa": "true",
                                    "ce:surname": "Carvalho",
                                    "ce:indexed-name": "Carvalho PB"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "B",
                                    "@_fa": "true",
                                    "ce:surname": "Rosa",
                                    "ce:indexed-name": "Rosa B"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Cotter",
                                    "ce:indexed-name": "Cotter J."
                                }
                            ]},
                            "ref-sourcetitle": "J Crohns Colitis"
                        },
                        "ce:source-text": "110. Carvalho PB, Rosa B, Cotter J. Mucosal healing in Crohn's disease - are we reaching as far as possible with capsule endoscopy? J Crohns Colitis 2014;8:1566-1567."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "111. Niv Y. Small-bowel mucosal healing assessment by capsule endoscopy as a predictor of long-term clinical remission in patients with Crohn's disease: a systematic review and metaanalysis. Eur J Gastroenterol Hepatol 2017;29:844-848.",
                        "@id": "111",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Small-bowel mucosal healing assessment by capsule endoscopy as a predictor of long-term clinical remission in patients with Crohn's disease: a systematic review and metaanalysis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85017425237",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "29"},
                                "pagerange": {
                                    "@first": "844",
                                    "@last": "848"
                                }
                            },
                            "ref-text": "111",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "Y.",
                                "@_fa": "true",
                                "ce:surname": "Niv",
                                "ce:indexed-name": "Niv Y."
                            }]},
                            "ref-sourcetitle": "Eur J Gastroenterol Hepatol"
                        },
                        "ce:source-text": "111. Niv Y. Small-bowel mucosal healing assessment by capsule endoscopy as a predictor of long-term clinical remission in patients with Crohn's disease: a systematic review and metaanalysis. Eur J Gastroenterol Hepatol 2017;29:844-848."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "112. Kopylov U, Yung DE, Engel T, et al. Diagnostic yield of capsule endoscopy versus magnetic resonance enterography and small bowel contrast ultrasound in the evaluation of small bowel Crohn's disease: systematic review and meta-analysis. Dig Liver Dis 2017;49:854-863.",
                        "@id": "112",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Diagnostic yield of capsule endoscopy versus magnetic resonance enterography and small bowel contrast ultrasound in the evaluation of small bowel Crohn's disease: systematic review and meta-analysis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85018903343",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "49"},
                                "pagerange": {
                                    "@first": "854",
                                    "@last": "863"
                                }
                            },
                            "ref-text": "112",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "U",
                                        "@_fa": "true",
                                        "ce:surname": "Kopylov",
                                        "ce:indexed-name": "Kopylov U"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "DE",
                                        "@_fa": "true",
                                        "ce:surname": "Yung",
                                        "ce:indexed-name": "Yung DE"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Engel",
                                        "ce:indexed-name": "Engel T"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Dig Liver Dis"
                        },
                        "ce:source-text": "112. Kopylov U, Yung DE, Engel T, et al. Diagnostic yield of capsule endoscopy versus magnetic resonance enterography and small bowel contrast ultrasound in the evaluation of small bowel Crohn's disease: systematic review and meta-analysis. Dig Liver Dis 2017;49:854-863."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "113. Cotter J, Dias de Castro F, Magalhes J, Moreira MJ, Rosa B. Validation of the Lewis score for the evaluation of small-bowel Crohn's disease activity. Endoscopy 2015;47:330-335.",
                        "@id": "113",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Validation of the Lewis score for the evaluation of small-bowel Crohn's disease activity"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84964239552",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "47"},
                                "pagerange": {
                                    "@first": "330",
                                    "@last": "335"
                                }
                            },
                            "ref-text": "113",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Cotter",
                                    "ce:indexed-name": "Cotter J"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "F",
                                    "@_fa": "true",
                                    "ce:surname": "Dias de Castro",
                                    "ce:indexed-name": "Dias de Castro F"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Magalhes",
                                    "ce:indexed-name": "Magalhaes J"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "MJ",
                                    "@_fa": "true",
                                    "ce:surname": "Moreira",
                                    "ce:indexed-name": "Moreira MJ"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Rosa",
                                    "ce:indexed-name": "Rosa B."
                                }
                            ]},
                            "ref-sourcetitle": "Endoscopy"
                        },
                        "ce:source-text": "113. Cotter J, Dias de Castro F, Magalhes J, Moreira MJ, Rosa B. Validation of the Lewis score for the evaluation of small-bowel Crohn's disease activity. Endoscopy 2015;47:330-335."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "114. Niv Y, Ilani S, Levi Z, et al. Validation of the capsule endoscopy Crohn's disease activity index (CECDAI or Niv score): a multicenter prospective study. Endoscopy 2012;44:21-26.",
                        "@id": "114",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Validation of the capsule endoscopy Crohn's disease activity index (CECDAI or Niv score): a multicenter prospective study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84455202340",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "44"},
                                "pagerange": {
                                    "@first": "21",
                                    "@last": "26"
                                }
                            },
                            "ref-text": "114",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Niv",
                                        "ce:indexed-name": "Niv Y"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Ilani",
                                        "ce:indexed-name": "Ilani S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Z",
                                        "@_fa": "true",
                                        "ce:surname": "Levi",
                                        "ce:indexed-name": "Levi Z"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Endoscopy"
                        },
                        "ce:source-text": "114. Niv Y, Ilani S, Levi Z, et al. Validation of the capsule endoscopy Crohn's disease activity index (CECDAI or Niv score): a multicenter prospective study. Endoscopy 2012;44:21-26."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "115. Enns RA, Hookey L, Armstrong D, et al. Clinical practice guidelines for the use of video capsule endoscopy. Gastroenterology 2017;152:497-514.",
                        "@id": "115",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Clinical practice guidelines for the use of video capsule endoscopy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85010749126",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "152"},
                                "pagerange": {
                                    "@first": "497",
                                    "@last": "514"
                                }
                            },
                            "ref-text": "115",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "RA",
                                        "@_fa": "true",
                                        "ce:surname": "Enns",
                                        "ce:indexed-name": "Enns RA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Hookey",
                                        "ce:indexed-name": "Hookey L"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Armstrong",
                                        "ce:indexed-name": "Armstrong D"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "115. Enns RA, Hookey L, Armstrong D, et al. Clinical practice guidelines for the use of video capsule endoscopy. Gastroenterology 2017;152:497-514."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "116. Cheifetz AS, Kornbluth AA, Legnani P, et al. The risk of retention of the capsule endoscope in patients with known or suspected Crohn's disease. Am J Gastroenterol 2006;101:2218-2222.",
                        "@id": "116",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "The risk of retention of the capsule endoscope in patients with known or suspected Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33749180455",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "101"},
                                "pagerange": {
                                    "@first": "2218",
                                    "@last": "2222"
                                }
                            },
                            "ref-text": "116",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "AS",
                                        "@_fa": "true",
                                        "ce:surname": "Cheifetz",
                                        "ce:indexed-name": "Cheifetz AS"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "AA",
                                        "@_fa": "true",
                                        "ce:surname": "Kornbluth",
                                        "ce:indexed-name": "Kornbluth AA"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Legnani",
                                        "ce:indexed-name": "Legnani P"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Am J Gastroenterol"
                        },
                        "ce:source-text": "116. Cheifetz AS, Kornbluth AA, Legnani P, et al. The risk of retention of the capsule endoscope in patients with known or suspected Crohn's disease. Am J Gastroenterol 2006;101:2218-2222."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "117. Liao Z, Gao R, Xu C, Li ZS. Indications and detection, completion, and retention rates of small-bowel capsule endoscopy: a systematic review. Gastrointest Endosc 2010;71:280-286.",
                        "@id": "117",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Indications and detection, completion, and retention rates of small-bowel capsule endoscopy: a systematic review"},
                            "refd-itemidlist": {"itemid": {
                                "$": "75749129045",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "71"},
                                "pagerange": {
                                    "@first": "280",
                                    "@last": "286"
                                }
                            },
                            "ref-text": "117",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "Z",
                                    "@_fa": "true",
                                    "ce:surname": "Liao",
                                    "ce:indexed-name": "Liao Z"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Gao",
                                    "ce:indexed-name": "Gao R"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C",
                                    "@_fa": "true",
                                    "ce:surname": "Xu",
                                    "ce:indexed-name": "Xu C"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "ZS.",
                                    "@_fa": "true",
                                    "ce:surname": "Li",
                                    "ce:indexed-name": "Li ZS."
                                }
                            ]},
                            "ref-sourcetitle": "Gastrointest Endosc"
                        },
                        "ce:source-text": "117. Liao Z, Gao R, Xu C, Li ZS. Indications and detection, completion, and retention rates of small-bowel capsule endoscopy: a systematic review. Gastrointest Endosc 2010;71:280-286."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "118. Postgate AJ, Burling D, Gupta A, Fitzpatrick A, Fraser C. Safety, reliability and limitations of the given patency capsule in patients at risk of capsule retention: a 3-year technical review. Dig Dis Sci 2008;53:2732-2738.",
                        "@id": "118",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Safety, reliability and limitations of the given patency capsule in patients at risk of capsule retention: a 3-year technical review"},
                            "refd-itemidlist": {"itemid": {
                                "$": "50949104729",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "53"},
                                "pagerange": {
                                    "@first": "2732",
                                    "@last": "2738"
                                }
                            },
                            "ref-text": "118",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "AJ",
                                    "@_fa": "true",
                                    "ce:surname": "Postgate",
                                    "ce:indexed-name": "Postgate AJ"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D",
                                    "@_fa": "true",
                                    "ce:surname": "Burling",
                                    "ce:indexed-name": "Burling D"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Gupta",
                                    "ce:indexed-name": "Gupta A"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Fitzpatrick",
                                    "ce:indexed-name": "Fitzpatrick A"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Fraser",
                                    "ce:indexed-name": "Fraser C."
                                }
                            ]},
                            "ref-sourcetitle": "Dig Dis Sci"
                        },
                        "ce:source-text": "118. Postgate AJ, Burling D, Gupta A, Fitzpatrick A, Fraser C. Safety, reliability and limitations of the given patency capsule in patients at risk of capsule retention: a 3-year technical review. Dig Dis Sci 2008;53:2732-2738."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "119. Hg CM, Bark L, Arkani J, Gorsetman J, Brostrm O, Sjqvist U. Capsule retentions and incomplete capsule endoscopy examinations: an analysis of 2300 examinations. Gastroenterol Res Pract 2012;2012:518718.",
                        "@id": "119",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Capsule retentions and incomplete capsule endoscopy examinations: an analysis of 2300 examinations"},
                            "refd-itemidlist": {"itemid": {
                                "$": "81555220071",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "2012"},
                                "pagerange": {"@first": "518718"}
                            },
                            "ref-text": "119",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "CM",
                                    "@_fa": "true",
                                    "ce:surname": "Hg",
                                    "ce:indexed-name": "Hoog CM"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L",
                                    "@_fa": "true",
                                    "ce:surname": "Bark",
                                    "ce:indexed-name": "Bark LA"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Arkani",
                                    "ce:indexed-name": "Arkani J"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Gorsetman",
                                    "ce:indexed-name": "Gorsetman J"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "O",
                                    "@_fa": "true",
                                    "ce:surname": "Brostrm",
                                    "ce:indexed-name": "Brostrom O"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "U.",
                                    "@_fa": "true",
                                    "ce:surname": "Sjqvist",
                                    "ce:indexed-name": "Sjoqvist U."
                                }
                            ]},
                            "ref-sourcetitle": "Gastroenterol Res Pract"
                        },
                        "ce:source-text": "119. Hg CM, Bark L, Arkani J, Gorsetman J, Brostrm O, Sjqvist U. Capsule retentions and incomplete capsule endoscopy examinations: an analysis of 2300 examinations. Gastroenterol Res Pract 2012;2012:518718."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "120. Ye CA, Gao YJ, Ge ZZ, et al. PillCam colon capsule endoscopy versus conventional colonoscopy for the detection of severity and extent of ulcerative colitis. J Dig Dis 2013;14:117-124.",
                        "@id": "120",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "PillCam colon capsule endoscopy versus conventional colonoscopy for the detection of severity and extent of ulcerative colitis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84874073319",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {
                                    "@first": "117",
                                    "@last": "124"
                                }
                            },
                            "ref-text": "120",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "CA",
                                        "@_fa": "true",
                                        "ce:surname": "Ye",
                                        "ce:indexed-name": "Ye CA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "YJ",
                                        "@_fa": "true",
                                        "ce:surname": "Gao",
                                        "ce:indexed-name": "Gao YJ"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "ZZ",
                                        "@_fa": "true",
                                        "ce:surname": "Ge",
                                        "ce:indexed-name": "Ge ZZ"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Dig Dis"
                        },
                        "ce:source-text": "120. Ye CA, Gao YJ, Ge ZZ, et al. PillCam colon capsule endoscopy versus conventional colonoscopy for the detection of severity and extent of ulcerative colitis. J Dig Dis 2013;14:117-124."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "121. Hosoe N, Matsuoka K, Naganuma M, et al. Applicability of second-generation colon capsule endoscope to ulcerative colitis: a clinical feasibility study. J Gastroenterol Hepatol 2013; 28:1174-1179.",
                        "@id": "121",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Applicability of second-generation colon capsule endoscope to ulcerative colitis: a clinical feasibility study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84879440007",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "28"},
                                "pagerange": {
                                    "@first": "1174",
                                    "@last": "1179"
                                }
                            },
                            "ref-text": "121",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Hosoe",
                                        "ce:indexed-name": "Hosoe N"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Matsuoka",
                                        "ce:indexed-name": "Matsuoka K"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Naganuma",
                                        "ce:indexed-name": "Naganuma M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Gastroenterol Hepatol"
                        },
                        "ce:source-text": "121. Hosoe N, Matsuoka K, Naganuma M, et al. Applicability of second-generation colon capsule endoscope to ulcerative colitis: a clinical feasibility study. J Gastroenterol Hepatol 2013; 28:1174-1179."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "122. Meister T, Heinzow HS, Domagk D, et al. Colon capsule endoscopy versus standard colonoscopy in assessing disease activity of ulcerative colitis: a prospective trial. Tech Coloproc-tol 2013;17:641-646.",
                        "@id": "122",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Colon capsule endoscopy versus standard colonoscopy in assessing disease activity of ulcerative colitis: a prospective trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84890561654",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "17"},
                                "pagerange": {
                                    "@first": "641",
                                    "@last": "646"
                                }
                            },
                            "ref-text": "122",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Meister",
                                        "ce:indexed-name": "Meister T"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "HS",
                                        "@_fa": "true",
                                        "ce:surname": "Heinzow",
                                        "ce:indexed-name": "Heinzow HS"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Domagk",
                                        "ce:indexed-name": "Domagk D"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Tech Coloproc-tol"
                        },
                        "ce:source-text": "122. Meister T, Heinzow HS, Domagk D, et al. Colon capsule endoscopy versus standard colonoscopy in assessing disease activity of ulcerative colitis: a prospective trial. Tech Coloproc-tol 2013;17:641-646."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "123. Sung J, Ho KY, Chiu HM, Ching J, Travis S, Peled R. The use of Pillcam Colon in assessing mucosal inflammation in ulcerative colitis: a multicenter study. Endoscopy 2012;44:754-758.",
                        "@id": "123",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "The use of Pillcam Colon in assessing mucosal inflammation in ulcerative colitis: a multicenter study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84864422717",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "44"},
                                "pagerange": {
                                    "@first": "754",
                                    "@last": "758"
                                }
                            },
                            "ref-text": "123",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Sung",
                                    "ce:indexed-name": "Sung J"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "KY",
                                    "@_fa": "true",
                                    "ce:surname": "Ho",
                                    "ce:indexed-name": "Ho KY"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "HM",
                                    "@_fa": "true",
                                    "ce:surname": "Chiu",
                                    "ce:indexed-name": "Chiu HM"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Ching",
                                    "ce:indexed-name": "Ching J"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Travis",
                                    "ce:indexed-name": "Travis S"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Peled",
                                    "ce:indexed-name": "Peled R."
                                }
                            ]},
                            "ref-sourcetitle": "Endoscopy"
                        },
                        "ce:source-text": "123. Sung J, Ho KY, Chiu HM, Ching J, Travis S, Peled R. The use of Pillcam Colon in assessing mucosal inflammation in ulcerative colitis: a multicenter study. Endoscopy 2012;44:754-758."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "124. Collins PD. Video capsule endoscopy in inflammatory bowel disease. World J Gastrointest Endosc 2016;8:477-488.",
                        "@id": "124",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Video capsule endoscopy in inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85020588565",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {
                                    "@first": "477",
                                    "@last": "488"
                                }
                            },
                            "ref-text": "124",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "PD.",
                                "@_fa": "true",
                                "ce:surname": "Collins",
                                "ce:indexed-name": "Collins PD."
                            }]},
                            "ref-sourcetitle": "World J Gastrointest Endosc"
                        },
                        "ce:source-text": "124. Collins PD. Video capsule endoscopy in inflammatory bowel disease. World J Gastrointest Endosc 2016;8:477-488."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "125. Reenaers C, Mary JY, Nachury M, et al. Outcomes 7 years after infliximab withdrawal for patients with Crohn's disease in sustained remission. Clin Gastroenterol Hepatol 2018;16:234-243.",
                        "@id": "125",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Outcomes 7 years after infliximab withdrawal for patients with Crohn's disease in sustained remission"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85044712911",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {
                                    "@first": "234",
                                    "@last": "243"
                                }
                            },
                            "ref-text": "125",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Reenaers",
                                        "ce:indexed-name": "Reenaers C"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "JY",
                                        "@_fa": "true",
                                        "ce:surname": "Mary",
                                        "ce:indexed-name": "Mary JY"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Nachury",
                                        "ce:indexed-name": "Nachury M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Gastroenterol Hepatol"
                        },
                        "ce:source-text": "125. Reenaers C, Mary JY, Nachury M, et al. Outcomes 7 years after infliximab withdrawal for patients with Crohn's disease in sustained remission. Clin Gastroenterol Hepatol 2018;16:234-243."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "126. Doherty G, Katsanos KH, Burisch J, et al. European Crohn's and Colitis Organisation Topical Review on Treatment Withdrawal [\u2018Exit Strategies'] in inflammatory bowel disease. J Crohns Colitis 2018;12:17-31.",
                        "@id": "126",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "European Crohn's and Colitis Organisation Topical Review on Treatment Withdrawal [\u2018Exit Strategies'] in inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85040567024",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {
                                    "@first": "17",
                                    "@last": "31"
                                }
                            },
                            "ref-text": "126",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Doherty",
                                        "ce:indexed-name": "Doherty G"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "KH",
                                        "@_fa": "true",
                                        "ce:surname": "Katsanos",
                                        "ce:indexed-name": "Katsanos KH"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Burisch",
                                        "ce:indexed-name": "Burisch J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Crohns Colitis"
                        },
                        "ce:source-text": "126. Doherty G, Katsanos KH, Burisch J, et al. European Crohn's and Colitis Organisation Topical Review on Treatment Withdrawal [\u2018Exit Strategies'] in inflammatory bowel disease. J Crohns Colitis 2018;12:17-31."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "127. Treton X, Bouhnik Y, Mary JY, et al. Azathioprine withdrawal in patients with Crohn's disease maintained on prolonged remission: a high risk of relapse. Clin Gastroenterol Hepatol 2009;7:80-85.",
                        "@id": "127",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Azathioprine withdrawal in patients with Crohn's disease maintained on prolonged remission: a high risk of relapse"},
                            "refd-itemidlist": {"itemid": {
                                "$": "58149136086",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {
                                    "@first": "80",
                                    "@last": "85"
                                }
                            },
                            "ref-text": "127",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "X",
                                        "@_fa": "true",
                                        "ce:surname": "Treton",
                                        "ce:indexed-name": "Treton X"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Bouhnik",
                                        "ce:indexed-name": "Bouhnik Y"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "JY",
                                        "@_fa": "true",
                                        "ce:surname": "Mary",
                                        "ce:indexed-name": "Mary JY"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Gastroenterol Hepatol"
                        },
                        "ce:source-text": "127. Treton X, Bouhnik Y, Mary JY, et al. Azathioprine withdrawal in patients with Crohn's disease maintained on prolonged remission: a high risk of relapse. Clin Gastroenterol Hepatol 2009;7:80-85."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "128. O'Donoghue DP, Dawson AM, Powell-Tuck J, Bown RL, Len-nard-Jones JE. Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease. Lancet 1978; 2:955-957.",
                        "@id": "128",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1978"},
                            "ref-title": {"ref-titletext": "Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0018117298",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "2"},
                                "pagerange": {
                                    "@first": "955",
                                    "@last": "957"
                                }
                            },
                            "ref-text": "128",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "DP",
                                    "@_fa": "true",
                                    "ce:surname": "O'Donoghue",
                                    "ce:indexed-name": "O'Donoghue DP"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "AM",
                                    "@_fa": "true",
                                    "ce:surname": "Dawson",
                                    "ce:indexed-name": "Dawson AM"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Powell-Tuck",
                                    "ce:indexed-name": "Powell-Tuck J"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "RL",
                                    "@_fa": "true",
                                    "ce:surname": "Bown",
                                    "ce:indexed-name": "Bown RL"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "JE.",
                                    "@_fa": "true",
                                    "ce:surname": "Len-nard-Jones",
                                    "ce:indexed-name": "Len-nard-Jones JE."
                                }
                            ]},
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "128. O'Donoghue DP, Dawson AM, Powell-Tuck J, Bown RL, Len-nard-Jones JE. Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease. Lancet 1978; 2:955-957."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "129. Hawthorne AB, Logan RF, Hawkey CJ, et al. Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ 1992;305:20-22.",
                        "@id": "129",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1992"},
                            "ref-title": {"ref-titletext": "Randomised controlled trial of azathioprine withdrawal in ulcerative colitis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0026693139",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "305"},
                                "pagerange": {
                                    "@first": "20",
                                    "@last": "22"
                                }
                            },
                            "ref-text": "129",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "AB",
                                        "@_fa": "true",
                                        "ce:surname": "Hawthorne",
                                        "ce:indexed-name": "Hawthorne AB"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "RF",
                                        "@_fa": "true",
                                        "ce:surname": "Logan",
                                        "ce:indexed-name": "Logan RF"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "CJ",
                                        "@_fa": "true",
                                        "ce:surname": "Hawkey",
                                        "ce:indexed-name": "Hawkey CJ"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "BMJ"
                        },
                        "ce:source-text": "129. Hawthorne AB, Logan RF, Hawkey CJ, et al. Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ 1992;305:20-22."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "130. Lmann M, Mary JY, Colombel JF, et al. A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine. Gastroenterology 2005;128:1812-1818.",
                        "@id": "130",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine"},
                            "refd-itemidlist": {"itemid": {
                                "$": "20444483170",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "128"},
                                "pagerange": {
                                    "@first": "1812",
                                    "@last": "1818"
                                }
                            },
                            "ref-text": "130",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Lmann",
                                        "ce:indexed-name": "Lemann M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "JY",
                                        "@_fa": "true",
                                        "ce:surname": "Mary",
                                        "ce:indexed-name": "Mary JY"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "JF",
                                        "@_fa": "true",
                                        "ce:surname": "Colombel",
                                        "ce:indexed-name": "Colombel JF"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "130. Lmann M, Mary JY, Colombel JF, et al. A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine. Gastroenterology 2005;128:1812-1818."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "131. Clarke K, Regueiro M. Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission. Inflamm Bowel Dis 2012;18:174-179.",
                        "@id": "131",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission"},
                            "refd-itemidlist": {"itemid": {
                                "$": "83555174451",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "18"},
                                "pagerange": {
                                    "@first": "174",
                                    "@last": "179"
                                }
                            },
                            "ref-text": "131",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K",
                                    "@_fa": "true",
                                    "ce:surname": "Clarke",
                                    "ce:indexed-name": "Clarke K"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Regueiro",
                                    "ce:indexed-name": "Regueiro M."
                                }
                            ]},
                            "ref-sourcetitle": "Inflamm Bowel Dis"
                        },
                        "ce:source-text": "131. Clarke K, Regueiro M. Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission. Inflamm Bowel Dis 2012;18:174-179."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "132. Pittet V, Froehlich F, Maillard MH, et al. When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel. J Crohns Colitis 2013;7:820-826.",
                        "@id": "132",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84884138341",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {
                                    "@first": "820",
                                    "@last": "826"
                                }
                            },
                            "ref-text": "132",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Pittet",
                                        "ce:indexed-name": "Pittet V"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Froehlich",
                                        "ce:indexed-name": "Froehlich F"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "MH",
                                        "@_fa": "true",
                                        "ce:surname": "Maillard",
                                        "ce:indexed-name": "Maillard MH"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Crohns Colitis"
                        },
                        "ce:source-text": "132. Pittet V, Froehlich F, Maillard MH, et al. When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel. J Crohns Colitis 2013;7:820-826."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "133. Kirchgesner J, Beaugerie L, Carrat F, et al. Impact on life expectancy of withdrawing thiopurines in patients with Crohn's disease in sustained clinical remission: a lifetime risk-benefit analysis. PLoS One 2016;11:e0157191.",
                        "@id": "133",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Impact on life expectancy of withdrawing thiopurines in patients with Crohn's disease in sustained clinical remission: a lifetime risk-benefit analysis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84974659808",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {"@first": "e0157191"}
                            },
                            "ref-text": "133",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Kirchgesner",
                                        "ce:indexed-name": "Kirchgesner J"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Beaugerie",
                                        "ce:indexed-name": "Beaugerie L"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Carrat",
                                        "ce:indexed-name": "Carrat F"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS One"
                        },
                        "ce:source-text": "133. Kirchgesner J, Beaugerie L, Carrat F, et al. Impact on life expectancy of withdrawing thiopurines in patients with Crohn's disease in sustained clinical remission: a lifetime risk-benefit analysis. PLoS One 2016;11:e0157191."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "134. Chouchana L, Roche D, Narjoz C, et al. Screening of TPMT deficiency by phenotyping and genotyping: a retrospective study among 1,500 IBD patients in France. Gastroenterology 2011;140(5 Suppl 1):S281-S282.",
                        "@id": "134",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Screening of TPMT deficiency by phenotyping and genotyping: a retrospective study among 1,500 IBD patients in France"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84858762138",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "140",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "S281",
                                    "@last": "S282"
                                }
                            },
                            "ref-text": "134. ;(Suppl 1)",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Chouchana",
                                        "ce:indexed-name": "Chouchana L"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Roche",
                                        "ce:indexed-name": "Roche D"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Narjoz",
                                        "ce:indexed-name": "Narjoz C"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "134. Chouchana L, Roche D, Narjoz C, et al. Screening of TPMT deficiency by phenotyping and genotyping: a retrospective study among 1,500 IBD patients in France. Gastroenterology 2011;140(5 Suppl 1):S281-S282."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "135. Chevaux JB, Peyrin-Biroulet L, Sparrow MP. Optimizing thiopurine therapy in inflammatory bowel disease. Inflamm Bowel Dis 2011;17:1428-1435.",
                        "@id": "135",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Optimizing thiopurine therapy in inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "79955820771",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "17"},
                                "pagerange": {
                                    "@first": "1428",
                                    "@last": "1435"
                                }
                            },
                            "ref-text": "135",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "JB",
                                    "@_fa": "true",
                                    "ce:surname": "Chevaux",
                                    "ce:indexed-name": "Chevaux JB"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L",
                                    "@_fa": "true",
                                    "ce:surname": "Peyrin-Biroulet",
                                    "ce:indexed-name": "Peyrin-Biroulet L"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "MP.",
                                    "@_fa": "true",
                                    "ce:surname": "Sparrow",
                                    "ce:indexed-name": "Sparrow MP."
                                }
                            ]},
                            "ref-sourcetitle": "Inflamm Bowel Dis"
                        },
                        "ce:source-text": "135. Chevaux JB, Peyrin-Biroulet L, Sparrow MP. Optimizing thiopurine therapy in inflammatory bowel disease. Inflamm Bowel Dis 2011;17:1428-1435."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "136. Kham SK, Soh CK, Liu TC, et al. Thiopurine S-methyltransfer-ase activity in three major Asian populations: a population-based study in Singapore. Eur J Clin Pharmacol 2008;64:373-379.",
                        "@id": "136",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Thiopurine S-methyltransfer-ase activity in three major Asian populations: a population-based study in Singapore"},
                            "refd-itemidlist": {"itemid": {
                                "$": "40049089901",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "64"},
                                "pagerange": {
                                    "@first": "373",
                                    "@last": "379"
                                }
                            },
                            "ref-text": "136",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "SK",
                                        "@_fa": "true",
                                        "ce:surname": "Kham",
                                        "ce:indexed-name": "Kham SK"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "CK",
                                        "@_fa": "true",
                                        "ce:surname": "Soh",
                                        "ce:indexed-name": "Soh CK"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "TC",
                                        "@_fa": "true",
                                        "ce:surname": "Liu",
                                        "ce:indexed-name": "Liu TC"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur J Clin Pharmacol"
                        },
                        "ce:source-text": "136. Kham SK, Soh CK, Liu TC, et al. Thiopurine S-methyltransfer-ase activity in three major Asian populations: a population-based study in Singapore. Eur J Clin Pharmacol 2008;64:373-379."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "137. Yang SK, Hong M, Baek J, et al. A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia. Nat Genet 2014;46:1017-1020.",
                        "@id": "137",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84922393995",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "46"},
                                "pagerange": {
                                    "@first": "1017",
                                    "@last": "1020"
                                }
                            },
                            "ref-text": "137",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "SK",
                                        "@_fa": "true",
                                        "ce:surname": "Yang",
                                        "ce:indexed-name": "Yang SK"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Hong",
                                        "ce:indexed-name": "Hong M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Baek",
                                        "ce:indexed-name": "Baek J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat Genet"
                        },
                        "ce:source-text": "137. Yang SK, Hong M, Baek J, et al. A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia. Nat Genet 2014;46:1017-1020."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "138. Takatsu N, Matsui T, Murakami Y, et al. Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyl-transferase genotype in Japanese patients with inflammatory bowel disease. J Gastroenterol Hepatol 2009;24:1258-1264.",
                        "@id": "138",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyl-transferase genotype in Japanese patients with inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "68749111832",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "24"},
                                "pagerange": {
                                    "@first": "1258",
                                    "@last": "1264"
                                }
                            },
                            "ref-text": "138",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Takatsu",
                                        "ce:indexed-name": "Takatsu N"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Matsui",
                                        "ce:indexed-name": "Matsui T"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Murakami",
                                        "ce:indexed-name": "Murakami Y"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Gastroenterol Hepatol"
                        },
                        "ce:source-text": "138. Takatsu N, Matsui T, Murakami Y, et al. Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyl-transferase genotype in Japanese patients with inflammatory bowel disease. J Gastroenterol Hepatol 2009;24:1258-1264."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "139. Fangbin Z, Xiang G, Minhu C, et al. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease? Ther Drug Monit 2012;34:695-701.",
                        "@id": "139",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84870039492",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "34"},
                                "pagerange": {
                                    "@first": "695",
                                    "@last": "701"
                                }
                            },
                            "ref-text": "139",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Z",
                                        "@_fa": "true",
                                        "ce:surname": "Fangbin",
                                        "ce:indexed-name": "Fangbin Z"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Xiang",
                                        "ce:indexed-name": "Xiang G"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Minhu",
                                        "ce:indexed-name": "Minhu C"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ther Drug Monit"
                        },
                        "ce:source-text": "139. Fangbin Z, Xiang G, Minhu C, et al. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease? Ther Drug Monit 2012;34:695-701."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "140. Moriyama T, Nishii R, Perez-Andreu V, et al. NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity. Nat Genet 2016;48:367-373.",
                        "@id": "140",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84958093148",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "48"},
                                "pagerange": {
                                    "@first": "367",
                                    "@last": "373"
                                }
                            },
                            "ref-text": "140",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Moriyama",
                                        "ce:indexed-name": "Moriyama T"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Nishii",
                                        "ce:indexed-name": "Nishii R"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Perez-Andreu",
                                        "ce:indexed-name": "Perez-Andreu V"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat Genet"
                        },
                        "ce:source-text": "140. Moriyama T, Nishii R, Perez-Andreu V, et al. NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity. Nat Genet 2016;48:367-373."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "141. Yang JJ, Landier W, Yang W, et al. Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia. J Clin Oncol 2015;33:1235-1242.",
                        "@id": "141",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84927137703",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "33"},
                                "pagerange": {
                                    "@first": "1235",
                                    "@last": "1242"
                                }
                            },
                            "ref-text": "141",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JJ",
                                        "@_fa": "true",
                                        "ce:surname": "Yang",
                                        "ce:indexed-name": "Yang JJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "W",
                                        "@_fa": "true",
                                        "ce:surname": "Landier",
                                        "ce:indexed-name": "Landier W"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W",
                                        "@_fa": "true",
                                        "ce:surname": "Yang",
                                        "ce:indexed-name": "Yang W"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "141. Yang JJ, Landier W, Yang W, et al. Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia. J Clin Oncol 2015;33:1235-1242."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "142. Zhang AL, Yang J, Wang H, Lu JL, Tang S, Zhang XJ. Association of NUDT15 c.415C>T allele and thiopurine-induced leu-kocytopenia in Asians: a systematic review and meta-analysis. Ir J Med Sci 2018;187:145-153.",
                        "@id": "142",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Association of NUDT15 c.415C>T allele and thiopurine-induced leu-kocytopenia in Asians: a systematic review and meta-analysis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85018971907",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "187"},
                                "pagerange": {
                                    "@first": "145",
                                    "@last": "153"
                                }
                            },
                            "ref-text": "142",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "AL",
                                    "@_fa": "true",
                                    "ce:surname": "Zhang",
                                    "ce:indexed-name": "Zhang AL"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Yang",
                                    "ce:indexed-name": "Yang J"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "H",
                                    "@_fa": "true",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang H"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "JL",
                                    "@_fa": "true",
                                    "ce:surname": "Lu",
                                    "ce:indexed-name": "Lu JL"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Tang",
                                    "ce:indexed-name": "Tang S"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "XJ.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhang",
                                    "ce:indexed-name": "Zhang XJ."
                                }
                            ]},
                            "ref-sourcetitle": "Ir J Med Sci"
                        },
                        "ce:source-text": "142. Zhang AL, Yang J, Wang H, Lu JL, Tang S, Zhang XJ. Association of NUDT15 c.415C>T allele and thiopurine-induced leu-kocytopenia in Asians: a systematic review and meta-analysis. Ir J Med Sci 2018;187:145-153."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "143. Steenholdt C, Bendtzen K, Brynskov J, Thomsen O0, Ainsworth MA. Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease. Scand J Gastroenterol 2011;46:310-318.",
                        "@id": "143",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "79751477764",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "46"},
                                "pagerange": {
                                    "@first": "310",
                                    "@last": "318"
                                }
                            },
                            "ref-text": "143",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C",
                                    "@_fa": "true",
                                    "ce:surname": "Steenholdt",
                                    "ce:indexed-name": "Steenholdt C"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "K",
                                    "@_fa": "true",
                                    "ce:surname": "Bendtzen",
                                    "ce:indexed-name": "Bendtzen K"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Brynskov",
                                    "ce:indexed-name": "Brynskov J"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "O0",
                                    "@_fa": "true",
                                    "ce:surname": "Thomsen",
                                    "ce:indexed-name": "Thomsen O0"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "MA.",
                                    "@_fa": "true",
                                    "ce:surname": "Ainsworth",
                                    "ce:indexed-name": "Ainsworth MA."
                                }
                            ]},
                            "ref-sourcetitle": "Scand J Gastroenterol"
                        },
                        "ce:source-text": "143. Steenholdt C, Bendtzen K, Brynskov J, Thomsen O0, Ainsworth MA. Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease. Scand J Gastroenterol 2011;46:310-318."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "144. Bortlik M, Duricova D, Malickova K, et al. Infliximab trough levels may predict sustained response to infliximab in patients with Crohn's disease. J Crohns Colitis 2013;7:736-743.",
                        "@id": "144",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Infliximab trough levels may predict sustained response to infliximab in patients with Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84881545776",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {
                                    "@first": "736",
                                    "@last": "743"
                                }
                            },
                            "ref-text": "144",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Bortlik",
                                        "ce:indexed-name": "Bortlik M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Duricova",
                                        "ce:indexed-name": "Duricova D"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Malickova",
                                        "ce:indexed-name": "Malickova K"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Crohns Colitis"
                        },
                        "ce:source-text": "144. Bortlik M, Duricova D, Malickova K, et al. Infliximab trough levels may predict sustained response to infliximab in patients with Crohn's disease. J Crohns Colitis 2013;7:736-743."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "145. Adedokun OJ, Sandborn WJ, Feagan BG, et al. Association between serum concentration of infliximab and efficacy in adult patients with ulcerative colitis. Gastroenterology 2014; 147:1296-1307.",
                        "@id": "145",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Association between serum concentration of infliximab and efficacy in adult patients with ulcerative colitis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84913534923",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "147"},
                                "pagerange": {
                                    "@first": "1296",
                                    "@last": "1307"
                                }
                            },
                            "ref-text": "145",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "OJ",
                                        "@_fa": "true",
                                        "ce:surname": "Adedokun",
                                        "ce:indexed-name": "Adedokun OJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "WJ",
                                        "@_fa": "true",
                                        "ce:surname": "Sandborn",
                                        "ce:indexed-name": "Sandborn WJ"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "BG",
                                        "@_fa": "true",
                                        "ce:surname": "Feagan",
                                        "ce:indexed-name": "Feagan BG"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "145. Adedokun OJ, Sandborn WJ, Feagan BG, et al. Association between serum concentration of infliximab and efficacy in adult patients with ulcerative colitis. Gastroenterology 2014; 147:1296-1307."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "146. Levesque BG, Greenberg GR, Zou G, et al. A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease. Aliment Pharmacol Ther 2014;39:1126-1135.",
                        "@id": "146",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84899129423",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "39"},
                                "pagerange": {
                                    "@first": "1126",
                                    "@last": "1135"
                                }
                            },
                            "ref-text": "146",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "BG",
                                        "@_fa": "true",
                                        "ce:surname": "Levesque",
                                        "ce:indexed-name": "Levesque BG"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "GR",
                                        "@_fa": "true",
                                        "ce:surname": "Greenberg",
                                        "ce:indexed-name": "Greenberg GR"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Zou",
                                        "ce:indexed-name": "Zou G"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Aliment Pharmacol Ther"
                        },
                        "ce:source-text": "146. Levesque BG, Greenberg GR, Zou G, et al. A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease. Aliment Pharmacol Ther 2014;39:1126-1135."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "147. Vande Casteele N, Khanna R, Levesque BG, et al. The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease. Gut 2015; 64:1539-1545.",
                        "@id": "147",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84941330342",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "64"},
                                "pagerange": {
                                    "@first": "1539",
                                    "@last": "1545"
                                }
                            },
                            "ref-text": "147",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Vande Casteele",
                                        "ce:indexed-name": "Vande Casteele N"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Khanna",
                                        "ce:indexed-name": "Khanna R"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "BG",
                                        "@_fa": "true",
                                        "ce:surname": "Levesque",
                                        "ce:indexed-name": "Levesque BG"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gut"
                        },
                        "ce:source-text": "147. Vande Casteele N, Khanna R, Levesque BG, et al. The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease. Gut 2015; 64:1539-1545."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "148. Reinisch W, Colombel JF, Sandborn WJ, et al. Factors associated with short- and long-term outcomes of therapy for Crohn's disease. Clin Gastroenterol Hepatol 2015;13:539-547.",
                        "@id": "148",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Factors associated with short- and long-term outcomes of therapy for Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84925329456",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "539",
                                    "@last": "547"
                                }
                            },
                            "ref-text": "148",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "W",
                                        "@_fa": "true",
                                        "ce:surname": "Reinisch",
                                        "ce:indexed-name": "Reinisch W"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "JF",
                                        "@_fa": "true",
                                        "ce:surname": "Colombel",
                                        "ce:indexed-name": "Colombel JF"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "WJ",
                                        "@_fa": "true",
                                        "ce:surname": "Sandborn",
                                        "ce:indexed-name": "Sandborn WJ"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Gastroenterol Hepatol"
                        },
                        "ce:source-text": "148. Reinisch W, Colombel JF, Sandborn WJ, et al. Factors associated with short- and long-term outcomes of therapy for Crohn's disease. Clin Gastroenterol Hepatol 2015;13:539-547."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "149. Vande Casteele N, Ferrante M, Van Assche G, et al. Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease. Gastroenterology 2015;148:1320-1329.",
                        "@id": "149",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84930015437",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "148"},
                                "pagerange": {
                                    "@first": "1320",
                                    "@last": "1329"
                                }
                            },
                            "ref-text": "149",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Vande Casteele",
                                        "ce:indexed-name": "Vande Casteele N"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Ferrante",
                                        "ce:indexed-name": "Ferrante M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Van Assche",
                                        "ce:indexed-name": "Van Assche G"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "149. Vande Casteele N, Ferrante M, Van Assche G, et al. Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease. Gastroenterology 2015;148:1320-1329."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "150. Karmiris K, Paintaud G, Noman M, et al. Influence of trough serum levels and immunogenicity on long-term outcome of adalimumab therapy in Crohn's disease. Gastroenterology 2009;137:1628-1640.",
                        "@id": "150",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Influence of trough serum levels and immunogenicity on long-term outcome of adalimumab therapy in Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "70350130547",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "137"},
                                "pagerange": {
                                    "@first": "1628",
                                    "@last": "1640"
                                }
                            },
                            "ref-text": "150",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Karmiris",
                                        "ce:indexed-name": "Karmiris K"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Paintaud",
                                        "ce:indexed-name": "Paintaud G"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Noman",
                                        "ce:indexed-name": "Noman M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "150. Karmiris K, Paintaud G, Noman M, et al. Influence of trough serum levels and immunogenicity on long-term outcome of adalimumab therapy in Crohn's disease. Gastroenterology 2009;137:1628-1640."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "151. Roblin X, Marotte H, Rinaudo M, et al. Association between pharmacokinetics of adalimumab and mucosal healing in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol 2014;12:80-84.",
                        "@id": "151",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Association between pharmacokinetics of adalimumab and mucosal healing in patients with inflammatory bowel diseases"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84890219983",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {
                                    "@first": "80",
                                    "@last": "84"
                                }
                            },
                            "ref-text": "151",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "X",
                                        "@_fa": "true",
                                        "ce:surname": "Roblin",
                                        "ce:indexed-name": "Roblin X"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Marotte",
                                        "ce:indexed-name": "Marotte H"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Rinaudo",
                                        "ce:indexed-name": "Rinaudo M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Gastroenterol Hepatol"
                        },
                        "ce:source-text": "151. Roblin X, Marotte H, Rinaudo M, et al. Association between pharmacokinetics of adalimumab and mucosal healing in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol 2014;12:80-84."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "152. Mazor Y, Almog R, Kopylov U, et al. Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease. Aliment Pharmacol Ther 2014;40:620-628.",
                        "@id": "152",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84906236434",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "40"},
                                "pagerange": {
                                    "@first": "620",
                                    "@last": "628"
                                }
                            },
                            "ref-text": "152",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Mazor",
                                        "ce:indexed-name": "Mazor Y"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Almog",
                                        "ce:indexed-name": "Almog R"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "U",
                                        "@_fa": "true",
                                        "ce:surname": "Kopylov",
                                        "ce:indexed-name": "Kopylov U"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Aliment Pharmacol Ther"
                        },
                        "ce:source-text": "152. Mazor Y, Almog R, Kopylov U, et al. Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease. Aliment Pharmacol Ther 2014;40:620-628."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "153. Roblin X, Rinaudo M, Del Tedesco E, et al. Development of an algorithm incorporating pharmacokinetics of adalimum-ab in inflammatory bowel diseases. Am J Gastroenterol 2014; 109:1250-1256.",
                        "@id": "153",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Development of an algorithm incorporating pharmacokinetics of adalimum-ab in inflammatory bowel diseases"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84905587709",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "109"},
                                "pagerange": {
                                    "@first": "1250",
                                    "@last": "1256"
                                }
                            },
                            "ref-text": "153",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "X",
                                        "@_fa": "true",
                                        "ce:surname": "Roblin",
                                        "ce:indexed-name": "Roblin X"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Rinaudo",
                                        "ce:indexed-name": "Rinaudo M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Del Tedesco",
                                        "ce:indexed-name": "Del Tedesco E"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Am J Gastroenterol"
                        },
                        "ce:source-text": "153. Roblin X, Rinaudo M, Del Tedesco E, et al. Development of an algorithm incorporating pharmacokinetics of adalimum-ab in inflammatory bowel diseases. Am J Gastroenterol 2014; 109:1250-1256."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "154. Morita Y, Imaeda H, Nishida A, et al. Association between serum adalimumab concentrations and endoscopic disease activity in patients with Crohn's disease. J Gastroenterol Hepatol 2016;31:1831-1836.",
                        "@id": "154",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Association between serum adalimumab concentrations and endoscopic disease activity in patients with Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84996537160",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "31"},
                                "pagerange": {
                                    "@first": "1831",
                                    "@last": "1836"
                                }
                            },
                            "ref-text": "154",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Morita",
                                        "ce:indexed-name": "Morita Y"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Imaeda",
                                        "ce:indexed-name": "Imaeda H"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Nishida",
                                        "ce:indexed-name": "Nishida A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Gastroenterol Hepatol"
                        },
                        "ce:source-text": "154. Morita Y, Imaeda H, Nishida A, et al. Association between serum adalimumab concentrations and endoscopic disease activity in patients with Crohn's disease. J Gastroenterol Hepatol 2016;31:1831-1836."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "155. Ungar B, Levy I, Yavne Y, et al. Optimizing anti-TNF-alpha therapy: serum levels of infliximab and adalimumab are associated with mucosal healing in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol 2016;14:550-557.",
                        "@id": "155",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Optimizing anti-TNF-alpha therapy: serum levels of infliximab and adalimumab are associated with mucosal healing in patients with inflammatory bowel diseases"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84960799161",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {
                                    "@first": "550",
                                    "@last": "557"
                                }
                            },
                            "ref-text": "155",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Ungar",
                                        "ce:indexed-name": "Ungar B"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "I",
                                        "@_fa": "true",
                                        "ce:surname": "Levy",
                                        "ce:indexed-name": "Levy I"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Yavne",
                                        "ce:indexed-name": "Yavne Y"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Gastroenterol Hepatol"
                        },
                        "ce:source-text": "155. Ungar B, Levy I, Yavne Y, et al. Optimizing anti-TNF-alpha therapy: serum levels of infliximab and adalimumab are associated with mucosal healing in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol 2016;14:550-557."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "156. Yanai H, Lichtenstein L, Assa A, et al. Levels of drug and antidrug antibodies are associated with outcome of interventions after loss of response to infliximab or adalimumab. Clin Gastroenterol Hepatol 2015;13:522-530.",
                        "@id": "156",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Levels of drug and antidrug antibodies are associated with outcome of interventions after loss of response to infliximab or adalimumab"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84925367939",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "522",
                                    "@last": "530"
                                }
                            },
                            "ref-text": "156",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Yanai",
                                        "ce:indexed-name": "Yanai H"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Lichtenstein",
                                        "ce:indexed-name": "Lichtenstein L"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Assa",
                                        "ce:indexed-name": "Assa A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Gastroenterol Hepatol"
                        },
                        "ce:source-text": "156. Yanai H, Lichtenstein L, Assa A, et al. Levels of drug and antidrug antibodies are associated with outcome of interventions after loss of response to infliximab or adalimumab. Clin Gastroenterol Hepatol 2015;13:522-530."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "157. Vande Casteele N, Gils A, Singh S, et al. Antibody response to infliximab and its impact on pharmacokinetics can be transient. Am J Gastroenterol 2013;108:962-971.",
                        "@id": "157",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Antibody response to infliximab and its impact on pharmacokinetics can be transient"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84878945732",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "108"},
                                "pagerange": {
                                    "@first": "962",
                                    "@last": "971"
                                }
                            },
                            "ref-text": "157",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Vande Casteele",
                                        "ce:indexed-name": "Vande Casteele N"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Gils",
                                        "ce:indexed-name": "Gils A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Singh",
                                        "ce:indexed-name": "Singh S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Am J Gastroenterol"
                        },
                        "ce:source-text": "157. Vande Casteele N, Gils A, Singh S, et al. Antibody response to infliximab and its impact on pharmacokinetics can be transient. Am J Gastroenterol 2013;108:962-971."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "158. Dignass A, Van Assche G, Lindsay JO, et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management. J Crohns Colitis 2010;4:28-62.",
                        "@id": "158",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management"},
                            "refd-itemidlist": {"itemid": {
                                "$": "75149161836",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "4"},
                                "pagerange": {
                                    "@first": "28",
                                    "@last": "62"
                                }
                            },
                            "ref-text": "158",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Dignass",
                                        "ce:indexed-name": "Dignass A"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Van Assche",
                                        "ce:indexed-name": "Van Assche G"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "JO",
                                        "@_fa": "true",
                                        "ce:surname": "Lindsay",
                                        "ce:indexed-name": "Lindsay JO"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Crohns Colitis"
                        },
                        "ce:source-text": "158. Dignass A, Van Assche G, Lindsay JO, et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management. J Crohns Colitis 2010;4:28-62."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "159. Candy S, Wright J, Gerber M, Adams G, Gerig M, Goodman R. A controlled double blind study of azathioprine in the management of Crohn's disease. Gut 1995;37:674-678.",
                        "@id": "159",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1995"},
                            "ref-title": {"ref-titletext": "A controlled double blind study of azathioprine in the management of Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0028790186",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "37"},
                                "pagerange": {
                                    "@first": "674",
                                    "@last": "678"
                                }
                            },
                            "ref-text": "159",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Candy",
                                    "ce:indexed-name": "Candy S"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Wright",
                                    "ce:indexed-name": "Wright J"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Gerber",
                                    "ce:indexed-name": "Gerber M"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "G",
                                    "@_fa": "true",
                                    "ce:surname": "Adams",
                                    "ce:indexed-name": "Adams G"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Gerig",
                                    "ce:indexed-name": "Gerig M"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Goodman",
                                    "ce:indexed-name": "Goodman R."
                                }
                            ]},
                            "ref-sourcetitle": "Gut"
                        },
                        "ce:source-text": "159. Candy S, Wright J, Gerber M, Adams G, Gerig M, Goodman R. A controlled double blind study of azathioprine in the management of Crohn's disease. Gut 1995;37:674-678."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "160. Present DH, Korelitz BI, Wisch N, Glass JL, Sachar DB, Pasternack BS. Treatment of Crohn's disease with 6-mercaptopu-rine: a long-term, randomized, double-blind study. N Engl J Med 1980;302:981-987.",
                        "@id": "160",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1980"},
                            "ref-title": {"ref-titletext": "Treatment of Crohn's disease with 6-mercaptopu-rine: a long-term, randomized, double-blind study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0018888679",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "302"},
                                "pagerange": {
                                    "@first": "981",
                                    "@last": "987"
                                }
                            },
                            "ref-text": "160",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "DH",
                                    "@_fa": "true",
                                    "ce:surname": "Present",
                                    "ce:indexed-name": "Present DH"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "BI",
                                    "@_fa": "true",
                                    "ce:surname": "Korelitz",
                                    "ce:indexed-name": "Korelitz BI"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "N",
                                    "@_fa": "true",
                                    "ce:surname": "Wisch",
                                    "ce:indexed-name": "Wisch N"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "JL",
                                    "@_fa": "true",
                                    "ce:surname": "Glass",
                                    "ce:indexed-name": "Glass JL"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "DB",
                                    "@_fa": "true",
                                    "ce:surname": "Sachar",
                                    "ce:indexed-name": "Sachar DB"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "BS.",
                                    "@_fa": "true",
                                    "ce:surname": "Pasternack",
                                    "ce:indexed-name": "Pasternack BS."
                                }
                            ]},
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "160. Present DH, Korelitz BI, Wisch N, Glass JL, Sachar DB, Pasternack BS. Treatment of Crohn's disease with 6-mercaptopu-rine: a long-term, randomized, double-blind study. N Engl J Med 1980;302:981-987."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "161. Dubinsky MC, Lamothe S, Yang HY, et al. Pharmacogenom-ics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 2000; 118:705-713.",
                        "@id": "161",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2000"},
                            "ref-title": {"ref-titletext": "Pharmacogenom-ics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0034067784",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "118"},
                                "pagerange": {
                                    "@first": "705",
                                    "@last": "713"
                                }
                            },
                            "ref-text": "161",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MC",
                                        "@_fa": "true",
                                        "ce:surname": "Dubinsky",
                                        "ce:indexed-name": "Dubinsky MC"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Lamothe",
                                        "ce:indexed-name": "Lamothe S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "HY",
                                        "@_fa": "true",
                                        "ce:surname": "Yang",
                                        "ce:indexed-name": "Yang HY"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "161. Dubinsky MC, Lamothe S, Yang HY, et al. Pharmacogenom-ics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 2000; 118:705-713."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "162. Osterman MT, Kundu R, Lichtenstein GR, Lewis JD. Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis. Gastroenterology 2006;130:1047-1053.",
                        "@id": "162",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33646011261",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "130"},
                                "pagerange": {
                                    "@first": "1047",
                                    "@last": "1053"
                                }
                            },
                            "ref-text": "162",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "MT",
                                    "@_fa": "true",
                                    "ce:surname": "Osterman",
                                    "ce:indexed-name": "Osterman MT"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Kundu",
                                    "ce:indexed-name": "Kundu R"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "GR",
                                    "@_fa": "true",
                                    "ce:surname": "Lichtenstein",
                                    "ce:indexed-name": "Lichtenstein GR"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "JD.",
                                    "@_fa": "true",
                                    "ce:surname": "Lewis",
                                    "ce:indexed-name": "Lewis JD."
                                }
                            ]},
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "162. Osterman MT, Kundu R, Lichtenstein GR, Lewis JD. Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis. Gastroenterology 2006;130:1047-1053."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "163. Hindorf U, Lindqvist M, Hildebrand H, Fagerberg U, Almer S. Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease. Aliment Pharmacol Ther 2006;24:331-342.",
                        "@id": "163",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33745650894",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "24"},
                                "pagerange": {
                                    "@first": "331",
                                    "@last": "342"
                                }
                            },
                            "ref-text": "163",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "U",
                                    "@_fa": "true",
                                    "ce:surname": "Hindorf",
                                    "ce:indexed-name": "Hindorf U"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Lindqvist",
                                    "ce:indexed-name": "Lindqvist M"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "H",
                                    "@_fa": "true",
                                    "ce:surname": "Hildebrand",
                                    "ce:indexed-name": "Hildebrand H"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "U",
                                    "@_fa": "true",
                                    "ce:surname": "Fagerberg",
                                    "ce:indexed-name": "Fagerberg U"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Almer",
                                    "ce:indexed-name": "Almer S."
                                }
                            ]},
                            "ref-sourcetitle": "Aliment Pharmacol Ther"
                        },
                        "ce:source-text": "163. Hindorf U, Lindqvist M, Hildebrand H, Fagerberg U, Almer S. Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease. Aliment Pharmacol Ther 2006;24:331-342."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "164. Gearry RB, Barclay ML. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease. J Gastroenterol Hepatol 2005;20:1149-1157.",
                        "@id": "164",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "27744461917",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "20"},
                                "pagerange": {
                                    "@first": "1149",
                                    "@last": "1157"
                                }
                            },
                            "ref-text": "164",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "RB",
                                    "@_fa": "true",
                                    "ce:surname": "Gearry",
                                    "ce:indexed-name": "Gearry RB"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "ML.",
                                    "@_fa": "true",
                                    "ce:surname": "Barclay",
                                    "ce:indexed-name": "Barclay ML."
                                }
                            ]},
                            "ref-sourcetitle": "J Gastroenterol Hepatol"
                        },
                        "ce:source-text": "164. Gearry RB, Barclay ML. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease. J Gastroenterol Hepatol 2005;20:1149-1157."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "165. Haines ML, Ajlouni Y, Irving PM, et al. Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease. Inflamm Bowel Dis 2011;17:1301-1307.",
                        "@id": "165",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "79955828365",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "17"},
                                "pagerange": {
                                    "@first": "1301",
                                    "@last": "1307"
                                }
                            },
                            "ref-text": "165",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "ML",
                                        "@_fa": "true",
                                        "ce:surname": "Haines",
                                        "ce:indexed-name": "Haines ML"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Ajlouni",
                                        "ce:indexed-name": "Ajlouni Y"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "PM",
                                        "@_fa": "true",
                                        "ce:surname": "Irving",
                                        "ce:indexed-name": "Irving PM"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Inflamm Bowel Dis"
                        },
                        "ce:source-text": "165. Haines ML, Ajlouni Y, Irving PM, et al. Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease. Inflamm Bowel Dis 2011;17:1301-1307."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "166. Kennedy NA, Asser TL, Mountifield RE, Doogue MP, Andrews JM, Bampton PA. Thiopurine metabolite measurement leads to changes in management of inflammatory bowel disease. Intern Med J 2013;43:278-286.",
                        "@id": "166",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Thiopurine metabolite measurement leads to changes in management of inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84874353885",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "43"},
                                "pagerange": {
                                    "@first": "278",
                                    "@last": "286"
                                }
                            },
                            "ref-text": "166",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "NA",
                                    "@_fa": "true",
                                    "ce:surname": "Kennedy",
                                    "ce:indexed-name": "Kennedy NA"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "TL",
                                    "@_fa": "true",
                                    "ce:surname": "Asser",
                                    "ce:indexed-name": "Asser TL"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "RE",
                                    "@_fa": "true",
                                    "ce:surname": "Mountifield",
                                    "ce:indexed-name": "Mountifield RE"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "MP",
                                    "@_fa": "true",
                                    "ce:surname": "Doogue",
                                    "ce:indexed-name": "Doogue MP"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "JM",
                                    "@_fa": "true",
                                    "ce:surname": "Andrews",
                                    "ce:indexed-name": "Andrews JM"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "PA.",
                                    "@_fa": "true",
                                    "ce:surname": "Bampton",
                                    "ce:indexed-name": "Bampton PA."
                                }
                            ]},
                            "ref-sourcetitle": "Intern Med J"
                        },
                        "ce:source-text": "166. Kennedy NA, Asser TL, Mountifield RE, Doogue MP, Andrews JM, Bampton PA. Thiopurine metabolite measurement leads to changes in management of inflammatory bowel disease. Intern Med J 2013;43:278-286."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "167. Baert F, Noman M, Vermeire S, et al. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. N Engl J Med 2003;348:601-608.",
                        "@id": "167",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0037434552",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "348"},
                                "pagerange": {
                                    "@first": "601",
                                    "@last": "608"
                                }
                            },
                            "ref-text": "167",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Baert",
                                        "ce:indexed-name": "Baert F"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Noman",
                                        "ce:indexed-name": "Noman M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Vermeire",
                                        "ce:indexed-name": "Vermeire S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "167. Baert F, Noman M, Vermeire S, et al. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. N Engl J Med 2003;348:601-608."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "168. Yarur AJ, Kubiliun MJ, Czul F, et al. Concentrations of 6-thio-guanine nucleotide correlate with trough levels of infliximab in patients with inflammatory bowel disease on combination therapy. Clin Gastroenterol Hepatol 2015;13:1118-1124.",
                        "@id": "168",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Concentrations of 6-thio-guanine nucleotide correlate with trough levels of infliximab in patients with inflammatory bowel disease on combination therapy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84928628450",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "1118",
                                    "@last": "1124"
                                }
                            },
                            "ref-text": "168",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "AJ",
                                        "@_fa": "true",
                                        "ce:surname": "Yarur",
                                        "ce:indexed-name": "Yarur AJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "MJ",
                                        "@_fa": "true",
                                        "ce:surname": "Kubiliun",
                                        "ce:indexed-name": "Kubiliun MJ"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Czul",
                                        "ce:indexed-name": "Czul F"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Gastroenterol Hepatol"
                        },
                        "ce:source-text": "168. Yarur AJ, Kubiliun MJ, Czul F, et al. Concentrations of 6-thio-guanine nucleotide correlate with trough levels of infliximab in patients with inflammatory bowel disease on combination therapy. Clin Gastroenterol Hepatol 2015;13:1118-1124."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "169. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 2012; 30:2212-2219.",
                        "@id": "169",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84857358267",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "30"},
                                "pagerange": {
                                    "@first": "2212",
                                    "@last": "2219"
                                }
                            },
                            "ref-text": "169",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "JJ",
                                    "@_fa": "true",
                                    "ce:surname": "Ott",
                                    "ce:indexed-name": "Ott JJ"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "GA",
                                    "@_fa": "true",
                                    "ce:surname": "Stevens",
                                    "ce:indexed-name": "Stevens GA"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Groeger",
                                    "ce:indexed-name": "Groeger J"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "ST.",
                                    "@_fa": "true",
                                    "ce:surname": "Wiersma",
                                    "ce:indexed-name": "Wiersma ST."
                                }
                            ]},
                            "ref-sourcetitle": "Vaccine"
                        },
                        "ce:source-text": "169. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 2012; 30:2212-2219."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "170. Cheon JH. Understanding the complications of anti-tumor necrosis factor therapy in East Asian patients with inflammatory bowel disease. J Gastroenterol Hepatol 2017;32:769-777.",
                        "@id": "170",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Understanding the complications of anti-tumor necrosis factor therapy in East Asian patients with inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85016093965",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "32"},
                                "pagerange": {
                                    "@first": "769",
                                    "@last": "777"
                                }
                            },
                            "ref-text": "170",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "JH.",
                                "@_fa": "true",
                                "ce:surname": "Cheon",
                                "ce:indexed-name": "Cheon JH."
                            }]},
                            "ref-sourcetitle": "J Gastroenterol Hepatol"
                        },
                        "ce:source-text": "170. Cheon JH. Understanding the complications of anti-tumor necrosis factor therapy in East Asian patients with inflammatory bowel disease. J Gastroenterol Hepatol 2017;32:769-777."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "171. Rahier JF, Magro F, Abreu C, et al. Second European evidencebased consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis 2014;8:443-468.",
                        "@id": "171",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Second European evidencebased consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84899719594",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {
                                    "@first": "443",
                                    "@last": "468"
                                }
                            },
                            "ref-text": "171",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JF",
                                        "@_fa": "true",
                                        "ce:surname": "Rahier",
                                        "ce:indexed-name": "Rahier JF"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Magro",
                                        "ce:indexed-name": "Magro F"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Abreu",
                                        "ce:indexed-name": "Abreu C"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Crohns Colitis"
                        },
                        "ce:source-text": "171. Rahier JF, Magro F, Abreu C, et al. Second European evidencebased consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis 2014;8:443-468."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "172. Loras C, Gisbert JP, Minguez M, et al. Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy. Gut 2010; 59:1340-1346.",
                        "@id": "172",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "77957188851",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "59"},
                                "pagerange": {
                                    "@first": "1340",
                                    "@last": "1346"
                                }
                            },
                            "ref-text": "172",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Loras",
                                        "ce:indexed-name": "Loras C"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "JP",
                                        "@_fa": "true",
                                        "ce:surname": "Gisbert",
                                        "ce:indexed-name": "Gisbert JP"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Minguez",
                                        "ce:indexed-name": "Minguez M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gut"
                        },
                        "ce:source-text": "172. Loras C, Gisbert JP, Minguez M, et al. Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy. Gut 2010; 59:1340-1346."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "173. Park SH, Yang SK, Lim YS, et al. Clinical courses of chronic hepatitis B virus infection and inflammatory bowel disease in patients with both diseases. Inflamm Bowel Dis 2012;18: 2004-2010.",
                        "@id": "173",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Clinical courses of chronic hepatitis B virus infection and inflammatory bowel disease in patients with both diseases"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84867577708",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "18"},
                                "pagerange": {
                                    "@first": "2004",
                                    "@last": "2010"
                                }
                            },
                            "ref-text": "173",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "SH",
                                        "@_fa": "true",
                                        "ce:surname": "Park",
                                        "ce:indexed-name": "Park SH"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "SK",
                                        "@_fa": "true",
                                        "ce:surname": "Yang",
                                        "ce:indexed-name": "Yang SK"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "YS",
                                        "@_fa": "true",
                                        "ce:surname": "Lim",
                                        "ce:indexed-name": "Lim YS"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Inflamm Bowel Dis"
                        },
                        "ce:source-text": "173. Park SH, Yang SK, Lim YS, et al. Clinical courses of chronic hepatitis B virus infection and inflammatory bowel disease in patients with both diseases. Inflamm Bowel Dis 2012;18: 2004-2010."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "174. Lin JN, Lai CH, Chen YH, et al. Risk factors for extra-pulmonary tuberculosis compared to pulmonary tuberculosis. Int J Tuberc Lung Dis 2009;13:620-625.",
                        "@id": "174",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Risk factors for extra-pulmonary tuberculosis compared to pulmonary tuberculosis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "67649510133",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "620",
                                    "@last": "625"
                                }
                            },
                            "ref-text": "174",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JN",
                                        "@_fa": "true",
                                        "ce:surname": "Lin",
                                        "ce:indexed-name": "Lin JN"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "CH",
                                        "@_fa": "true",
                                        "ce:surname": "Lai",
                                        "ce:indexed-name": "Lai CH"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "YH",
                                        "@_fa": "true",
                                        "ce:surname": "Chen",
                                        "ce:indexed-name": "Chen YH"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int J Tuberc Lung Dis"
                        },
                        "ce:source-text": "174. Lin JN, Lai CH, Chen YH, et al. Risk factors for extra-pulmonary tuberculosis compared to pulmonary tuberculosis. Int J Tuberc Lung Dis 2009;13:620-625."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "175. Kulchavenya E. Extrapulmonary tuberculosis: are statistical reports accurate? Ther Adv Infect Dis 2014;2:61-70.",
                        "@id": "175",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Extrapulmonary tuberculosis: are statistical reports accurate?"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84993728260",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "2"},
                                "pagerange": {
                                    "@first": "61",
                                    "@last": "70"
                                }
                            },
                            "ref-text": "175",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "E.",
                                "@_fa": "true",
                                "ce:surname": "Kulchavenya",
                                "ce:indexed-name": "Kulchavenya E."
                            }]},
                            "ref-sourcetitle": "Ther Adv Infect Dis"
                        },
                        "ce:source-text": "175. Kulchavenya E. Extrapulmonary tuberculosis: are statistical reports accurate? Ther Adv Infect Dis 2014;2:61-70."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "176. Lim CH, Chen HH, Chen YH, et al. The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: a 15-year real world experience in Taiwan. PLoS One 2017;12:e0178035.",
                        "@id": "176",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: a 15-year real world experience in Taiwan"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85020005894",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {"@first": "e0178035"}
                            },
                            "ref-text": "176",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "CH",
                                        "@_fa": "true",
                                        "ce:surname": "Lim",
                                        "ce:indexed-name": "Lim CH"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "HH",
                                        "@_fa": "true",
                                        "ce:surname": "Chen",
                                        "ce:indexed-name": "Chen HH"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "YH",
                                        "@_fa": "true",
                                        "ce:surname": "Chen",
                                        "ce:indexed-name": "Chen YH"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS One"
                        },
                        "ce:source-text": "176. Lim CH, Chen HH, Chen YH, et al. The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: a 15-year real world experience in Taiwan. PLoS One 2017;12:e0178035."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "177. Weng MT, Wei SC, Lin CC, et al. Seminar report from the 2014 Taiwan Society of Inflammatory Bowel Disease (TSIBD) spring forum (May 24th, 2014): Crohn's disease versus intestinal tuberculosis infection. Intest Res 2015;13:6-10.",
                        "@id": "177",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Seminar report from the 2014 Taiwan Society of Inflammatory Bowel Disease (TSIBD) spring forum (May 24th, 2014): Crohn's disease versus intestinal tuberculosis infection"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84942608818",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "6",
                                    "@last": "10"
                                }
                            },
                            "ref-text": "177",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MT",
                                        "@_fa": "true",
                                        "ce:surname": "Weng",
                                        "ce:indexed-name": "Weng MT"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "SC",
                                        "@_fa": "true",
                                        "ce:surname": "Wei",
                                        "ce:indexed-name": "Wei SC"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "CC",
                                        "@_fa": "true",
                                        "ce:surname": "Lin",
                                        "ce:indexed-name": "Lin CC"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Intest Res"
                        },
                        "ce:source-text": "177. Weng MT, Wei SC, Lin CC, et al. Seminar report from the 2014 Taiwan Society of Inflammatory Bowel Disease (TSIBD) spring forum (May 24th, 2014): Crohn's disease versus intestinal tuberculosis infection. Intest Res 2015;13:6-10."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "178. Horsburgh CR Jr, Rubin EJ. Clinical practice: latent tuberculosis infection in the United States. N Engl J Med 2011;364:1441-1448.",
                        "@id": "178",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Clinical practice: latent tuberculosis infection in the United States"},
                            "refd-itemidlist": {"itemid": {
                                "$": "79954473147",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "364"},
                                "pagerange": {
                                    "@first": "1441",
                                    "@last": "1448"
                                }
                            },
                            "ref-text": "178",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "CR",
                                    "@_fa": "true",
                                    "ce:surname": "Horsburgh",
                                    "ce:indexed-name": "Horsburgh CR"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "EJ.",
                                    "@_fa": "true",
                                    "ce:surname": "Rubin",
                                    "ce:indexed-name": "Rubin EJ."
                                }
                            ]},
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "178. Horsburgh CR Jr, Rubin EJ. Clinical practice: latent tuberculosis infection in the United States. N Engl J Med 2011;364:1441-1448."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "179. Lee J, Kim E, Jang EJ, et al. Efficacy of treatment for latent tuberculosis in patients undergoing treatment with a tumor necrosis factor antagonist. Ann Am Thorac Soc 2017;14:690-697.",
                        "@id": "179",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Efficacy of treatment for latent tuberculosis in patients undergoing treatment with a tumor necrosis factor antagonist"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85018975934",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {
                                    "@first": "690",
                                    "@last": "697"
                                }
                            },
                            "ref-text": "179",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee J"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim E"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "EJ",
                                        "@_fa": "true",
                                        "ce:surname": "Jang",
                                        "ce:indexed-name": "Jang EJ"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Am Thorac Soc"
                        },
                        "ce:source-text": "179. Lee J, Kim E, Jang EJ, et al. Efficacy of treatment for latent tuberculosis in patients undergoing treatment with a tumor necrosis factor antagonist. Ann Am Thorac Soc 2017;14:690-697."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "180. Park DI, Hisamatsu T, Chen M, et al. Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: management. J Gastroenterol Hepatol 2018;33:30-36.",
                        "@id": "180",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: management"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85039451691",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "33"},
                                "pagerange": {
                                    "@first": "30",
                                    "@last": "36"
                                }
                            },
                            "ref-text": "180",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "DI",
                                        "@_fa": "true",
                                        "ce:surname": "Park",
                                        "ce:indexed-name": "Park DI"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Hisamatsu",
                                        "ce:indexed-name": "Hisamatsu T"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Chen",
                                        "ce:indexed-name": "Chen M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Gastroenterol Hepatol"
                        },
                        "ce:source-text": "180. Park DI, Hisamatsu T, Chen M, et al. Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: management. J Gastroenterol Hepatol 2018;33:30-36."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "181. Naderi HR, Sheybani F, Rezaei Pajand S. How should we manage latent tuberculosis infection in patients receiving anti-TNF-alpha drugs: literature review. Iran Red Crescent Med J 2016;18:e27756.",
                        "@id": "181",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "How should we manage latent tuberculosis infection in patients receiving anti-TNF-alpha drugs: literature review"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85006971144",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "18"},
                                "pagerange": {"@first": "e27756"}
                            },
                            "ref-text": "181",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "HR",
                                    "@_fa": "true",
                                    "ce:surname": "Naderi",
                                    "ce:indexed-name": "Naderi HR"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "F",
                                    "@_fa": "true",
                                    "ce:surname": "Sheybani",
                                    "ce:indexed-name": "Sheybani F"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Rezaei Pajand",
                                    "ce:indexed-name": "Rezaei Pajand S."
                                }
                            ]},
                            "ref-sourcetitle": "Iran Red Crescent Med J"
                        },
                        "ce:source-text": "181. Naderi HR, Sheybani F, Rezaei Pajand S. How should we manage latent tuberculosis infection in patients receiving anti-TNF-alpha drugs: literature review. Iran Red Crescent Med J 2016;18:e27756."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "182. Demir S, Sadi Aykan F, Oztuna D. Latent tuberculosis treatment results in patients that taken TNF-alpha blockers at Ankara Numune Training and Research Hospital Chest Diseases Clinic for last 8 years (2006-2013). Tuberk Toraks 2014;62: 286-290.",
                        "@id": "182",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Latent tuberculosis treatment results in patients that taken TNF-alpha blockers at Ankara Numune Training and Research Hospital Chest Diseases Clinic for last 8 years (2006-2013)"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84919761483",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "62"},
                                "pagerange": {
                                    "@first": "286",
                                    "@last": "290"
                                }
                            },
                            "ref-text": "182",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Demir",
                                    "ce:indexed-name": "Demir S"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "F",
                                    "@_fa": "true",
                                    "ce:surname": "Sadi Aykan",
                                    "ce:indexed-name": "Sadi Aykan F"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Oztuna",
                                    "ce:indexed-name": "Oztuna D."
                                }
                            ]},
                            "ref-sourcetitle": "Tuberk Toraks"
                        },
                        "ce:source-text": "182. Demir S, Sadi Aykan F, Oztuna D. Latent tuberculosis treatment results in patients that taken TNF-alpha blockers at Ankara Numune Training and Research Hospital Chest Diseases Clinic for last 8 years (2006-2013). Tuberk Toraks 2014;62: 286-290."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Seoul",
            "@id": "60006240",
            "affilname": "University of Ulsan College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006240",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Singapore City",
            "@id": "60095034",
            "affilname": "Duke-NUS Medical School",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60095034",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Shanghai",
            "@id": "60082819",
            "affilname": "Shanghai Jiao Tong University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60082819",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Chengdu",
            "@id": "60073509",
            "affilname": "West China School of Medicine/West China Hospital of Sichuan University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073509",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Taipei",
            "@id": "60073385",
            "affilname": "National Taiwan University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073385",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Manila",
            "@id": "60071488",
            "affilname": "University of Santo Tomas, Manila",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071488",
            "affiliation-country": "Philippines"
        },
        {
            "affiliation-city": "Kelaniya",
            "@id": "60071104",
            "affilname": "University of Kelaniya",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071104",
            "affiliation-country": "Sri Lanka"
        },
        {
            "affiliation-city": "Central Jakarta",
            "@id": "60069378",
            "affilname": "Universitas Indonesia, RSUPN Dr. Cipto Mangunkusumo",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60069378",
            "affiliation-country": "Indonesia"
        },
        {
            "affiliation-city": "Depok",
            "@id": "60069377",
            "affilname": "Universitas Indonesia",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60069377",
            "affiliation-country": "Indonesia"
        },
        {
            "affiliation-city": "Singapore City",
            "@id": "60031325",
            "affilname": "National University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031325",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Sydney",
            "@id": "60029482",
            "affilname": "Concord Repatriation General Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029482",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Kuala Lumpur",
            "@id": "60029157",
            "affilname": "Universiti Malaya",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029157",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Guangzhou",
            "@id": "60021182",
            "affilname": "Sun Yat-Sen University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021182",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Mitaka",
            "@id": "60019092",
            "affilname": "Kyorin University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60019092",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Singapore City",
            "@id": "60017958",
            "affilname": "Singapore General Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017958",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Suwon",
            "@id": "60016329",
            "affilname": "SKKU School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016329",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Hyderabad",
            "@id": "60016172",
            "affilname": "Asian Institute of Gastroenterology India",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016172",
            "affiliation-country": "India"
        },
        {
            "affiliation-city": "Kuala Lumpur",
            "@id": "60013665",
            "affilname": "University of Malaya Medical Centre",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013665",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Kaohsiung",
            "@id": "60012256",
            "affilname": "Kaohsiung Medical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012256",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "New Delhi",
            "@id": "60009790",
            "affilname": "All India Institute of Medical Sciences, New Delhi",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009790",
            "affiliation-country": "India"
        },
        {
            "affiliation-city": "Singapore City",
            "@id": "60007189",
            "affilname": "Gleneagles Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007189",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Hong Kong",
            "@id": "60006541",
            "affilname": "The University of Hong Kong",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006541",
            "affiliation-country": "Hong Kong"
        },
        {
            "affiliation-city": "Hong Kong",
            "@id": "60002798",
            "affilname": "Chinese University of Hong Kong",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002798",
            "affiliation-country": "Hong Kong"
        },
        {
            "affiliation-city": "Kubang Kerian",
            "@id": "60002512",
            "affilname": "School of Medical Sciences, Universiti Sains Malaysia",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002512",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Singapore City",
            "@id": "60002481",
            "affilname": "Tan Tock Seng Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002481",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Christchurch",
            "@id": "60002143",
            "affilname": "University of Otago, Christchurch",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002143",
            "affiliation-country": "New Zealand"
        },
        {
            "affiliation-city": "Bangi",
            "@id": "60001821",
            "affilname": "Universiti Kebangsaan Malaysia",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60001821",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "122799584",
            "affilname": "Bumrungrad International University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/122799584",
            "affiliation-country": "Thailand"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85074733082",
        "dc:description": "This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The Asia-Pacific Working Group on inflammatory bowel disease (IBD) was established in Cebu, Philippines, under the auspices of the Asian Pacific Association of Gastroenterology with the goal of improving IBD care in Asia. This consensus is carried out in collaboration with Asian Organization for Crohn's and Colitis. With biologic agents and biosimilars becoming more established, it is necessary to conduct a review on existing literature and establish a consensus on when and how to introduce biologic agents and biosimilars in the conjunction with conventional treatments for ulcerative colitis (UC) and Crohn's disease (CD) in Asia. These statements also address how pharmacogenetics influence the treatments of UC and CD and provide guidance on response monitoring and strategies to restore loss of response. Finally, the review includes statements on how to manage treatment alongside possible hepatitis B and tuberculosis infections, both common in Asia. These statements have been prepared and voted upon by members of IBD workgroup employing the modified Delphi process. These statements do not intend to be all-encompassing and future revisions are likely as new data continue to emerge. (Intest Res 2019;17:285-310)",
        "prism:coverDate": "2019-01-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85074733082",
        "dc:creator": {"author": [{
            "ce:given-name": "Choon Jin",
            "preferred-name": {
                "ce:given-name": "Choon Jin",
                "ce:initials": "C.J.",
                "ce:surname": "Ooi",
                "ce:indexed-name": "Ooi C.J."
            },
            "@seq": "1",
            "ce:initials": "C.J.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60017958",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017958"
                },
                {
                    "@id": "60095034",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60095034"
                }
            ],
            "ce:surname": "Ooi",
            "@auid": "57200088391",
            "author-url": "https://api.elsevier.com/content/author/author_id/57200088391",
            "ce:indexed-name": "Ooi C.J."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85074733082"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85074733082&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85074733082&origin=inward"
            }
        ],
        "source-id": "21100788713",
        "citedby-count": "64",
        "prism:volume": "17",
        "subtype": "ar",
        "dc:title": "Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia",
        "openaccess": "1",
        "prism:issn": "22881956 15989100",
        "publishercopyright": " 2019. Korean Association for the Study of Intestinal Diseases. All Rights Reserved.",
        "prism:issueIdentifier": "3",
        "subtypeDescription": "Article",
        "prism:publicationName": "Intestinal Research",
        "prism:pageRange": "285-310",
        "prism:endingPage": "310",
        "openaccessFlag": "true",
        "prism:doi": "10.5217/ir.2019.00026",
        "prism:startingPage": "285",
        "dc:identifier": "SCOPUS_ID:85074733082",
        "dc:publisher": "Korean Association for the Study of Intestinal Diseases"
    },
    "idxterms": null,
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "Adalimumab"
        },
        {
            "@_fa": "true",
            "$": "Colitis"
        },
        {
            "@_fa": "true",
            "$": "Crohn disease"
        },
        {
            "@_fa": "true",
            "$": "Inflammatory bowel disease"
        },
        {
            "@_fa": "true",
            "$": "Infliximab"
        },
        {
            "@_fa": "true",
            "$": "ulcerative"
        }
    ]},
    "subject-areas": {"subject-area": [{
        "@_fa": "true",
        "$": "Gastroenterology",
        "@code": "2715",
        "@abbrev": "MEDI"
    }]},
    "authors": {"author": [
        {
            "ce:given-name": "Choon Jin",
            "preferred-name": {
                "ce:given-name": "Choon Jin",
                "ce:initials": "C.J.",
                "ce:surname": "Ooi",
                "ce:indexed-name": "Ooi C.J."
            },
            "@seq": "1",
            "ce:initials": "C.J.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60017958",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017958"
                },
                {
                    "@id": "60095034",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60095034"
                }
            ],
            "ce:surname": "Ooi",
            "@auid": "57200088391",
            "author-url": "https://api.elsevier.com/content/author/author_id/57200088391",
            "ce:indexed-name": "Ooi C.J."
        },
        {
            "ce:given-name": "Ida",
            "preferred-name": {
                "ce:given-name": "Ida",
                "ce:initials": "I.",
                "ce:surname": "Hilmi",
                "ce:indexed-name": "Hilmi I."
            },
            "@seq": "2",
            "ce:initials": "I.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60013665",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013665"
            },
            "ce:surname": "Hilmi",
            "@auid": "12780634900",
            "author-url": "https://api.elsevier.com/content/author/author_id/12780634900",
            "ce:indexed-name": "Hilmi I."
        },
        {
            "ce:given-name": "Rupa",
            "preferred-name": {
                "ce:given-name": "Rupa",
                "ce:initials": "R.",
                "ce:surname": "Banerjee",
                "ce:indexed-name": "Banerjee R."
            },
            "@seq": "3",
            "ce:initials": "R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60016172",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016172"
            },
            "ce:surname": "Banerjee",
            "@auid": "8976969300",
            "author-url": "https://api.elsevier.com/content/author/author_id/8976969300",
            "ce:indexed-name": "Banerjee R."
        },
        {
            "ce:given-name": "Sai Wei",
            "preferred-name": {
                "ce:given-name": "Sai Wei",
                "ce:initials": "S.W.",
                "ce:surname": "Chuah",
                "ce:indexed-name": "Chuah S.W."
            },
            "@seq": "4",
            "ce:initials": "S.W.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60007189",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007189"
            },
            "ce:surname": "Chuah",
            "@auid": "55659296200",
            "author-url": "https://api.elsevier.com/content/author/author_id/55659296200",
            "ce:indexed-name": "Chuah S.W."
        },
        {
            "ce:given-name": "Siew Chien",
            "preferred-name": {
                "ce:given-name": "Siew Chien",
                "ce:initials": "S.C.",
                "ce:surname": "Ng",
                "ce:indexed-name": "Ng S.C."
            },
            "@seq": "5",
            "ce:initials": "S.C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002798",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002798"
            },
            "ce:surname": "Ng",
            "@auid": "16319816500",
            "author-url": "https://api.elsevier.com/content/author/author_id/16319816500",
            "ce:indexed-name": "Ng S.C."
        },
        {
            "ce:given-name": "Shu Chen",
            "preferred-name": {
                "ce:given-name": "Shu Chen",
                "ce:initials": "S.C.",
                "ce:surname": "Wei",
                "ce:indexed-name": "Wei S.C."
            },
            "@seq": "6",
            "ce:initials": "S.C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60073385",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073385"
            },
            "ce:surname": "Wei",
            "@auid": "7401765271",
            "author-url": "https://api.elsevier.com/content/author/author_id/7401765271",
            "ce:indexed-name": "Wei S.C."
        },
        {
            "ce:given-name": "Govind K",
            "preferred-name": {
                "ce:given-name": "Govind K.",
                "ce:initials": "G.K.",
                "ce:surname": "Makharia",
                "ce:indexed-name": "Makharia G.K."
            },
            "@seq": "7",
            "ce:initials": "G.K.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60009790",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009790"
            },
            "ce:surname": "Makharia",
            "@auid": "6701885809",
            "author-url": "https://api.elsevier.com/content/author/author_id/6701885809",
            "ce:indexed-name": "Makharia G.K."
        },
        {
            "ce:given-name": "Pises",
            "preferred-name": {
                "ce:given-name": "Pises",
                "ce:initials": "P.",
                "ce:surname": "Pisespongsa",
                "ce:indexed-name": "Pisespongsa P."
            },
            "@seq": "8",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "122799584",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/122799584"
            },
            "ce:surname": "Pisespongsa",
            "@auid": "15846592300",
            "author-url": "https://api.elsevier.com/content/author/author_id/15846592300",
            "ce:indexed-name": "Pisespongsa P."
        },
        {
            "ce:given-name": "Min Hu",
            "preferred-name": {
                "ce:given-name": "Min Hu",
                "ce:initials": "M.H.",
                "ce:surname": "Chen",
                "ce:indexed-name": "Chen M.H."
            },
            "@seq": "9",
            "ce:initials": "M.H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60021182",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021182"
            },
            "ce:surname": "Chen",
            "@auid": "8642044500",
            "author-url": "https://api.elsevier.com/content/author/author_id/8642044500",
            "ce:indexed-name": "Chen M.H."
        },
        {
            "ce:given-name": "Zhi Hua",
            "preferred-name": {
                "ce:given-name": "Zhi Hua",
                "ce:initials": "Z.H.",
                "ce:surname": "Ran",
                "ce:indexed-name": "Ran Z.H."
            },
            "@seq": "10",
            "ce:initials": "Z.H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60082819",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60082819"
            },
            "ce:surname": "Ran",
            "@auid": "7003301114",
            "author-url": "https://api.elsevier.com/content/author/author_id/7003301114",
            "ce:indexed-name": "Ran Z.H."
        },
        {
            "ce:given-name": "Byong Duk",
            "preferred-name": {
                "ce:given-name": "Byong Duk",
                "ce:initials": "B.D.",
                "ce:surname": "Ye",
                "ce:indexed-name": "Ye B.D."
            },
            "@seq": "11",
            "ce:initials": "B.D.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60006240",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006240"
            },
            "ce:surname": "Ye",
            "@auid": "14069472300",
            "author-url": "https://api.elsevier.com/content/author/author_id/14069472300",
            "ce:indexed-name": "Ye B.D."
        },
        {
            "ce:given-name": "Dong Il",
            "preferred-name": {
                "ce:given-name": "Dong Il",
                "ce:initials": "D.I.",
                "ce:surname": "Park",
                "ce:indexed-name": "Park D.I."
            },
            "@seq": "12",
            "ce:initials": "D.I.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60016329",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016329"
            },
            "ce:surname": "Park",
            "@auid": "56524839700",
            "author-url": "https://api.elsevier.com/content/author/author_id/56524839700",
            "ce:indexed-name": "Park D.I."
        },
        {
            "ce:given-name": "Khoon Lin",
            "preferred-name": {
                "ce:given-name": "Khoon Lin",
                "ce:initials": "K.L.",
                "ce:surname": "Ling",
                "ce:indexed-name": "Ling K.L."
            },
            "@seq": "13",
            "ce:initials": "K.L.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60095034",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60095034"
            },
            "ce:surname": "Ling",
            "@auid": "7102763009",
            "author-url": "https://api.elsevier.com/content/author/author_id/7102763009",
            "ce:indexed-name": "Ling K.L."
        },
        {
            "ce:given-name": "David",
            "preferred-name": {
                "ce:given-name": "David",
                "ce:initials": "D.",
                "ce:surname": "Ong",
                "ce:indexed-name": "Ong D."
            },
            "@seq": "14",
            "ce:initials": "D.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60031325",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031325"
            },
            "ce:surname": "Ong",
            "@auid": "56013316700",
            "author-url": "https://api.elsevier.com/content/author/author_id/56013316700",
            "ce:indexed-name": "Ong D."
        },
        {
            "ce:given-name": "Vineet",
            "preferred-name": {
                "ce:given-name": "Vineet",
                "ce:initials": "V.",
                "ce:surname": "Ahuja",
                "ce:indexed-name": "Ahuja V."
            },
            "@seq": "15",
            "ce:initials": "V.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60073385",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073385"
            },
            "ce:surname": "Ahuja",
            "@auid": "24176922100",
            "author-url": "https://api.elsevier.com/content/author/author_id/24176922100",
            "ce:indexed-name": "Ahuja V."
        },
        {
            "ce:given-name": "Khean Lee",
            "preferred-name": {
                "ce:given-name": "Khean Lee",
                "ce:initials": "K.L.",
                "ce:surname": "Goh",
                "ce:indexed-name": "Goh K.L."
            },
            "@seq": "16",
            "ce:initials": "K.L.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60029157",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029157"
            },
            "ce:surname": "Goh",
            "@auid": "7201860992",
            "author-url": "https://api.elsevier.com/content/author/author_id/7201860992",
            "ce:indexed-name": "Goh K.L."
        },
        {
            "ce:given-name": "Jose",
            "preferred-name": {
                "ce:given-name": "Jose",
                "ce:initials": "J.",
                "ce:surname": "Sollano",
                "ce:indexed-name": "Sollano J."
            },
            "@seq": "17",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60071488",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071488"
            },
            "ce:surname": "Sollano",
            "@auid": "6602099153",
            "author-url": "https://api.elsevier.com/content/author/author_id/6602099153",
            "ce:indexed-name": "Sollano J."
        },
        {
            "ce:given-name": "Wee Chian",
            "preferred-name": {
                "ce:given-name": "Wee Chian",
                "ce:initials": "W.C.",
                "ce:surname": "Lim",
                "ce:indexed-name": "Lim W.C."
            },
            "@seq": "18",
            "ce:initials": "W.C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002481",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002481"
            },
            "ce:surname": "Lim",
            "@auid": "8752049200",
            "author-url": "https://api.elsevier.com/content/author/author_id/8752049200",
            "ce:indexed-name": "Lim W.C."
        },
        {
            "ce:given-name": "Wai Keung",
            "preferred-name": {
                "ce:given-name": "Wai Keung",
                "ce:initials": "W.K.",
                "ce:surname": "Leung",
                "ce:indexed-name": "Leung W.K."
            },
            "@seq": "19",
            "ce:initials": "W.K.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60006541",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006541"
            },
            "ce:surname": "Leung",
            "@auid": "57188802557",
            "author-url": "https://api.elsevier.com/content/author/author_id/57188802557",
            "ce:indexed-name": "Leung W.K."
        },
        {
            "ce:given-name": "Raja Affendi Raja",
            "preferred-name": {
                "ce:given-name": "Raja Affendi Raja",
                "ce:initials": "R.A.R.",
                "ce:surname": "Ali",
                "ce:indexed-name": "Ali R.A.R."
            },
            "@seq": "20",
            "ce:initials": "R.A.R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60001821",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60001821"
            },
            "ce:surname": "Ali",
            "@auid": "40762153700",
            "author-url": "https://api.elsevier.com/content/author/author_id/40762153700",
            "ce:indexed-name": "Ali R.A.R."
        },
        {
            "ce:given-name": "Deng Chyang",
            "preferred-name": {
                "ce:given-name": "Deng Chyang",
                "ce:initials": "D.C.",
                "ce:surname": "Wu",
                "ce:indexed-name": "Wu D.C."
            },
            "@seq": "21",
            "ce:initials": "D.C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60012256",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012256"
            },
            "ce:surname": "Wu",
            "@auid": "57154894800",
            "author-url": "https://api.elsevier.com/content/author/author_id/57154894800",
            "ce:indexed-name": "Wu D.C."
        },
        {
            "ce:given-name": "Evan",
            "preferred-name": {
                "ce:given-name": "Evan",
                "ce:initials": "E.",
                "ce:surname": "Ong",
                "ce:indexed-name": "Ong E."
            },
            "@seq": "22",
            "ce:initials": "E.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60071488",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071488"
            },
            "ce:surname": "Ong",
            "@auid": "57220521066",
            "author-url": "https://api.elsevier.com/content/author/author_id/57220521066",
            "ce:indexed-name": "Ong E."
        },
        {
            "ce:given-name": "Nazri",
            "preferred-name": {
                "ce:given-name": "Nazri",
                "ce:initials": "N.",
                "ce:surname": "Mustaffa",
                "ce:indexed-name": "Mustaffa N."
            },
            "@seq": "23",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002512",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002512"
            },
            "ce:surname": "Mustaffa",
            "@auid": "37108082500",
            "author-url": "https://api.elsevier.com/content/author/author_id/37108082500",
            "ce:indexed-name": "Mustaffa N."
        },
        {
            "ce:given-name": "Julajak",
            "preferred-name": {
                "ce:given-name": "Julajak",
                "ce:initials": "J.",
                "ce:surname": "Limsrivilai",
                "ce:indexed-name": "Limsrivilai J."
            },
            "@seq": "24",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60199575",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575"
            },
            "ce:surname": "Limsrivilai",
            "@auid": "12772292800",
            "author-url": "https://api.elsevier.com/content/author/author_id/12772292800",
            "ce:indexed-name": "Limsrivilai J."
        },
        {
            "ce:given-name": "Tadakazu",
            "preferred-name": {
                "ce:given-name": "Tadakazu",
                "ce:initials": "T.",
                "ce:surname": "Hisamatsu",
                "ce:indexed-name": "Hisamatsu T."
            },
            "@seq": "25",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60019092",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60019092"
            },
            "ce:surname": "Hisamatsu",
            "@auid": "7005662302",
            "author-url": "https://api.elsevier.com/content/author/author_id/7005662302",
            "ce:indexed-name": "Hisamatsu T."
        },
        {
            "ce:given-name": "Suk Kyun",
            "preferred-name": {
                "ce:given-name": "Suk Kyun",
                "ce:initials": "S.K.",
                "ce:surname": "Yang",
                "ce:indexed-name": "Yang S.K."
            },
            "@seq": "26",
            "ce:initials": "S.K.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60006240",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006240"
            },
            "ce:surname": "Yang",
            "@auid": "7406948347",
            "author-url": "https://api.elsevier.com/content/author/author_id/7406948347",
            "ce:indexed-name": "Yang S.K."
        },
        {
            "ce:given-name": "Qin",
            "preferred-name": {
                "ce:given-name": "Qin",
                "ce:initials": "Q.",
                "ce:surname": "Ouyang",
                "ce:indexed-name": "Ouyang Q."
            },
            "@seq": "27",
            "ce:initials": "Q.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60073509",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073509"
            },
            "ce:surname": "Ouyang",
            "@auid": "55626361500",
            "author-url": "https://api.elsevier.com/content/author/author_id/55626361500",
            "ce:indexed-name": "Ouyang Q."
        },
        {
            "ce:given-name": "Richard",
            "preferred-name": {
                "ce:given-name": "Richard",
                "ce:initials": "R.",
                "ce:surname": "Geary",
                "ce:indexed-name": "Geary R."
            },
            "@seq": "28",
            "ce:initials": "R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002143",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002143"
            },
            "ce:surname": "Geary",
            "@auid": "57209651723",
            "author-url": "https://api.elsevier.com/content/author/author_id/57209651723",
            "ce:indexed-name": "Geary R."
        },
        {
            "ce:given-name": "Janaka H",
            "preferred-name": {
                "ce:given-name": "Janaka H.",
                "ce:initials": "J.H.",
                "ce:surname": "De Silva",
                "ce:indexed-name": "De Silva J.H."
            },
            "@seq": "29",
            "ce:initials": "J.H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60071104",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071104"
            },
            "ce:surname": "De Silva",
            "@auid": "7005406595",
            "author-url": "https://api.elsevier.com/content/author/author_id/7005406595",
            "ce:indexed-name": "De Silva J.H."
        },
        {
            "ce:given-name": "Rungsun",
            "preferred-name": {
                "ce:given-name": "Rungsun",
                "ce:initials": "R.",
                "ce:surname": "Rerknimitr",
                "ce:indexed-name": "Rerknimitr R."
            },
            "@seq": "30",
            "ce:initials": "R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Rerknimitr",
            "@auid": "6603607086",
            "author-url": "https://api.elsevier.com/content/author/author_id/6603607086",
            "ce:indexed-name": "Rerknimitr R."
        },
        {
            "ce:given-name": "Marcellus",
            "preferred-name": {
                "ce:given-name": "Marcellus",
                "ce:initials": "M.",
                "ce:surname": "Simadibrata",
                "ce:indexed-name": "Simadibrata M."
            },
            "@seq": "31",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60069377",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60069377"
            },
            "ce:surname": "Simadibrata",
            "@auid": "23499598400",
            "author-url": "https://api.elsevier.com/content/author/author_id/23499598400",
            "ce:indexed-name": "Simadibrata M."
        },
        {
            "ce:given-name": "Murdani",
            "preferred-name": {
                "ce:given-name": "Murdani",
                "ce:initials": "M.",
                "ce:surname": "Abdullah",
                "ce:indexed-name": "Abdullah M."
            },
            "@seq": "32",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60069378",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60069378"
            },
            "ce:surname": "Abdullah",
            "@auid": "7103393434",
            "author-url": "https://api.elsevier.com/content/author/author_id/7103393434",
            "ce:indexed-name": "Abdullah M."
        },
        {
            "ce:given-name": "Rupert WL",
            "preferred-name": {
                "ce:given-name": "Rupert WL",
                "ce:initials": "R.W.",
                "ce:surname": "Leong",
                "ce:indexed-name": "Leong R.W."
            },
            "@seq": "33",
            "ce:initials": "R.W.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60029482",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029482"
            },
            "ce:surname": "Leong",
            "@auid": "57218574553",
            "author-url": "https://api.elsevier.com/content/author/author_id/57218574553",
            "ce:indexed-name": "Leong R.W."
        }
    ]}
}}